Voya Financial (VOYA) 10-Q 6 Nov 24 2024 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2024	Nov. 01, 2024
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	001-35897
Entity Registrant Name	Voya Financial, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	52-1222820
Entity Address, Address Line One	230 Park Avenue
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10169
City Area Code	212
Local Phone Number	309-8200
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		96,218,368
Entity Central Index Key	0001535929
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Amendment Flag	false
Common Stock, $.01 par value
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, $.01 par value
Trading Symbol	VOYA
Security Exchange Name	NYSE
Depositary Shares, each representing a 1/40th
Entity Information [Line Items]
Title of 12(b) Security	Depositary Shares, each representing a 1/40th
Trading Symbol	VOYAPrB
Security Exchange Name	NYSE

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Investments:
Short-term investments under securities loan agreements, including collateral delivered	$ 1,262	$ 1,015
Accrued investment income	416	411
Premium receivable and reinsurance recoverable (net of allowance for credit losses of $20 and $28 as of 2024 and 2023, respectively)	11,486	11,982
Deferred policy acquisition costs and Value of business acquired	2,173	2,250
Deferred income taxes	1,955	2,160
Goodwill	748	748
Other intangibles, net	862	857
Assets held in separate accounts	103,532	93,133
Total assets	166,933	157,085
Liabilities:
Future policy benefits	9,543	9,560
Contract owner account balances	37,513	39,174
Payables under securities loan and repurchase agreements, including collateral held	1,368	1,121
Short-term debt	397	1
Long-term debt	2,103	2,097
Derivatives	359	371
Liabilities related to separate accounts	103,532	93,133
Total liabilities	160,351	151,032
Commitments and Contingencies (Note 17)
Mezzanine equity:
Redeemable noncontrolling interest	198	175
Shareholders' equity:
Preferred stock ($0.01 par value per share; $625 aggregate liquidation preference as of 2024 and 2023)	0	0
Common stock ($0.01 par value per share; 900,000,000 shares authorized; 105,429,736 and 103,584,699 shares issued as of 2024 and 2023, respectively; 97,141,793 and 102,854,569 shares outstanding as of 2024 and 2023, respectively)	1	1
Treasury stock (at cost; 8,287,943 and 730,130 shares as of 2024 and 2023, respectively)	(604)	(56)
Additional paid-in capital	6,227	6,143
Accumulated other comprehensive income (loss)	(1,812)	(2,400)
Retained earnings (deficit):
Unappropriated	907	505
Total Voya Financial, Inc. shareholders' equity	4,719	4,193
Noncontrolling interest	1,665	1,685
Total shareholders' equity	6,384	5,878
Total liabilities, mezzanine equity and shareholders' equity	166,933	157,085
Excluding consolidated VIEs
Investments:
Fixed maturities, available-for-sale, at fair value (amortized cost of $26,668 and $27,690 as of 2024 and 2023, respectively; net of allowance for credit losses of $32 and $17 as of 2024 and 2023, respectively)	25,074	25,375
Fixed maturities, at fair value using the fair value option	2,009	2,076
Equity securities, at fair value	251	236
Short-term investments	103	213
Mortgage loans on real estate (net of allowance for credit losses of $24 and $26 as of 2024 and 2023, respectively)	4,822	5,192
Policy loans	345	352
Limited partnerships/corporations	1,736	1,621
Derivatives	225	311
Other investments	66	64
Securities pledged (amortized cost of $1,543 and $1,232 as of 2024 and 2023, respectively)	1,463	1,160
Total investments	36,094	36,600
Cash and cash equivalents	1,457	937
Other assets	2,295	2,372
Corporate loans, at fair value using the fair value option	4,822	5,192
Liabilities:
Other liabilities	2,935	2,956
VIEs
Investments:
Mortgage loans on real estate (net of allowance for credit losses of $24 and $26 as of 2024 and 2023, respectively)	1,345	1,404
Limited partnerships/corporations	3,033	2,861
Cash and cash equivalents	88	181
Other assets	187	174
Corporate loans, at fair value using the fair value option	1,345	1,404
Liabilities:
Other liabilities	1,478	1,287
Collateralized loan obligations notes, at fair value using the fair value option	$ 1,123	$ 1,332

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Fixed maturities, Amortized Cost	$ 26,668	$ 27,690
Fixed maturities, allowance for credit losses	32	17
Mortgage loans, allowance for credit losses	24	26
Securities pledged, amortized cost	1,543	1,232
Premium receivable and reinsurance recoverable, allowance for credit losses	20	28
Other assets, allowance for credit losses	$ 1	$ 1
Preferred stock, par value (usd per share)	$ 0.01	$ 0.01
Preferred stock, aggregate liquidation preference	$ 625	$ 625
Common stock, par value (usd per share)	$ 0.01	$ 0.01
Common stock, shares outstanding (in shares)	900,000,000	900,000,000
Common stock, shares issued (in shares)	105,429,736	103,584,699
Common stock, shares outstanding (in shares)	97,141,793	102,854,569
Treasury stock (in shares)	8,287,943	730,130

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues:
Net investment income	$ 506	$ 547	$ 1,553	$ 1,637
Fee income	540	489	1,570	1,427
Premiums	796	682	2,386	2,044
Net gains (losses)	(14)	(7)	25	(79)
Other revenue	103	81	289	245
Income (loss) related to CIEs:
Net investment income	25	31	217	255
Total revenues	1,956	1,823	6,040	5,529
Benefits and expenses:
Policyholder benefits	681	471	1,884	1,419
Interest credited to contract owner account balances	257	328	748	813
Operating expenses	775	717	2,326	2,323
Net amortization of Deferred policy acquisition costs and Value of business acquired	55	57	167	173
Interest expense	29	31	89	102
Operating expenses related to CIEs:
Interest expense	40	45	135	116
Other expense	3	2	12	7
Total benefits and expenses	1,840	1,651	5,361	4,953
Income (loss) before income taxes	116	172	679	576
Income tax expense (benefit)	18	(74)	58	(34)
Net income (loss)	98	246	621	610
Less: Net income (loss) attributable to noncontrolling interest	(16)	(16)	51	107
Net income (loss) available to Voya Financial, Inc.	114	262	570	503
Less: Preferred stock dividends	16	14	37	32
Net income (loss) available to Voya Financial, Inc.'s common shareholders	$ 98	$ 248	$ 533	$ 471
Net income (loss) available to Voya Financial, Inc.'s common shareholders per common share:
Basic (usd per share)	$ 1	$ 2.35	$ 5.32	$ 4.62
Diluted (usd per share)	$ 0.98	$ 2.29	$ 5.20	$ 4.31

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 98	$ 246	$ 621	$ 610
Other comprehensive income (loss), before tax:
Change in current discount rate	(20)	(23)	52	7
Unrealized gains (losses) on securities	995	(916)	692	(612)
Other comprehensive income (loss), before tax	975	(939)	744	(605)
Income tax expense (benefit) related to items of other comprehensive income (loss)	204	(197)	156	(127)
Other comprehensive income (loss), after tax	771	(742)	588	(478)
Comprehensive income (loss)	869	(496)	1,209	132
Less: Comprehensive income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest	(16)	(16)	51	107
Comprehensive income (loss) attributable to Voya Financial, Inc.	$ 885	$ (480)	$ 1,158	$ 25

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Millions	Total	Preferred Stock	Common Stock	Total Voya Financial, Inc. Shareholders' Equity	Total Voya Financial, Inc. Shareholders' Equity Preferred Stock	Total Voya Financial, Inc. Shareholders' Equity Common Stock	Common Stock	Treasury Stock	Additional Paid-In Capital	Additional Paid-In Capital Preferred Stock	Additional Paid-In Capital Common Stock	Accumulated Other Comprehensive Income (Loss)	Retained Earnings (Deficit), Unappropriated	Noncontrolling Interest
Beginning balance at Dec. 31, 2022	$ 4,831			$ 3,349			$ 1	$ (39)	$ 6,643			$ (3,055)	$ (201)	$ 1,482
Comprehensive income (loss):
Net income (loss)	590			503									503	87
Other comprehensive income (loss), after tax	(478)			(478)								(478)
Total comprehensive income (loss)	132			25
Total comprehensive income (loss)	107													87
Total comprehensive income (loss)	112
Common stock acquired - Share repurchase	(216)			(216)				(216)
Dividends		$ (32)	$ (83)		$ (32)	$ (83)				$ (32)	$ (83)
Share-based compensation	84			84				(52)	136
Contributions from (Distributions to) noncontrolling interest, net	90													90
Ending Balance at Sep. 30, 2023	4,786			3,127			1	(307)	6,664			(3,533)	302	1,659
Mezzanine Equity: Redeemable Noncontrolling Interest, Beginning Balance at Dec. 31, 2022	166
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income (loss)	20
Total comprehensive income (loss)	20
Contributions from (Distributions to) noncontrolling interest, net	(13)
Mezzanine Equity: Redeemable Noncontrolling Interest, Ending Balance at Sep. 30, 2023	173
Beginning balance at Jun. 30, 2023	5,357			3,697			1	(248)	6,695			(2,791)	40	1,660
Comprehensive income (loss):
Net income (loss)	237			262									262	(25)
Other comprehensive income (loss), after tax	(742)			(742)								(742)
Total comprehensive income (loss)	(496)			(480)
Total comprehensive income (loss)	(16)													(25)
Total comprehensive income (loss)	(505)
Common stock acquired - Share repurchase	(54)			(54)				(54)
Dividends		$ (14)	$ (42)		$ (14)	$ (42)				$ (14)	$ (42)
Share-based compensation	20			20				(5)	25
Contributions from (Distributions to) noncontrolling interest, net	24			0										24
Ending Balance at Sep. 30, 2023	4,786			3,127			1	(307)	6,664			(3,533)	302	1,659
Mezzanine Equity: Redeemable Noncontrolling Interest, Beginning Balance at Jun. 30, 2023	171
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income (loss)	9
Total comprehensive income (loss)	9
Contributions from (Distributions to) noncontrolling interest, net	(7)
Mezzanine Equity: Redeemable Noncontrolling Interest, Ending Balance at Sep. 30, 2023	173
Beginning balance at Dec. 31, 2023	5,878			4,193			1	(56)	6,143			(2,400)	505	1,685
Comprehensive income (loss):
Net income (loss)	588			570									570	18
Other comprehensive income (loss), after tax	588			588								588
Total comprehensive income (loss)	1,209			1,158
Total comprehensive income (loss)	51													18
Total comprehensive income (loss)	1,176
Net consolidations (deconsolidations) of CIEs	(2)			0										(2)
Common stock issuance	6			6					6
Common stock acquired - Share repurchase	(520)			(520)				(500)	(20)
Dividends on preferred stock	(37)			(37)									(37)
Dividends on common stock	(125)			(125)									(125)
Share-based compensation	46			46				(48)	98				(4)
Contributions from (Distributions to) noncontrolling interest, net	(38)			(2)									(2)	(36)
Ending Balance at Sep. 30, 2024	6,384			4,719			1	(604)	6,227			(1,812)	907	1,665
Mezzanine Equity: Redeemable Noncontrolling Interest, Beginning Balance at Dec. 31, 2023	175
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income (loss)	33
Total comprehensive income (loss)	33
Contributions from (Distributions to) noncontrolling interest, net	(10)
Mezzanine Equity: Redeemable Noncontrolling Interest, Ending Balance at Sep. 30, 2024	198
Beginning balance at Jun. 30, 2024	5,686			4,043			1	(448)	6,218			(2,583)	855	1,643
Comprehensive income (loss):
Net income (loss)	84			114									114	(30)
Other comprehensive income (loss), after tax	771			771								771
Total comprehensive income (loss)	869			885
Total comprehensive income (loss)	(16)													(30)
Total comprehensive income (loss)	855
Common stock issuance	3			3					3
Common stock acquired - Share repurchase	(172)			(172)				(152)	(20)
Dividends on preferred stock	(16)			(16)									(16)
Dividends on common stock	(44)			(44)									(44)
Share-based compensation	20			20				(4)	26				(2)
Contributions from (Distributions to) noncontrolling interest, net	52			0										52
Ending Balance at Sep. 30, 2024	6,384			$ 4,719			$ 1	$ (604)	$ 6,227			$ (1,812)	$ 907	$ 1,665
Mezzanine Equity: Redeemable Noncontrolling Interest, Beginning Balance at Jun. 30, 2024	183
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income (loss)	14
Total comprehensive income (loss)	14
Contributions from (Distributions to) noncontrolling interest, net	1
Mezzanine Equity: Redeemable Noncontrolling Interest, Ending Balance at Sep. 30, 2024	$ 198

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash Flows from Operating Activities:
Net cash provided by operating activities	$ 1,266	$ 1,274
Proceeds from the sale, maturity, disposal or redemption of:
Fixed maturities	4,021	5,578
Equity securities	36	31
Mortgage loans on real estate	578	447
Limited partnerships/corporations	210	124
Acquisition of:
Fixed maturities	(3,306)	(3,655)
Equity securities	(59)	(25)
Mortgage loans on real estate	(242)	(376)
Limited partnerships/corporations	(290)	(131)
Short-term investments, net	111	60
Derivatives, net	116	54
Sales from CIEs	1,168	652
Purchases within CIEs	(1,925)	(780)
Collateral received (delivered), net	(2)	166
Receipts on deposit asset contracts	176	208
Payments for business acquisitions, net of cash acquired	0	(584)
Other, net	(88)	(70)
Net cash provided by (used in) investing activities	504	1,699
Cash Flows from Financing Activities:
Deposits received for investment contracts	2,231	1,718
Maturities and withdrawals from investment contracts	(4,301)	(4,460)
Proceeds from issuance of long-term debt, net	397	388
Repayments of long-term debt, including current maturities	0	(539)
Borrowings of CIEs	763	232
Repayments of borrowings of CIEs	(693)	(388)
Contributions from (distributions to) participants in CIEs, net	1,026	385
Proceeds from issuance of common stock, net	6	0
Common stock acquired - Share repurchase	(520)	(212)
Dividends paid on preferred stock	(37)	(32)
Dividends paid on common stock (including dividend equivalent payments of $3 and $2 as of 2024 and 2023, respectively)	(128)	(85)
Other, net	(87)	(70)
Net cash provided by (used in) financing activities	(1,343)	(3,063)
Net increase (decrease) in cash and cash equivalents, including cash in CIEs	427	(90)
Cash and cash equivalents, including cash in CIEs, beginning of period	1,118	1,007
Cash and cash equivalents, including cash in CIEs, end of period	1,545	$ 917
Total cash and cash equivalents, including cash in CIEs	1,545
Excluding consolidated VIEs
Cash and cash equivalents	1,457
VIEs
Cash and cash equivalents	$ 88

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Statement of Cash Flows [Abstract]
Dividends, Common Stock	$ 3	$ 2

Business, Basis of Presentation

Business, Basis of Presentation and Significant Accounting Policies	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Business Description and Basis of Presentation	Business, Basis of Presentation and Significant Accounting Policies Business Voya Financial, Inc., together with its subsidiaries (collectively, the "Company"), is a financial services organization that offers a broad range of retirement services, group insurance and supplemental health products, investment management services and mutual funds primarily in the United States. P roducts and services are provided by the Company through three segments: Wealth Solutions, Health Solutions and Investment Management . Activities not directly related to the Company's segments and certain run-off activities that are not meaningful to the Company's business strategy are included within Corporate. See the Segments Note to these Condensed Consolidated Financial Statements. On January 24, 2023, the Company acquired all outstanding shares of Benefitfocus, Inc. ("Benefitfocus"), pursuant to an agreement and plan of merger (the "Merger Agreement") entered into on November 1, 2022. The acquisition expands the Company’s capacity to meet the growing demand for comprehensive benefits and savings solutions and increases its ability to deliver innovative solutions for employers and health plans. The total purchase consideration for the acquisition was $595, of which $583 was paid in cash ($558 paid by the Company and $25 of the cash acquired was used to fund the transaction). Net assets acquired as part of this transaction included cash of $49, goodwill of $319, intangible assets of $275, deferred tax assets of $45 and assumed lease liabilities of $91. Intangible assets primarily include customer relationships of $190 with a useful life of 15 years, and software of $70 with a useful life of 5 years. On August 1, 2023, the Company acquired all remaining equity interest in VFI SLK Global Services Private Limited previously held by SLK Software Private Limited ("SLK") and renamed the entity as Voya Global Services Private Limited ("Voya India"). Voya India was a private limited company in India formed pursuant to a joint venture agreement between the Company and SLK on August 1, 2019, with the Company and SLK holding 49% and 51% of ownership shares, respectively. The purpose of Voya India is to provide technology and business operation services to the Company. As a result of the acquisition, Voya India has become a wholly owned subsidiary of the Company and provides the Company with improved strategic and operational flexibility. As part of the purchase consideration, an upfront payment of approximately $53 was made at closing. Net assets acquired as part of this transaction included goodwill of $102. On September 11, 2024, the Company announced a definitive agreement to acquire the full-service retirement plan business of OneAmerica Financial. This acquisition will be accomplished through the purchase of legal entities and an indemnity reinsurance agreement. The acquisition adds scale and a broader set of capabilities to the Company's full-service business in Wealth Solutions, including incremental assets in attractive emerging and mid-market segments, employee stock ownership plan capabilities and new opportunities for distribution partnerships. The transaction, subject to customary closing conditions, is expected to close on January 1, 2025. The purchase consideration includes approximately $50 in cash to be paid at closing and contingent consideration of up to $160 based on plan persistency and transition incentives. Basis of Presentation The accompanying Condensed Consolidated Financial Statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") and are unaudited. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Those estimates are inherently subject to change and actual results could differ from those estimates, and the differences may be material to the Condensed Consolidated Financial Statements. The Condensed Consolidated Financial Statements include the accounts of Voya Financial, Inc. and its subsidiaries, as well as other voting interest entities ("VOEs") and variable interest entities ("VIEs") in which the Company has a controlling financial interest. See the Consolidated and Nonconsolidated Investment Entities Note to these Condensed Consolidated Financial Statements. Intercompany transactions and balances have been eliminated. Certain reclassifications have been made to prior-period amounts to conform to current-period reporting classifications. These reclassifications had no impact on Net income (loss) or Total shareholders’ equity. The accompanying Condensed Consolidated Financial Statements are unaudited and reflect adjustments (including normal, recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows for the interim periods presented in conformity with U.S. GAAP. Interim results are not necessarily indicative of full year performance. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and related notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2023. Adoption of New Pronouncements Equity Securities Subject to Contractual Sale Restrictions In June 2022, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2022-03, "Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions" ("ASU 2022-03"), which clarifies that contractual restrictions on equity security sales are not considered part of the security unit of account and, therefore, are not considered in measuring the fair value. In addition, the restrictions cannot be recognized and measured as separate units of account. Disclosures on such restrictions are also required. The provisions of ASU 2022-03 were adopted prospectively on January 1, 2024. The adoption did not have an impact on the Company's financial condition, results of operations, or cash flows. Future Adoption of Accounting Pronouncements Profits Interest and Similar Awards In March 2024, the FASB issued ASU 2024-01, "Compensation - Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards" ("ASU 2024-01"), which adds incremental clarity for how profits interests should be accounted. ASU 2024-01 is effective for annual periods beginning after December 15, 2024 and interim periods within those annual periods with early adoption permitted. The Company intends to adopt ASU 2024-01 as of January 1, 2025 on a prospective basis, and does not expect this ASU to have a material impact on the Company's financial condition, results of operations, or cash flows. Income Tax Disclosures In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures" ("ASU 2023-09"), which requires: • A tabular rate reconciliation of (1) reported income tax expense/benefit from continuing operations, to (2) the product of the income/loss from continuing operations before income taxes and the statutory federal income tax rate, using specific categories, as well as disclosure of certain reconciling items based on a 5% threshold. • Year-to-date net income taxes paid, disaggregated by federal, state, and foreign, as well as disaggregated information on net income taxes paid to an individual jurisdiction based on a 5% threshold. The amendments are effective for annual periods beginning after December 15, 2024 and should be applied prospectively, with retrospective application permitted. Early adoption is also permitted. The Company is currently in the process of determining the disclosures that may be required by the adoption of the provisions of ASU 2023-09. Segment Disclosures In November 2023, the FASB issued ASU 2023-07 "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" ("ASU 2023-07"), which requires all current annual disclosures about segment profit/loss and assets to be reported in interim periods, as well as enhanced disclosures about significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods beginning after December 15, 2024, and are required to be applied retrospectively. Restated prior period disclosures should be based on the significant segment expense categories disclosed in the period of adoption. The Company is currently in the process of determining the disclosures that may be required by the adoption of the provisions of ASU 2023-07. Climate Related Disclosures In March 2024, the SEC adopted a final rule under SEC Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors, to enhance and standardize climate-related disclosures. The rule will require companies to disclose material Scope 1 and Scope 2 greenhouse gas emissions; climate-related risks, governance, and oversight; and the financial effects of severe weather events and other natural conditions. These disclosures will be phased in beginning with the Company's annual report for the year ending December 31, 2025. While the implementation of this rule is pending the outcome of legal challenges, the Company is currently assessing the disclosures that may be required by the adoption in the event that the stay is lifted.

Investments (excluding Consolid

Investments (excluding Consolidated Investment Entities)	9 Months Ended
	Sep. 30, 2024
Investments, Debt and Equity Securities [Abstract]
Investments (excluding Consolidated Investment Entities)	50% - 60% >60% - 70% >70% - 80% >80% and above Total 2024 $ 129 $ 83 $ 15 $ — $ — $ 227 2023 117 222 39 — — 378 2022 231 295 105 — — 631 2021 238 196 115 — — 549 2020 186 86 — — — 272 Prior 2,570 185 16 — 18 2,789 Total $ 3,471 $ 1,067 $ 290 $ — $ 18 $ 4,846 As of December 31, 2023 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% -70% >70% - 80% >80% and above Total 2023 $ 150 $ 222 $ — $ — $ — $ 372 2022 252 326 73 — — 651 2021 244 214 209 — — 667 2020 168 112 — 10 16 306 2019 238 68 28 — — 334 Prior 2,586 280 4 — 18 2,888 Total $ 3,638 $ 1,222 $ 314 $ 10 $ 34 $ 5,218 The following tables present commercial mortgage loans by year of origination and DSC ratio as of the dates indicated. The information is updated as of September 30, 2024 and December 31, 2023, respectively. As of September 30, 2024 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2024 $ 96 $ 91 $ 33 $ 7 $ 227 2023 114 74 179 11 378 2022 271 76 84 200 631 2021 259 12 83 195 549 2020 209 19 20 24 272 Prior 2,109 228 350 102 2,789 Total $ 3,058 $ 500 $ 749 $ 539 $ 4,846 *No commercial mortgage loans were secured by land or construction loans As of December 31, 2023 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2023 $ 189 $ 116 $ 67 $ — $ 372 2022 204 68 192 187 651 2021 260 14 64 329 667 2020 211 24 21 50 306 2019 203 26 84 21 334 Prior 2,216 264 255 153 2,888 Total $ 3,283 $ 512 $ 683 $ 740 $ 5,218 *No commercial mortgage loans were secured by land or construction loans The following tables present the commercial mortgage loans by year of origination and U.S. region as of the dates indicated. The information is updated as of September 30, 2024 and December 31, 2023, respectively. As of September 30, 2024 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2024 $ 28 $ 80 $ 34 $ 44 $ 20 $ 1 $ 8 $ 3 $ 9 $ 227 2023 69 84 12 102 39 40 3 26 3 378 2022 140 132 49 98 94 92 5 1 20 631 2021 96 51 116 93 97 47 9 40 — 549 2020 62 134 17 10 12 15 — 7 15 272 Prior 721 657 665 178 228 136 58 117 29 2,789 Total $ 1,116 $ 1,138 $ 893 $ 525 $ 490 $ 331 $ 83 $ 194 $ 76 $ 4,846 As of December 31, 2023 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2023 $ 69 $ 77 $ 12 $ 101 $ 39 $ 42 $ 3 $ 26 $ 3 $ 372 2022 140 132 47 100 113 93 5 1 20 651 2021 96 63 124 148 111 75 9 40 1 667 2020 63 155 17 10 12 26 — 7 16 306 2019 53 100 10 74 45 4 14 13 21 334 Prior 734 605 765 189 214 171 47 144 19 2,888 Total $ 1,155 $ 1,132 $ 975 $ 622 $ 534 $ 411 $ 78 $ 231 $ 80 $ 5,218 The following tables present the commercial mortgage loans by year of origination and property type as of the dates indicated. The information is updated as of September 30, 2024 and December 31, 2023, respectively. As of September 30, 2024 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2024 $ 25 $ 130 $ 57 $ 15 $ — $ — $ — $ 227 2023 125 171 33 17 32 — — 378 2022 79 262 236 34 10 10 — 631 2021 35 131 245 111 — 18 9 549 2020 56 48 71 97 — — — 272 Prior 676 727 672 442 68 157 47 2,789 Total $ 996 $ 1,469 $ 1,314 $ 716 $ 110 $ 185 $ 56 $ 4,846 As of December 31, 2023 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2023 $ 125 $ 164 $ 33 $ 18 $ 32 $ — $ — $ 372 2022 79 263 255 34 10 10 — 651 2021 36 145 335 123 — 18 10 667 2020 57 49 72 128 — — — 306 2019 45 82 160 36 11 — — 334 Prior 780 755 618 463 60 163 49 2,888 Total $ 1,122 $ 1,458 $ 1,473 $ 802 $ 113 $ 191 $ 59 $ 5,218 The following table summarizes the activity in the allowance for losses for commercial mortgage loans for the periods indicated: September 30, 2024 December 31, 2023 Allowance for credit losses, beginning of period $ 26 $ 18 Credit losses on mortgage loans for which credit losses were not previously recorded — 2 Increase (decrease) on mortgage loans with an allowance recorded in a previous period 1 9 Provision for expected credit losses 27 29 Write-offs (3) (3) Recoveries of amounts previously written-off — — Allowance for credit losses, end of period $ 24 $ 26 The following table presents the payment status of commercial mortgage loans as of the dates indicated: September 30, 2024 December 31, 2023 Current $ 4,808 $ 5,202 30-59 days past due — — 60-89 days past due 12 — Greater than 90 days past due 26 16 Total $ 4,846 $ 5,218 Commercial mortgage loans are placed on non-accrual status when 90 days in arrears, when the Company has concerns regarding the collectability of future payments, or when a loan has matured without being paid off or extended. As of September 30, 2024 and December 31, 2023, the Company had $38 and $16, respectively, of commercial mortgage loans in non-accrual status. The amount of interest income recognized on loans in non-accrual status for the nine months ended September 30, 2024 and the year ended December 31, 2023 was immaterial. Net Investment Income The following table summarizes Net investment income by investment type for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Fixed maturities $ 420 $ 438 $ 1,252 $ 1,336 Equity securities 7 3 16 17 Mortgage loans on real estate 58 64 179 187 Policy loans 6 5 16 16 Short-term investments and cash equivalents 11 10 31 28 Limited partnerships and other 26 44 116 106 Gross investment income 528 564 1,610 1,690 Less: Investment expenses 22 17 57 53 Net investment income $ 506 $ 547 $ 1,553 $ 1,637 As of September 30, 2024 and December 31, 2023, the Company had $6 and $10, respectively, of investments in fixed maturities that did not produce net investment income. Fixed maturities are moved to a non-accrual status when the investment defaults. Net Gains (Losses) Net gains (losses) were as follows for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Fixed maturities, available-for-sale, including securities pledged $ 15 $ (24) $ (19) $ (41) Fixed maturities, at fair value option 96 (135) (15) (243) Equity securities, at fair value 7 (3) 11 (6) Derivatives (128) 134 48 199 Embedded derivatives - fixed maturities 3 (3) 1 (4) Other derivatives 1 — 1 — Standalone derivatives (1) 1 — 1 Managed custody guarantees 6 (15) 6 (12) Stabilizer (6) (9) (7) (9) Mortgage loans (4) (1) (1) (11) Other investments (3) 48 — 47 Net gains (losses) $ (14) $ (7) $ 25 $ (79) Proceeds from the sale of fixed maturities, available-for-sale and equity securities and the related gross realized gains and losses, before tax, were as follows for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Proceeds on sales $ 753 $ 862 $ 2,199 $ 4,499 Gross gains 18 11 37 54 Gross losses 13 14 49 69 " id="sjs-B4" xml:space="preserve">Investments (excluding Consolidated Investment Entities) Fixed Maturities Available-for-sale and fair value option ("FVO") fixed maturities were as follows as of September 30, 2024: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Allowance for credit losses Fair Value Fixed maturities: U.S. Treasuries $ 388 $ 6 $ 20 $ — $ — $ 374 U.S. Government agencies and authorities 29 2 — — — 31 State, municipalities and political subdivisions 717 — 82 — — 635 U.S. corporate public securities 7,826 207 780 — — 7,253 U.S. corporate private securities 5,162 75 236 — 6 4,995 Foreign corporate public securities and foreign governments (1) 2,686 71 206 — 2 2,549 Foreign corporate private securities (1) 2,761 48 96 — 1 2,712 Residential mortgage-backed securities 3,974 42 200 3 — 3,819 Commercial mortgage-backed securities 3,890 3 483 — 17 3,393 Other asset-backed securities 2,787 41 37 — 6 2,785 Total fixed maturities, including securities pledged 30,220 495 2,140 3 32 28,546 Less: Securities pledged 1,543 — 80 — — 1,463 Total fixed maturities $ 28,677 $ 495 $ 2,060 $ 3 $ 32 $ 27,083 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Net gains (losses) in the Condensed Consolidated Statements of Operations. Available-for-sale and FVO fixed maturities were as follows as of December 31, 2023: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Allowance for credit losses Fair Value Fixed maturities: U.S. Treasuries $ 417 $ 7 $ 21 $ — $ — $ 403 U.S. Government agencies and authorities 54 3 1 — — 56 State, municipalities and political subdivisions 871 1 101 — — 771 U.S. corporate public securities 8,402 168 904 — — 7,666 U.S. corporate private securities 5,040 44 324 — — 4,760 Foreign corporate public securities and foreign governments (1) 2,928 47 270 — 3 2,702 Foreign corporate private securities (1) 2,916 27 129 — 2 2,812 Residential mortgage-backed securities 3,695 36 257 2 — 3,476 Commercial mortgage-backed securities 4,147 1 644 — 9 3,495 Other asset-backed securities 2,528 16 71 — 3 2,470 Total fixed maturities, including securities pledged 30,998 350 2,722 2 17 28,611 Less: Securities pledged 1,232 — 72 — — 1,160 Total fixed maturities $ 29,766 $ 350 $ 2,650 $ 2 $ 17 $ 27,451 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Net gains (losses) in the Condensed Consolidated Statements of Operations. The amortized cost and fair value of fixed maturities, including securities pledged, as of September 30, 2024, are shown below by contractual maturity. Actual maturities may differ from contractual maturities as securities may be restructured, called or prepaid. Mortgage-backed securities ("MBS") and Other asset-backed securities ("ABS") are shown separately because they are not due at a single maturity date. Amortized Cost Fair Value Due to mature: One year or less $ 610 $ 593 After one year through five years 3,848 3,798 After five years through ten years 3,664 3,655 After ten years 11,447 10,503 Mortgage-backed securities 7,864 7,212 Other asset-backed securities 2,787 2,785 Fixed maturities, including securities pledged $ 30,220 $ 28,546 As of September 30, 2024 and December 31, 2023, the Company did not have any investments in a single issuer, other than obligations of the U.S. Government and government agencies, with a carrying value in excess of 10% of the Company’s Total shareholders' equity. Repurchase Agreements and Securities Pledged As of September 30, 2024 and December 31, 2023, the Company did not have any securities pledged in dollar rolls or reverse repurchase agreements. The Company engages in securities lending whereby the initial collateral is required at a rate of at least 102% of the market value of the loaned securities. The lending agent retains the collateral and invests it in high quality liquid assets on behalf of the Company. The market value of the loaned securities is monitored on a daily basis with additional collateral obtained or refunded as the market value of the loaned securities fluctuates. The lending agent indemnifies the Company against losses resulting from the failure of a counterparty to return securities pledged where collateral is insufficient to cover the loss. In the normal course of business, the Company receives cash collateral and non-cash collateral in the form of securities. If cash is received as collateral, the lending agent retains the cash collateral and invests it in short-term liquid assets on behalf of the Company. Securities retained as collateral by the lending agent may not be sold or re-pledged, except in the event of default, and are not reflected on the Company’s Condensed Consolidated Balance Sheets. This collateral generally consists of U.S. Treasury, U.S. Government agency securities and MBS pools. The following table presents Securities pledged as of the dates indicated: September 30, 2024 December 31, 2023 Securities pledged/obligations under repurchase agreements (1) $ 204 $ 117 Securities loaned to lending agent (2) 1,091 842 Securities pledged as collateral (2)(3) 168 201 Total $ 1,463 $ 1,160 (1) Comprised of other asset-backed securities and included in Securities pledged and Payables under securities loan and repurchase agreements, including collateral held on the Condensed Consolidated Balance Sheets. (2) Included in Securities pledged on the Condensed Consolidated Balance Sheets. (3) See Collateral within the Derivatives Note to these Condensed Consolidated Financial Statements for more information. The following table presents collateral held by asset class that the Company pledged under securities lending as of the dates indicated: September 30, 2024 December 31, 2023 U.S. Treasuries $ 13 $ 14 U.S. corporate public securities 649 568 Short-term investments 155 55 Foreign corporate public securities and foreign governments 315 238 Total (1) $ 1,132 $ 875 (1) As of September 30, 2024 and December 31, 2023, liabilities to return cash collateral were $925 and $660, respectively, and included in Payables under securities loan and repurchase agreements, including collateral held on the Condensed Consolidated Balance Sheets. The Company's securities lending activities are conducted on an overnight basis, and all securities loaned can be recalled at any time. The Company does not offset assets and liabilities associated with its securities lending program. Allowance for credit losses The following tables presents a rollforward of the allowance for credit losses on available-for-sale fixed maturity securities for the periods presented: Nine Months Ended September 30, 2024 U.S. corporate private securities Commercial mortgage-backed securities Foreign corporate public securities and foreign governments Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ — $ 9 $ 3 $ 2 $ 3 $ 17 Credit losses on securities for which credit losses were not previously recorded 6 9 — — 1 16 Reductions for securities sold during the period — — (1) — — (1) Increase (decrease) on securities with allowance recorded in previous period — (1) — (1) 2 — Balance as of September 30 $ 6 $ 17 $ 2 $ 1 $ 6 $ 32 Year Ended December 31, 2023 U.S. corporate private securities Commercial mortgage-backed securities Foreign corporate public securities and foreign governments Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ — $ — $ 9 $ 2 $ 1 $ 12 Credit losses on securities for which credit losses were not previously recorded — 9 — — 2 11 Reductions for securities sold during the period — — (5) — — (5) Increase (decrease) on securities with allowance recorded in previous period — — (1) — — (1) Balance as of December 31 $ — $ 9 $ 3 $ 2 $ 3 $ 17 For additional information about the Company’s methodology and significant inputs used in determining whether a credit loss exists, see the Business, Basis of Presentation and Significant Accounting Policies Note to the Consolidated Financial Statements in Part II, Item 8. of the Annual Report on Form 10-K . Unrealized Capital Losses The following tables present available-for-sale fixed maturities, including securities pledged, for which an allowance for credit losses has not been recorded by investment category and duration as of the dates indicated: As of September 30, 2024 Twelve Months or Less More Than Twelve Months Below Amortized Cost Total Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses U.S. Treasuries $ 66 $ 1 $ 150 $ 19 $ 216 $ 20 State, municipalities and political subdivisions 1 — 618 82 619 82 U.S. corporate public securities 96 8 4,573 772 4,669 780 U.S. corporate private securities 178 2 3,061 234 3,239 236 Foreign corporate public securities and foreign governments 47 2 1,367 204 1,414 206 Foreign corporate private securities 10 — 1,605 96 1,615 96 Residential mortgage-backed 19 — 1,290 200 1,309 200 Commercial mortgage-backed 32 — 3,091 483 3,123 483 Other asset-backed 34 1 371 36 405 37 Total $ 483 $ 14 $ 16,126 $ 2,126 $ 16,609 $ 2,140 As of December 31, 2023 Twelve Months or Less More Than Twelve Months Below Amortized Cost Total Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses U.S. Treasuries $ 99 $ 3 $ 109 $ 18 $ 208 $ 21 U.S. Government agencies and authorities — — 3 1 3 1 State, municipalities and political subdivisions 20 — 731 101 751 101 U.S. corporate public securities 321 17 5,101 887 5,422 904 U.S. corporate private securities 176 7 3,365 317 3,541 324 Foreign corporate public securities and foreign governments 82 2 1,749 268 1,831 270 Foreign corporate private securities 189 5 2,101 124 2,290 129 Residential mortgage-backed 114 3 1,354 254 1,468 257 Commercial mortgage-backed 84 2 3,269 642 3,353 644 Other asset-backed 136 3 1,156 68 1,292 71 Total $ 1,221 $ 42 $ 18,938 $ 2,680 $ 20,159 $ 2,722 As of September 30, 2024, the average duration of our fixed maturities portfolio, including securities pledged, is between 6 and 6.5 years. As of September 30, 2024 and December 31, 2023, the Company concluded that an allowance for credit losses was not warranted for the securities above because the unrealized losses are interest rate related. The Company does not intend to sell the investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost bases. Evaluating Securities for Impairments The Company performs a regular evaluation, on a security-by-security basis, of its available-for-sale securities holdings, including fixed maturity securities, in accordance with its impairment policy in order to evaluate whether such investments are impaired. Intent impairments were $1 and $6 for the three and nine months ended September 30, 2024, respectively, and $18 and $25 for the three and nine months ended September 30, 2023, respectively. The Company may sell securities during the period in which fair value has declined below amortized cost for fixed maturities. In certain situations, new factors, including changes in the business environment, can change the Company’s previous intent to continue holding a security. Accordingly, these factors may lead the Company to record additional intent related capital losses. Debt Modifications The Company evaluates all debt modifications to determine whether a modification results in a new loan or a continuation of an existing loan. Disclosures are required for loan modifications with borrowers experiencing financial difficulty. For the three and nine months ended September 30, 2024 and 2023, the Company had no material debt modifications that require such disclosure. Mortgage Loans on Real Estate The Company diversifies its commercial mortgage loan portfolio by geographic region and property type to reduce concentration risk. The Company manages risk when originating commercial mortgage loans by generally lending only up to 75% of the estimated fair value of the underlying real estate. Subsequently, the Company continuously evaluates mortgage loans based on relevant current information including a review of loan-specific performance, property characteristics and market trends. Loan performance is monitored on a loan specific basis through the review of submitted appraisals, operating statements, rent revenues and annual inspection reports, among other items. This review ensures properties are performing at a consistent and acceptable level to secure the debt. The components to evaluate debt service coverage are received and reviewed at least annually to determine the level of risk. Loan-to-value ("LTV") and debt service coverage ("DSC") ratios are measures commonly used to assess the risk and quality of mortgage loans. These ratios are utilized as part of the review process described above. The following tables present commercial mortgage loans by year of origination and LTV ratio as of the dates indicated. The information is updated as of September 30, 2024 and December 31, 2023, respectively. As of September 30, 2024 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2024 $ 129 $ 83 $ 15 $ — $ — $ 227 2023 117 222 39 — — 378 2022 231 295 105 — — 631 2021 238 196 115 — — 549 2020 186 86 — — — 272 Prior 2,570 185 16 — 18 2,789 Total $ 3,471 $ 1,067 $ 290 $ — $ 18 $ 4,846 As of December 31, 2023 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% -70% >70% - 80% >80% and above Total 2023 $ 150 $ 222 $ — $ — $ — $ 372 2022 252 326 73 — — 651 2021 244 214 209 — — 667 2020 168 112 — 10 16 306 2019 238 68 28 — — 334 Prior 2,586 280 4 — 18 2,888 Total $ 3,638 $ 1,222 $ 314 $ 10 $ 34 $ 5,218 The following tables present commercial mortgage loans by year of origination and DSC ratio as of the dates indicated. The information is updated as of September 30, 2024 and December 31, 2023, respectively. As of September 30, 2024 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2024 $ 96 $ 91 $ 33 $ 7 $ 227 2023 114 74 179 11 378 2022 271 76 84 200 631 2021 259 12 83 195 549 2020 209 19 20 24 272 Prior 2,109 228 350 102 2,789 Total $ 3,058 $ 500 $ 749 $ 539 $ 4,846 *No commercial mortgage loans were secured by land or construction loans As of December 31, 2023 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2023 $ 189 $ 116 $ 67 $ — $ 372 2022 204 68 192 187 651 2021 260 14 64 329 667 2020 211 24 21 50 306 2019 203 26 84 21 334 Prior 2,216 264 255 153 2,888 Total $ 3,283 $ 512 $ 683 $ 740 $ 5,218 *No commercial mortgage loans were secured by land or construction loans The following tables present the commercial mortgage loans by year of origination and U.S. region as of the dates indicated. The information is updated as of September 30, 2024 and December 31, 2023, respectively. As of September 30, 2024 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2024 $ 28 $ 80 $ 34 $ 44 $ 20 $ 1 $ 8 $ 3 $ 9 $ 227 2023 69 84 12 102 39 40 3 26 3 378 2022 140 132 49 98 94 92 5 1 20 631 2021 96 51 116 93 97 47 9 40 — 549 2020 62 134 17 10 12 15 — 7 15 272 Prior 721 657 665 178 228 136 58 117 29 2,789 Total $ 1,116 $ 1,138 $ 893 $ 525 $ 490 $ 331 $ 83 $ 194 $ 76 $ 4,846 As of December 31, 2023 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2023 $ 69 $ 77 $ 12 $ 101 $ 39 $ 42 $ 3 $ 26 $ 3 $ 372 2022 140 132 47 100 113 93 5 1 20 651 2021 96 63 124 148 111 75 9 40 1 667 2020 63 155 17 10 12 26 — 7 16 306 2019 53 100 10 74 45 4 14 13 21 334 Prior 734 605 765 189 214 171 47 144 19 2,888 Total $ 1,155 $ 1,132 $ 975 $ 622 $ 534 $ 411 $ 78 $ 231 $ 80 $ 5,218 The following tables present the commercial mortgage loans by year of origination and property type as of the dates indicated. The information is updated as of September 30, 2024 and December 31, 2023, respectively. As of September 30, 2024 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2024 $ 25 $ 130 $ 57 $ 15 $ — $ — $ — $ 227 2023 125 171 33 17 32 — — 378 2022 79 262 236 34 10 10 — 631 2021 35 131 245 111 — 18 9 549 2020 56 48 71 97 — — — 272 Prior 676 727 672 442 68 157 47 2,789 Total $ 996 $ 1,469 $ 1,314 $ 716 $ 110 $ 185 $ 56 $ 4,846 As of December 31, 2023 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2023 $ 125 $ 164 $ 33 $ 18 $ 32 $ — $ — $ 372 2022 79 263 255 34 10 10 — 651 2021 36 145 335 123 — 18 10 667 2020 57 49 72 128 — — — 306 2019 45 82 160 36 11 — — 334 Prior 780 755 618 463 60 163 49 2,888 Total $ 1,122 $ 1,458 $ 1,473 $ 802 $ 113 $ 191 $ 59 $ 5,218 The following table summarizes the activity in the allowance for losses for commercial mortgage loans for the periods indicated: September 30, 2024 December 31, 2023 Allowance for credit losses, beginning of period $ 26 $ 18 Credit losses on mortgage loans for which credit losses were not previously recorded — 2 Increase (decrease) on mortgage loans with an allowance recorded in a previous period 1 9 Provision for expected credit losses 27 29 Write-offs (3) (3) Recoveries of amounts previously written-off — — Allowance for credit losses, end of period $ 24 $ 26 The following table presents the payment status of commercial mortgage loans as of the dates indicated: September 30, 2024 December 31, 2023 Current $ 4,808 $ 5,202 30-59 days past due — — 60-89 days past due 12 — Greater than 90 days past due 26 16 Total $ 4,846 $ 5,218 Commercial mortgage loans are placed on non-accrual status when 90 days in arrears, when the Company has concerns regarding the collectability of future payments, or when a loan has matured without being paid off or extended. As of September 30, 2024 and December 31, 2023, the Company had $38 and $16, respectively, of commercial mortgage loans in non-accrual status. The amount of interest income recognized on loans in non-accrual status for the nine months ended September 30, 2024 and the year ended December 31, 2023 was immaterial. Net Investment Income The following table summarizes Net investment income by investment type for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Fixed maturities $ 420 $ 438 $ 1,252 $ 1,336 Equity securities 7 3 16 17 Mortgage loans on real estate 58 64 179 187 Policy loans 6 5 16 16 Short-term investments and cash equivalents 11 10 31 28 Limited partnerships and other 26 44 116 106 Gross investment income 528 564 1,610 1,690 Less: Investment expenses 22 17 57 53 Net investment income $ 506 $ 547 $ 1,553 $ 1,637 As of September 30, 2024 and December 31, 2023, the Company had $6 and $10, respectively, of investments in fixed maturities that did not produce net investment income. Fixed maturities are moved to a non-accrual status when the investment defaults. Net Gains (Losses) Net gains (losses) were as follows for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Fixed maturities, available-for-sale, including securities pledged $ 15 $ (24) $ (19) $ (41) Fixed maturities, at fair value option 96 (135) (15) (243) Equity securities, at fair value 7 (3) 11 (6) Derivatives (128) 134 48 199 Embedded derivatives - fixed maturities 3 (3) 1 (4) Other derivatives 1 — 1 — Standalone derivatives (1) 1 — 1 Managed custody guarantees 6 (15) 6 (12) Stabilizer (6) (9) (7) (9) Mortgage loans (4) (1) (1) (11) Other investments (3) 48 — 47 Net gains (losses) $ (14) $ (7) $ 25 $ (79) Proceeds from the sale of fixed maturities, available-for-sale and equity securities and the related gross realized gains and losses, before tax, were as follows for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Proceeds on sales $ 753 $ 862 $ 2,199 $ 4,499 Gross gains 18 11 37 54 Gross losses 13 14 49 69

Derivative Financial Instrument

Derivative Financial Instruments	9 Months Ended
	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The Company primarily enters into the following types of derivatives: Interest rate swaps: Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and/or liabilities. Interest rate swaps are also used to hedge the interest rate risk associated with the value of assets it owns or in an anticipation of acquiring them. Using interest rate swaps, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest payments, calculated by reference to an agreed upon notional principal amount. These transactions are entered into pursuant to master agreements that provide for a single net payment to be made to/from the counterparty at each due date. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Foreign exchange swaps: The Company uses foreign exchange or currency swaps to reduce the risk of change in the value, yield or cash flows associated with certain foreign denominated invested assets. Foreign exchange swaps represent contracts that require the exchange of foreign currency cash flows against U.S. dollar cash flows at regular periods, typically quarterly or semi-annually. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Total return swaps: The Company uses total return swaps as a hedge of interest related risks within various Legacy Annuity and Retirement products. Total return swaps are also used as a hedge of other corporate liabilities. Using total return swaps, the Company agrees with another party to exchange, at specified intervals, the difference between the economic performance of assets or a market index and a fixed or variable funding multiplied by reference to an agreed upon notional amount. No cash is exchanged at the onset of the contracts. Cash is paid and received over the life of the contract based upon the terms of the swaps. The Company utilizes these contracts in non-qualifying hedging relationships. Futures: Futures contracts are used to hedge against a decrease in certain equity indices. The Company also uses interest rate futures contracts to hedge its exposure to market risks due to changes in interest rates. The Company enters into exchange traded futures with regulated futures commissions that are members of the exchange. The Company also posts initial and variation margins, with the exchange, on a daily basis. The Company utilizes exchange-traded futures in non-qualifying hedging relationships. Embedded derivatives: The Company also invests in certain fixed maturity instruments and has issued certain products that contain embedded derivatives for which market value is at least partially determined by, among other things, levels of or changes in domestic and/or foreign interest rates (short-term or long-term), exchange rates, prepayment rates, equity rates or credit ratings/spreads. In addition, the Company has entered into coinsurance with funds withheld arrangements, which contain embedded derivatives. The Company utilizes derivative contracts mainly to hedge exposure to variability in cash flows, interest rate risk, credit risk, foreign exchange risk and equity market risk. The majority of derivatives used by the Company are designated as product hedges, which hedge the exposure arising from insurance liabilities or guarantees embedded in the contracts the Company offers through various product lines. The Company also uses derivatives contracts to hedge its exposure to various risks associated with the investment portfolio. The Company also uses credit default swaps coupled with other investments in order to produce the investment characteristics of otherwise permissible investments. Based on the notional amounts, a substantial portion of the Company’s derivative positions was not designated or did not qualify for hedge accounting as part of a hedging relationship as outlined in ASC Topic 815 as of September 30, 2024 and December 31, 2023. The notional amounts and fair values of derivatives were as follows as of the dates indicated: September 30, 2024 December 31, 2023 Notional Asset Fair Value Liability Notional Asset Fair Value Liability Derivatives: Qualifying for hedge accounting (1) Fair value hedges: Interest rate contracts $ 200 $ — $ 7 $ — $ — $ — Foreign exchange contracts 100 — 2 98 — 4 Cash flow hedges: Interest rate contracts 12 — — 12 — — Foreign exchange contracts 655 21 11 718 33 7 Derivatives: Non-qualifying for hedge accounting (1) Interest rate contracts 15,005 195 331 16,773 270 354 Foreign exchange contracts 173 2 3 183 4 2 Equity contracts 286 7 3 255 4 2 Credit contracts 126 — 2 137 — 2 Embedded derivatives and Managed custody guarantees ("MCGs"): Within fixed maturity investments (2) N/A 3 — N/A 2 — Within reinsurance agreements (4) N/A 40 45 N/A 61 49 MCGs (3) N/A — 2 N/A — 8 Stabilizers (3) N/A — 8 N/A — 1 Total $ 268 $ 414 $ 374 $ 429 (1) Open derivative contracts are reported as Derivatives assets or liabilities at fair value on the Condensed Consolidated Balance Sheets. (2) Included in Fixed maturities, available-for-sale, at fair value on the Condensed Consolidated Balance Sheets. (3) Included in Contract owner account balances on the Condensed Consolidated Balance Sheets. (4) Included in Other liabilities, Other assets and Premium receivable and reinsurance recoverable on the Condensed Consolidated Balance Sheets. N/A - Not applicable The Company does not offset any derivative assets and liabilities in the Condensed Consolidated Balance Sheets. The disclosures set out in the table below include the fair values of Over-The-Counter (“OTC”) and cleared derivatives excluding exchange traded contracts subject to master netting agreements or similar agreements as of the dates indicated: Gross Amount Recognized (1) Counterparty Netting (2) Cash Collateral Netting (2) Securities Collateral Netting (2) Net Receivables/ Payables September 30, 2024 Derivative assets $ 224 $ (193) $ (25) $ (2) $ 4 Derivative liabilities 359 (193) (158) (5) 3 December 31, 2023 Derivative assets 311 (216) (76) (8) 11 Derivative liabilities 370 (216) (150) (3) 1 (1) As of September 30, 2024, gross amounts exclude asset and liability exchange traded contracts of $1 and $0, respectively. As of December 31, 2023, gross amounts exclude asset and liability exchange traded contracts of $0 and $1, respectively. (2) Represents the netting of receivable with payable balances, net of collateral, for the same counterparty under eligible netting agreements. Collateral Under the terms of the OTC Derivative International Swaps and Derivatives Association, Inc. ("ISDA") agreements, the Company may receive from, or deliver to, counterparties collateral to assure that terms of the ISDA agreements will be met with regard to the Credit Support Annex ("CSA"). The terms of the CSA call for the Company to pay interest on any cash received equal to the Federal Funds rate. To the extent cash collateral is received and delivered, it is included in Payables under securities loan and repurchase agreements, including collateral held and Short-term investments under securities loan agreements, including collateral delivered, respectively, on the Condensed Consolidated Balance Sheets and is reinvested in short-term investments. Collateral held is used in accordance with the CSA to satisfy any obligations. Investment grade bonds owned by the Company are the source of noncash collateral posted, which is reported in Securities pledged on the Condensed Consolidated Balance Sheets. As of September 30, 2024, the Company held $25 and pledged $159 of net cash collateral related to OTC derivative contracts and cleared derivative contracts, respectively. As of December 31, 2023, the Company held $84 and pledged $147 of net cash collateral related to OTC derivative contracts and cleared derivative contracts, respectively. In addition, as of September 30, 2024, the Company delivered $168 of securities and held $3 of securities as collateral. As of December 31, 2023, the Company delivered $201 of securities and held $11 of securities as collateral. The location and effect of derivatives qualifying for hedge accounting on the Condensed Consolidated Statements of Operations and Condensed Consolidated Statements of Comprehensive Income are as follows for the periods indicated: 2024 2023 Interest Rate Contracts Foreign Exchange Contracts Interest Rate Contracts Foreign Exchange Contracts Location of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income into Income Net investment income Net investment income and Net gains (losses) Net investment income Net investment income and Net gains (losses) Three Months Ended September 30, Amount of Gain (Loss) Recognized in Other Comprehensive Income $ — $ (29) $ — $ 7 Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income — 5 — 3 Nine Months Ended September 30, Amount of Gain (Loss) Recognized in Other Comprehensive Income $ — $ (18) $ — $ (11) Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income — 11 — 8 The location and amount of gain (loss) recognized in the Condensed Consolidated Statements of Operations for derivatives qualifying for hedge accounting are as follows for the periods indicated: 2024 2023 Net investment income Net gains (losses) Net investment income Net gains (losses) Three Months Ended September 30, Total amounts of line items presented in the statements of operations in which the effects of fair value or cash flow hedges are recorded $ 506 $ (14) $ 547 $ (7) Fair value hedges: Interest rate contracts: Hedged items — 7 — — Derivatives designated as hedging instruments — (7) — — Foreign exchange contracts: Hedged items — 3 — (3) Derivatives designated as hedging instruments (1) — (4) — 4 Cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income 2 3 3 — Nine Months Ended September 30, Total amounts of line items presented in the statements of operations in which the effects of fair value or cash flow hedges are recorded $ 1,553 $ 25 $ 1,637 $ (79) Fair value hedges: Interest rate contracts: Hedged items — 8 Derivatives designated as hedging instruments — (8) Foreign exchange contracts: Hedged items — 1 — (1) Derivatives designated as hedging instruments (1) — — — 3 Cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income 7 4 8 — (1) The change in derivative instruments designated and qualifying as fair value hedges of $0 and $1 were excluded from the assessment of hedge effectiveness and recognized currently in earnings for the three and nine months ended September 30, 2024, respectively. The change in derivative instruments designated and qualifying as fair value hedges of $1 and $2 were excluded from the assessment of hedge effectiveness and recognized currently in earnings for three and nine months ended September 30, 2023, respectively. The location and effect of derivatives not designated as hedging instruments on the Condensed Consolidated Statements of Operations are as follows for the periods indicated: Location of Gain (Loss) Recognized on Derivative Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Derivatives: Non-qualifying for hedge accounting Interest rate contracts Net gains (losses) $ (129) $ 138 $ 36 $ 196 Foreign exchange contracts Net gains (losses) (1) (2) (4) (1) Equity contracts Net gains (losses) 8 (7) 19 1 Credit contracts Net gains (losses) 1 1 — — Embedded derivatives and Managed custody guarantees: Within fixed maturity investments Net gains (losses) 3 (3) 1 (4) Within reinsurance agreements (1) Policyholder benefits (27) 29 (23) 11 MCGs Net gains (losses) 6 (15) 6 (12) Stabilizers Net gains (losses) (6) (9) (7) (9) Total $ (145) $ 132 $ 28 $ 182 (1) For the three months ended September 30, 2024, the amount excluded gains (losses) of $(1) from standalone derivatives recognized in Net gains (losses). For the nine months ended September 30, 2024, the amount excluded gains (losses) of $0 from standalone derivatives recognized in Net gains (losses). For the three and nine months ended September 30, 2023, the amount excluded gains (losses) of $1 from standalone derivatives recognized in Net gains (losses).

Fair Value Measurements (exclud

Fair Value Measurements (excluding Consolidated Investment Entities)	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements (excluding Consolidated Investment Entities)	Fair Value Measurements (excluding Consolidated Investment Entities) Fair Value Measurement The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of September 30, 2024: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 319 $ 55 $ — $ 374 U.S. Government agencies and authorities — 31 — 31 State, municipalities and political subdivisions — 635 — 635 U.S. corporate public securities — 7,242 11 7,253 U.S. corporate private securities — 3,550 1,445 4,995 Foreign corporate public securities and foreign governments (1) — 2,539 10 2,549 Foreign corporate private securities (1) — 2,244 468 2,712 Residential mortgage-backed securities — 3,753 66 3,819 Commercial mortgage-backed securities — 3,393 — 3,393 Other asset-backed securities — 2,751 34 2,785 Total fixed maturities, including securities pledged 319 26,193 2,034 28,546 Equity securities 149 — 102 251 Derivatives: Interest rate contracts 2 193 — 195 Foreign exchange contracts — 23 — 23 Equity contracts — 7 — 7 Embedded derivative on reinsurance — 40 — 40 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,808 14 — 2,822 Assets held in separate accounts 97,372 5,812 348 103,532 Total assets $ 100,650 $ 32,282 $ 2,484 $ 135,416 Liabilities: Contingent consideration $ — $ — $ 35 $ 35 Stabilizer and MCGs — — 10 10 Derivatives: Interest rate contracts 1 337 — 338 Foreign exchange contracts — 16 — 16 Equity contracts — 3 — 3 Credit contracts — 2 — 2 Embedded derivative on reinsurance — (7) (2) 52 45 Total liabilities $ 1 $ 351 $ 97 $ 449 (1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within liabilities given the underlying nature of the balance and the right-of-offset. The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of December 31, 2023: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 346 $ 57 $ — $ 403 U.S. Government agencies and authorities — 55 1 56 State, municipalities and political subdivisions — 771 — 771 U.S. corporate public securities — 7,648 18 7,666 U.S. corporate private securities — 3,234 1,526 4,760 Foreign corporate public securities and foreign governments (1) — 2,702 — 2,702 Foreign corporate private securities (1) — 2,376 436 2,812 Residential mortgage-backed securities — 3,419 57 3,476 Commercial mortgage-backed securities — 3,495 — 3,495 Other asset-backed securities — 2,418 52 2,470 Total fixed maturities, including securities pledged 346 26,175 2,090 28,611 Equity securities 140 — 96 236 Derivatives: Interest rate contracts 7 263 — 270 Foreign exchange contracts — 37 — 37 Equity contracts — 4 — 4 Embedded derivative on reinsurance — 61 — 61 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,148 17 — 2,165 Assets held in separate accounts 87,180 5,605 348 93,133 Total assets $ 89,821 $ 32,162 $ 2,534 $ 124,517 Liabilities: Contingent consideration $ — $ — $ 51 $ 51 Stabilizer and MCGs — — 9 9 Derivatives: Interest rate contracts — 354 — 354 Foreign exchange contracts — 13 — 13 Equity contracts — 2 — 2 Credit contracts — 2 — 2 Embedded derivative on reinsurance — (9) (2) 58 49 Total liabilities $ — $ 362 $ 118 $ 480 (1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within liabilities given the underlying nature of the balance and the right-of-offset. Valuation of Financial Assets and Liabilities at Fair Value Certain assets and liabilities are measured at estimated fair value on the Company's Condensed Consolidated Balance Sheets. The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The exit price and the transaction (or entry) price will be the same at initial recognition in many circumstances. However, in certain cases, the transaction price may not represent fair value. The fair value of a liability is based on the amount that would be paid to transfer a liability to a third-party with an equal credit standing. Fair value is required to be a market-based measurement that is determined based on a hypothetical transaction at the measurement date, from a market participant’s perspective. The Company considers three broad valuation approaches when a quoted price is unavailable: (i) the market approach, (ii) the income approach and (iii) the cost approach. The Company determines the most appropriate valuation technique to use, given the instrument being measured and the availability of sufficient inputs. The Company prioritizes the inputs to fair valuation approaches and allows for the use of unobservable inputs to the extent that observable inputs are not available. The Company utilizes a number of valuation methodologies to determine the fair values of its financial assets and liabilities in conformity with the concepts of exit price and the fair value hierarchy as prescribed in ASC Topic 820. Valuations are obtained from third-party commercial pricing services, brokers and industry-standard, vendor-provided software that models the value based on market observable inputs. The valuations obtained from third-party commercial pricing services are non-binding. The Company reviews the assumptions and inputs used by third-party commercial pricing services for each reporting period in order to determine an appropriate fair value hierarchy level. The documentation and analysis obtained from third-party commercial pricing services are reviewed by the Company, including in-depth validation procedures confirming the observability of inputs. The valuations are reviewed and validated monthly through the internal valuation committee price variance review, comparisons to internal pricing models, back testing to recent trades or monitoring of trading volumes. When available, the fair value of the Company's financial assets and liabilities are based on quoted prices of identical assets in active markets and therefore, reflected in Level 1. The valuation approaches and key inputs for each category of assets or liabilities that are classified within Level 2 and Level 3 of the fair value hierarchy are presented below. For fixed maturities classified as Level 2 assets, fair values are determined using a matrix-based market approach, based on prices obtained from third-party commercial pricing services and the Company’s matrix and analytics-based pricing models, which in each case incorporate a variety of market observable information as valuation inputs. The market observable inputs used for these fair value measurements, by fixed maturity asset class, are as follows: U.S. Treasuries: Fair value is determined using third-party commercial pricing services, with the primary inputs being stripped interest and principal U.S. Treasury yield curves that represent a U.S. Treasury zero-coupon curve. U.S. government agencies and authorities, State, municipalities and political subdivisions: Fair value is determined using third-party commercial pricing services, with the primary inputs being U.S. Treasury yield curves, trades of comparable securities, credit spreads off benchmark yields and issuer ratings. U.S. corporate public securities, Foreign corporate public securities and foreign governments: Fair value is determined using third-party commercial pricing services, with the primary inputs being benchmark yields, trades of comparable securities, issuer ratings, bids and credit spreads off benchmark yields. U.S. corporate private securities and Foreign corporate private securities: Fair values are determined using a matrix and analytics-based pricing model. The model incorporates the current level of risk-free interest rates, current corporate credit spreads, credit quality of the issuer and cash flow characteristics of the security. The model also considers a liquidity spread, the value of any collateral, the capital structure of the issuer, the presence of guarantees, and prices and quotes for comparably rated publicly traded securities. RMBS, CMBS and ABS: Fair value is determined using third-party commercial pricing services, with the primary inputs being credit spreads off benchmark yields, prepayment speed assumptions, current and forecasted loss severity, debt service coverage ratios, collateral type, payment priority within tranche and the vintage of the loans underlying the security. Generally, the Company does not obtain more than one vendor price from pricing services per instrument. The Company uses a hierarchy process in which prices are obtained from a primary vendor and, if that vendor is unable to provide the price, the next vendor in the hierarchy is contacted until a price is obtained or it is determined that a price cannot be obtained from a commercial pricing service. When a price cannot be obtained from a commercial pricing service, independent broker quotes are solicited. Securities priced using independent broker quotes are classified as Level 3. Fair values of privately placed bonds are determined primarily using a matrix-based pricing model and are generally classified as Level 2 assets. The model considers the current level of risk-free interest rates, current corporate spreads, the credit quality of the issuer and cash flow characteristics of the security. Also considered are factors such as the net worth of the borrower, the value of collateral, the capital structure of the borrower, the presence of guarantees and the Company’s evaluation of the borrower’s ability to compete in its relevant market. Using this data, the model generates estimated market values, which the Company considers reflective of the fair value of each privately placed bond. Equity securities: Level 2 and Level 3 equity securities, typically private equities or equity securities not traded on an exchange, are valued by other sources such as analytics or brokers. Derivatives: Derivatives are carried at fair value, which is determined using the Company’s derivative accounting system in conjunction with observable key financial data from third-party sources, such as yield curves, exchange rates, S&P 500 Index prices, Overnight Index Swap ("OIS") rates, and Secured Overnight Financing Rate ("SOFR"). The Company uses SOFR discounting for valuations of interest rate derivatives; however, certain legacy positions may continue to be discounted on OIS. The Company uses OIS for valuations of collateralized interest rate derivatives, which are obtained from third-party sources. For those derivatives that are unable to be valued by the accounting system, the Company typically utilizes values established by third-party brokers. Counterparty credit risk is considered and incorporated in the Company’s valuation process through counterparty credit rating requirements and monitoring of overall exposure. It is the Company’s policy to transact only with investment grade counterparties with a credit rating of A- or better. The Company’s nonperformance risk is also considered and incorporated in the Company’s valuation process. The Company also has certain credit default swaps and options that are priced by third party vendors or by using models that primarily use market observable inputs, but contain inputs that are not observable to market participants, which have been classified as Level 3. The remaining derivative instruments are valued based on market observable inputs and are classified as Level 2. Contingent consideration: The fair value of the contingent consideration liability associated with the Company’s acquisitions uses unobservable inputs and as such are reported as Level 3. Unobservable inputs include projected revenues, duration of earnouts and other metrics as well as discount rate. Changes in the fair value of the contingent consideration are recorded in Operating expenses in the Company’s Condensed Consolidated Statements of Operations. Stabilizer and MCGs : The Company records reserves for Stabilizer and MCG contracts containing guaranteed credited rates. The guarantee is treated as an embedded derivative or a stand-alone derivative (depending on the underlying product) and is required to be reported at fair value. The estimated fair value is determined based on the present value of projected future claims, minus the present value of future guaranteed premiums. At inception of the contract, the Company projects a guaranteed premium to be equal to the present value of the projected future claims. The income associated with the contracts is projected using relevant actuarial and capital market assumptions, including benefits and related contract charges, over the anticipated life of the related contracts. The cash flow estimates are projected under multiple capital market scenarios using observable risk-free rates and other best estimate assumptions. These derivatives are classified as Level 3 liabilities. The discount rate used to determine the fair value of the Company's Stabilizer embedded derivative liabilities and MCG stand-alone derivative includes an adjustment to reflect the risk that these obligations will not be fulfilled ("nonperformance risk"). The nonperformance risk adjustment incorporates a blend of observable, similarly rated peer holding company credit spreads, adjusted to reflect the credit quality of the individual insurance subsidiary that issued the guarantee, as well as an adjustment to reflect the non-default spreads and the priority and recovery rates of policyholder claims. Embedded derivatives on reinsurance: The carrying value of embedded derivatives is estimated based upon the change in the fair value of the assets supporting the funds withheld payable under reinsurance agreements. The fair value of the embedded derivative is based on market observable inputs and is classified as Level 2. The remaining derivative instruments are classified as Level 3 and are estimated using the income approach. The fair value is calculated by estimating future cash flows for a certain discrete projection period, estimating the terminal value, if appropriate, and discounting these amounts to present value at a rate of return that considers the relative risk of the cash flows and the time value of money. Level 3 Financial Instruments The fair values of certain assets and liabilities are determined using prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement (i.e., Level 3 as defined by ASC Topic 820), including but not limited to liquidity spreads for investments within markets deemed not currently active. These valuations, whether derived internally or obtained from a third-party, use critical assumptions that are not widely available to estimate market participant expectations in valuing the asset or liability. In addition, the Company has determined, for certain financial instruments, an active market is such a significant input to determine fair value that the presence of an inactive market may lead to classification in Level 3. In light of the methodologies employed to obtain the fair values of financial assets and liabilities classified as Level 3, additional information is presented below. Significant Unobservable Inputs The Company's Level 3 fair value measurements of its fixed maturities, equity securities and equity and credit derivative contracts are primarily based on broker quotes for which the quantitative detail of the unobservable inputs is neither provided nor reasonably corroborated, thus negating the ability to perform a sensitivity analysis. The Company performs a review of broker quotes by performing a monthly price variance comparison and back tests broker quotes to recent trade prices. The following tables summarize the change in fair value of the Company's Level 3 assets and liabilities and transfers in and out of Level 3 for the periods indicated: Three Months Ended September 30, 2024 Fair Value as of July 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of September 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. corporate public securities 12 — (1) — — — — — — 11 — (1) U.S. corporate private securities 1,464 (4) 58 118 — (3) (81) — (107) 1,445 2 54 Foreign corporate public securities and foreign governments (1) 17 — 1 10 — (18) — — — 10 — — Foreign corporate private securities (1) 444 2 2 22 — — (2) — — 468 1 3 Residential mortgage-backed securities 49 4 — 13 — — — — — 66 5 — Other asset-backed securities 24 — — 12 — — (2) — — 34 — — Total fixed maturities, including securities pledged 2,010 2 60 175 — (21) (85) — (107) 2,034 8 56 Equity securities, at fair value 98 4 — — — — — — — 102 4 — Contingent consideration (49) — — — — — 14 — — (35) — — Stabilizer and MCGs (2) (10) — — — — — — — — (10) — — Embedded derivatives on reinsurance (57) (1) — — — — 6 — — (52) — — Assets held in separate accounts (4) 363 11 — 12 — (9) — — (29) 348 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of September 30 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Nine Months Ended September 30, 2024 Fair Value as of January 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of September 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. Government agencies and authorities $ 1 $ — $ — $ — $ — $ — $ — $ — $ (1) $ — $ — $ — U.S. corporate public securities 18 — — — — — (7) — — 11 — (1) U.S. corporate private securities 1,526 (5) 36 240 — (9) (196) — (147) 1,445 1 29 Foreign corporate public securities and foreign governments (1) — — — 10 — — — — — 10 — — Foreign corporate private securities (1) 436 2 (9) 43 — (9) (46) 51 — 468 1 (9) Residential mortgage-backed securities 57 — — 13 — — — — (4) 66 1 — Other asset-backed securities 52 — — 12 — — (5) — (25) 34 — — Total fixed maturities, including securities pledged 2,090 (3) 27 318 — (18) (254) 51 (177) 2,034 3 19 Equity securities, at fair value 96 6 — — — — — — — 102 6 — Contingent consideration (51) — — — — — 16 — — (35) — — Stabilizer and MCGs (2) (9) — — — (1) — — — — (10) — — Embedded derivatives on reinsurance (58) — — — — — 6 — — (52) — — Assets held in separate accounts (4) 348 12 — 47 — (24) — 5 (40) 348 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of September 30 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Three Months Ended September 30, 2023 Fair Value as of July 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of September 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. Government agencies and authorities $ 1 $ — $ — $ — $ — $ — $ — $ — $ — $ 1 $ — $ — U.S. corporate public securities 20 — 1 — — — — — (3) 18 — — U.S. corporate private securities 1,732 — (49) 24 — — (46) 63 (256) 1,468 — (49) Foreign corporate private securities (1) 413 (2) (6) 58 — — (20) 53 (21) 475 (2) (6) Residential mortgage-backed securities 57 (3) — 3 — — — 6 — 63 (3) — Other asset-backed securities 45 — — 10 — — (1) — (4) 50 — — Total fixed maturities, including securities pledged 2,268 (5) (54) 95 — — (67) 122 (284) 2,075 (5) (55) Equity securities, at fair value 192 (2) — — — — — — — 190 (2) — Contingent consideration (112) — — — — — — — — (112) — — Stabilizer and MCGs (2) (3) (24) — — — — — — — (27) — — Embedded derivatives on reinsurance (58) 1 — — — — — — — (57) — — Assets held in separate accounts (4) 344 (5) — 1 — (4) — 6 (1) 341 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of September 30 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Nine Months Ended September 30, 2023 Fair Value as of January 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of September 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. Government agencies and authorities $ 1 $ — $ — $ — $ — $ — $ — $ — $ — $ 1 $ — $ — U.S. corporate public securities 20 — — — — — 1 — (3) 18 — — U.S. corporate private securities 1,801 — (46) 104 — (3) (137) 45 (296) 1,468 — (48) Foreign corporate public securities and foreign governments (1) 3 — — — — — — — (3) — — — Foreign corporate private securities (1) 432 1 1 115 — — (197) 130 (7) 475 1 — Residential mortgage-backed securities 28 (6) — 37 — — — 4 — 63 (6) — Other asset-backed securities 64 — (1) 10 — — (1) — (22) 50 — (1) Total fixed maturities, including securities pledged 2,349 (5) (46) 266 — (3) (334) 179 (331) 2,075 (5) (49) Equity securities, at fair value 196 (10) — — — — — 4 — 190 (10) — Contingent consideration (112) — — — — — — — — (112) — — Stabilizer and MCGs (2) (6) (20) — — (1) — — — — (27) — — Embedded derivatives on reinsurance (58) 1 — — — — — — — (57) — — Assets held in separate accounts (4) 347 (9) — 8 — (13) — 9 (1) 341 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of September 30 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. For the three and nine months ended September 30, 2024 and 2023, the transfers in and out of Level 3 for fixed maturities were due to the variation in inputs relied upon for valuation each quarter. Securities that are primarily valued using independent broker quotes when prices are not available from one of the commercial pricing services are reflected as transfers into Level 3. When securities are valued using more widely available information, the securities are transferred out of Level 3 and into Level 1 or 2, as appropriate. Other Financial Instruments The following disclosures are made in accordance with the requirements of ASC Topic 825 which requires disclosure of fair value information about financial instruments, whether or not recognized at fair value on the Condensed Consolidated Balance Sheets. ASC Topic 825 excludes certain financial instruments, including insurance contracts and all nonfinancial instruments from its disclosure requirements. Accordingly, the aggregate fair value amounts presented do not represent the underlying value of the Company. The carrying values and estimated fair values of the Company's financial instruments as of the dates indicated: September 30, 2024 December 31, 2023 Carrying Fair Carrying Fair Assets: Fixed maturities, including securities pledged $ 28,546 $ 28,546 $ 28,611 $ 28,611 Equity securities 251 251 236 236 Mortgage loans on real estate 4,846 4,702 5,218 4,941 Policy loans 345 345 352 352 Cash, cash equivalents, short-term investments and short-term investments under securities loan agreements 2,822 2,822 2,165 2,165 Derivatives 225 225 311 311 Embedded derivatives on reinsurance 40 40 61 61 Other investments 66 66 64 64 Assets held in separate accounts 103,532 103,532 93,133 93,133 Liabilities: Investment contract liabilities: Funding agreements without fixed maturities and deferred annuities (1) $ 31,403 $ 34,625 $ 32,848 $ 34,856 Funding agreements with fixed maturities 1,251 1,207 1,175 1,178 Supplementary contracts, immediate annuities and other 582 539 628 571 Stabilizer and MCGs 10 10 9 9 Derivatives 359 359 371 371 Embedded derivative on reinsurance 45 45 49 49 Short-term debt 397 396 1 1 Long-term debt 2,103 2,083 2,097 1,998 (1) Certain amounts included in Funding agreements without fixed maturities and deferred annuities are also reflected within the Stabilizer and MCGs section of the table above. The following table presents the classification of financial instruments which are not carried at fair value on the Condensed Consolidated Balance Sheets: Financial Instrument Classification Mortgage loans on real estate Level 3 Policy loans Level 2 Other investments Level 2 Funding agreements without fixed maturities and deferred annuities Level 3 Funding agreements with fixed maturities Level 2 Supplementary contracts, immediate annuities and other Level 3 Short-term debt and Long-term debt Level 2

Deferred Policy Acquisition Cos

Deferred Policy Acquisition Costs and Value of Business Acquired	9 Months Ended
	Sep. 30, 2024
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net [Abstract]
Deferred Policy Acquisition Costs and Value of Business Acquired	Deferred Policy Acquisition Costs and Value of Business Acquired The following table presents a rollforward of deferred policy acquisition costs ("DAC") and value of business acquired ("VOBA") for the periods indicated: DAC VOBA (1) Wealth Solutions Deferred and Individual Annuities Health Solutions Voluntary (2) Businesses exited Balance as of January 1, 2023 $ 691 $ 171 $ 1,043 $ 439 Deferrals of commissions and expenses 59 54 — 4 Amortization expense (55) (32) (105) (37) Balance as of December 31, 2023 $ 695 $ 193 $ 938 $ 406 Deferrals of commissions and expenses 45 42 — 3 Amortization expense (41) (25) (76) (25) Balance as of September 30, 2024 $ 699 $ 210 $ 862 $ 384 (1) There was no loss recognition related to VOBA during the periods presented. (2) During the second quarter of 2024, the Company reclassified certain insurance products within the Health Solutions segment from Group to Voluntary. As a result, the rollforward above and the reconciliation table below have been updated for 2023 to reflect this change. The following table shows a reconciliation of DAC and VOBA balances to the Condensed Consolidated Balance Sheets for the periods indicated: September 30, 2024 December 31, 2023 DAC: Wealth Solutions Deferred and Individual Annuities $ 699 $ 695 Health Solutions Voluntary 210 193 Businesses exited 862 938 Other 18 18 VOBA 384 406 Total $ 2,173 $ 2,250

Reserves for Future Policy Bene

Reserves for Future Policy Benefits and Contract Owner Account Balances	9 Months Ended
	Sep. 30, 2024
Reserves for Future Policy Benefits and Contract Owner Balances [Abstract]
Reserves for Future Policy Benefits and Contract Owner Account Balances	Reserves for Future Policy Benefits and Contract Owner Account Balances Health Solutions Group products include long-duration term life insurance, as well as long-term disability products that are mostly employer paid. Health Solutions Voluntary products include long-duration whole life insurance, critical illness, and accident and hospital indemnity insurance that are mostly employee paid. The following tables present the balances and changes in the liability for future policy benefits for Health Solutions Group, Health Solutions Voluntary and Businesses Exited as of September 30, 2024 and December 31, 2023. Health Solutions Group Health Solutions Voluntary Businesses Exited 2024 2023 2024 2023 2024 2023 Present Value of Expected Net Premiums: Balance at January 1 $ 68 $ 77 $ 101 $ 97 $ 3,145 $ 4,244 Beginning balance at original discount rate 71 84 102 100 2,992 4,128 Reclassifications (2) (65) — 65 — — — Effect of change in cash flow assumptions (1) (6) (1) 6 (5) (921) Effect of actual variances from expected experience — 11 33 8 (105) (91) Adjusted balance at January 1 5 89 199 114 2,882 3,116 Interest accrual — 2 6 4 119 196 Net premiums collected (1) (1) (20) (25) (16) (234) (320) Ending balance at original discount rate 4 71 180 102 2,767 2,992 Effects of changes in discount rate assumptions — (3) (2) (1) 162 153 Balance at end of period $ 4 $ 68 $ 178 $ 101 $ 2,929 $ 3,145 Present Value of Expected Future Policy Benefits: Balance at January 1 $ 899 $ 881 $ 307 $ 285 $ 7,538 $ 8,639 Beginning balance at original discount rate 918 913 307 294 7,404 8,644 Reclassifications (2) (150) — 150 — — — Effect of change in cash flow assumptions (12) (8) (1) 13 10 (805) Effect of actual variances from expected experience (2) (16) 44 9 (91) (123) Adjusted balance at January 1 754 889 500 316 7,323 7,716 Issuances 94 136 — — 11 17 Interest accrual 16 24 14 14 278 412 Benefit payments (90) (131) (32) (23) (550) (741) Ending balance at original discount rate 774 918 482 307 7,062 7,404 Effects of changes in discount rate assumptions (7) (19) (2) — 191 134 Balance at end of period $ 767 $ 899 $ 480 $ 307 $ 7,253 $ 7,538 Net liability for future policy benefits $ 763 $ 831 $ 302 $ 206 $ 4,324 $ 4,392 Less: Reinsurance recoverable 328 315 9 — 4,237 4,342 Net liability for future policy benefits, after reinsurance recoverable $ 435 $ 516 $ 293 $ 206 $ 87 $ 50 (1) Net Premiums collected represent the portion of gross premiums collected from policyholders that is used to fund expected benefit payments. (2) During the second quarter 2024, the Company reclassified certain insurance products within the Health Solutions from Group to Voluntary. The table was not updated to reflect the reclassification impact on the comparative information and the impacts were primarily related to Net premiums collected and Benefit payments of $(17) and $(17), respectively. The following table presents a rollforward of the additional reserve liability for Businesses exited for the periods indicated: Businesses exited September 30, 2024 December 31, 2023 Balance at beginning of period $ 2,001 $ 2,107 Effect of change in cash flow assumptions (38) (44) Effect of actual variances from expected experience (12) (100) Adjusted balance at January 1 1,951 1,963 Interest accrual 62 84 Excess Benefits (304) (417) Assessments 201 371 Balance at end of period 1,910 2,001 Less: Reinsurance recoverable 1,858 1,950 Net additional liability, after reinsurance recoverable $ 52 $ 51 The reconciliation of the net liability for future policy benefits to the liability for future policy benefits in the Condensed Consolidated Balance Sheets is presented below: September 30, 2024 December 31, 2023 Health Solutions Group $ 763 $ 831 Health Solutions Voluntary 302 206 Businesses Exited - Future policy benefits 4,324 4,392 Businesses Exited - Additional liability 1,910 2,001 Business Exited - Other 1,305 1,335 Other (1) 939 795 Total $ 9,543 $ 9,560 (1) Primarily consists of short-duration contracts. The amount of undiscounted expected gross premiums and future benefit payments is presented in the table below: September 30, 2024 December 31, 2023 Undiscounted Discounted Undiscounted Discounted Health Solutions Group Expected future benefit payments $ 967 $ 774 $ 1,144 $ 918 Expected future gross premiums 11 9 271 214 Health Solutions Voluntary Expected future benefit payments 865 482 668 307 Expected future gross premiums 631 445 341 213 The following table presents the weighted average duration of the liability for future policy benefits and the weighted average interest rates for the periods indicated: Health Solutions Group Health Solutions Voluntary Businesses Exited September 30, 2024 December 31, 2023 September 30, 2024 December 31, 2023 September 30, 2024 December 31, 2023 Weighted average duration (in years) (1) 7 7 14 14 8 8 Interest accretion rate 4.0 % 4.0 % 5.1 % 5.2 % 5.0 % 4.9 % Current discount rate 4.8 % 4.9 % 5.1 % 5.1 % 5.0 % 5.1 % (1) Weighted average duration (in years) for Businesses Exited includes additional liability. The weighted average interest rates for the additional liability related to businesses exited were 4.3% and 4.2% for the periods ended September 30, 2024 and December 31, 2023, respectively. The following table presents a rollforward of Contract owner account balances for the periods indicated: Wealth Solutions Deferred Group and Individual Annuity Businesses Exited September 30, 2024 December 31, 2023 September 30, 2024 December 31, 2023 Balance at January 1 $ 31,139 $ 33,622 $ 4,635 $ 5,146 Deposits 1,837 2,309 214 288 Fee income (36) (9) (275) (373) Surrenders, withdrawals and benefits (3,780) (5,663) (430) (577) Net transfers (from) to the general account (1) 105 (5) 4 10 Interest credited 635 885 130 141 Ending Balance $ 29,900 $ 31,139 $ 4,278 $ 4,635 Weighted-average crediting rate 2.8 % 2.8 % 3.9 % 2.5 % Net amount at risk (2) $ 96 $ 123 $ 686 $ 734 Cash surrender value $ 29,441 $ 30,676 $ 1,284 $ 1,491 (1) Net transfers (from) to the general account for Wealth Solutions includes transfers of $(866) and $(523) for 2024 and 2023, respectively, related to Voya-managed institutional/mutual fund plan assets in trust that are not reflected on the Condensed Consolidated Balance Sheets. (2) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date and is calculated at a contract level. When a contract has both a living benefit and a death benefit, the Company calculates NAR at a contract level and aggregates the higher of the two values together. The following table presents a reconciliation of the Contract owner account balances to the Condensed Consolidated Balance Sheets for the periods indicated: September 30, 2024 December 31, 2023 Wealth Solutions Deferred group and individual annuity $ 29,900 $ 31,139 Businesses exited 4,278 4,635 Non-puttable funding agreements 1,251 1,175 Business exited - Other 1,188 1,275 Other (1) 896 950 Total $ 37,513 $ 39,174 (1) Primarily consists of universal life contracts. The following table summarizes detail on the differences between the interest rate being credited to contract holders as of the periods indicated, and the respective guaranteed minimum interest rates ("GMIRs"): Account Value (1) Excess of crediting rate over GMIR At GMIR Up to .50% Above GMIR 0.51% - 1.00% 1.01% - 1.50% Above GMIR 1.51% - 2.00% Above GMIR More than 2.00% Above GMIR Total As of September 30, 2024 Up to 1.00% $ 90 $ 4,544 $ 3,676 $ 1,731 $ 1,478 $ 870 $ 12,389 1.01% - 2.00% 452 118 50 7 3 6 636 2.01% - 3.00% 10,331 96 65 105 — 4 10,601 3.01% - 4.00% 8,492 151 — 11 — — 8,654 4.01% and Above 1,492 80 — — — — 1,572 Renewable beyond 12 months (2) 377 — — — 2 — 379 Total discretionary rate setting products $ 21,234 $ 4,989 $ 3,791 $ 1,854 $ 1,483 $ 880 $ 34,231 As of December 31, 2023 Up to 1.00% $ 120 $ 5,070 $ 3,460 $ 2,215 $ 863 $ 800 $ 12,528 1.01% - 2.00% 527 131 50 8 3 6 725 2.01% - 3.00% 11,225 93 63 108 — 3 11,492 3.01% - 4.00% 8,873 152 — 6 — — 9,031 4.01% and Above 1,566 83 — — — — 1,649 Renewable beyond 12 months (2) 428 — — — 3 — 431 Total discretionary rate setting products $ 22,739 $ 5,529 $ 3,573 $ 2,337 $ 869 $ 809 $ 35,856 (1) Includes only the account values for investment spread products with GMIRs and discretionary crediting rates, net of policy loans. Excludes Stabilizer products, which are fee based. (2) Represents multi year guaranteed annuity ("MYGA") contracts with renewal dates after September 30, 2024 and December 31, 2023 on which we are required to credit interest above the contractual GMIR for the next twelve months.

Reinsurance

Reinsurance	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Reinsurance	Reinsurance The Company reinsures its business through a diversified group of reinsurers. However, the Company remains liable to the extent its reinsurers do not meet their obligations under the reinsurance agreements. The Company monitors trends in arbitration and any litigation outcomes with its reinsurers. Collectability of reinsurance balances are evaluated by monitoring ratings and evaluating the financial strength of its reinsurers. Large reinsurance recoverable balances with offshore or other non-accredited reinsurers are secured through various forms of collateral, including secured trusts, funds withheld accounts and irrevocable letters of credit ("LOC"). Information regarding the effect of reinsurance on the Condensed Consolidated Balance Sheets is as follows as of the periods indicated: Direct Assumed Ceded Total, Net of Reinsurance September 30, 2024 Assets Premiums receivable $ 208 $ 11 $ (235) $ (16) Reinsurance recoverable, net of allowance for credit losses — — 11,502 11,502 Total $ 208 $ 11 $ 11,267 $ 11,486 Liabilities Future policy benefits and contract owner account balances $ 46,150 $ 906 $ — $ 47,056 Liability for funds withheld under reinsurance agreements 108 — — 108 Total $ 46,258 $ 906 $ — $ 47,164 December 31, 2023 Assets Premiums receivable $ 193 $ 9 $ (219) $ (17) Reinsurance recoverable, net of allowance for credit losses — — 11,999 11,999 Total $ 193 $ 9 $ 11,780 $ 11,982 Liabilities Future policy benefits and contract owner account balances $ 47,781 $ 953 $ — $ 48,734 Liability for funds withheld under reinsurance agreements 103 — — 103 Total $ 47,884 $ 953 $ — $ 48,837 Information regarding the effect of reinsurance on the Condensed Consolidated Statements of Operations is as follows for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Premiums: Direct premiums $ 1,016 $ 896 $ 3,070 $ 2,706 Reinsurance assumed 6 5 17 20 Reinsurance ceded (226) (219) (701) (682) Net premiums $ 796 $ 682 $ 2,386 $ 2,044 Fee income: Gross fee income $ 634 $ 585 $ 1,854 $ 1,718 Reinsurance assumed 4 4 12 13 Reinsurance ceded (98) (100) (296) (304) Net fee income $ 540 $ 489 $ 1,570 $ 1,427 Interest credited and other benefits to contract owners / policyholders: Direct interest credited and other benefits to contract owners / policyholders $ 1,233 $ 1,099 $ 3,571 $ 3,221 Reinsurance assumed 7 21 43 51 Reinsurance ceded (302) (321) (982) (1,040) Net interest credited and other benefits to contract owners / policyholders $ 938 $ 799 $ 2,632 $ 2,232 If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. As of September 30, 2024 and December 31, 2023, the Company had a deposit asset net of the allowance for credit losses of $1.1 billion and $1.2 billion, respectively, which is reported in Other assets on the Condensed Consolidated Balance Sheets.

Separate Accounts

Separate Accounts	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Separate Accounts	Separate Accounts The following tables present a rollforward of separate account liabilities for the Wealth Solutions stabilizer and deferred annuity business, including a reconciliation to the Condensed Consolidated Balance Sheets, for the periods indicated: September 30, 2024 December 31, 2023 Wealth Solutions Stabilizer Deferred Annuity Total Stabilizer Deferred Annuity Total Balance at January 1 $ 7,175 $ 82,310 $ 89,485 $ 7,196 $ 69,152 $ 76,348 Premiums and deposits 702 7,510 8,212 940 10,052 10,992 Fee income (25) (358) (383) (34) (426) (460) Surrenders, withdrawals and benefits (1,019) (8,999) (10,018) (1,342) (9,631) (10,973) Net transfers (from) to the separate account — (971) (971) — (518) (518) Investment performance 384 12,846 13,230 415 13,681 14,096 Balance at end of period $ 7,217 $ 92,338 $ 99,555 $ 7,175 $ 82,310 $ 89,485 Reconciliation to Condensed Consolidated Balance Sheets: Other 3,977 3,648 Total Separate Account liabilities $ 103,532 $ 93,133 Stabilizer products allow the contract holder to select either the market value of the account or the book value of the account at termination. The book value of the account is equal to deposits plus interest, less any withdrawals. The fair value is estimated using the income approach. Cash surrender value represents the amount of the contract holders' account balances distributable at the balance sheet date, less certain surrender charges. The cash surrender value for Wealth Solutions deferred annuity products was $92,314 and $82,286, as of September 30, 2024 and December 31, 2023, respectively. The aggregate fair value of assets, by major investment asset category, supporting separate accounts was as follows for the periods indicated: September 30, 2024 December 31, 2023 U.S. Treasury securities and obligations of U.S. government corporations and agencies $ 886 $ 1,015 Corporate and foreign debt securities 2,756 2,528 Mortgage-backed securities 3,191 3,231 Equity securities (including mutual funds) 96,257 85,916 Cash, cash equivalents and short-term investments 300 399 Receivable for securities and accruals 142 44 Total $ 103,532 $ 93,133

Segments

Segments	9 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
Segments	Segments The Company provides its principal products and services through three segments: Wealth Solutions, Health Solutions and Investment Management. The Company's chief operating decision maker views and manages the business through these three segments. The Wealth Solutions segment provides tax-deferred, employer-sponsored retirement savings plans and administrative services to corporate, education, healthcare, other non-profit and government entities, and stable value products to institutional clients where the Company may or may not be providing defined contribution products and services, as well as individual retirement accounts ("IRAs"), other retail financial products and comprehensive financial services to individual customers. The Health Solutions segment provides stop loss, group life, voluntary employee-paid and disability products to mid-sized and large businesses as well as benefit administration software solutions to employers and health plans. On January 24, 2023, the Company completed its acquisition of Benefitfocus. The financial results of Benefitfocus are reported in the Health Solutions segment for periods after the acquisition. The Investment Management segment provides investment products and retirement solutions across a broad range of geographies, market sectors, investment styles and capitalization spectrums. Products and services are offered to institutional clients, including public, corporate and union retirement plans, endowments and foundations and insurance companies, as well as individual investors and general accounts of the Company's insurance subsidiaries and are distributed through the Company's direct sales force, consultant channel and intermediary partners (such as banks, broker-dealers and independent financial advisers). The following corporate and business activities are included in Corporate Adjusted operating earnings before income taxes: • corporate operations, corporate level assets and financial obligations, financing and interest expenses, dividend payments made to preferred shareholders, and other items not allocated or directly related to the Company's segments, including items such as certain expenses and liabilities of employee benefit plans, certain adjustments to short-term and long-term incentive accruals, certain insurance costs and intercompany eliminations; and • investment income on assets backing surplus in excess of amounts held at the segment level. Measurement Adjusted operating earnings before income taxes is a meaningful measure used by management to evaluate its business and segment performance. This measure enhances the understanding of the Company’s financial results by focusing on the operating performance and trends of the underlying core business segments by excluding items that tend to be highly variable from period to period based on capital market conditions and/or other factors. The Company uses the same accounting policies and procedures to measure segment Adjusted operating earnings before income taxes as it does for the directly comparable U.S. GAAP measure Income (loss) before income taxes. Adjusted operating earnings before income taxes does not replace Income (loss) before income taxes as the U.S. GAAP measure of the Company’s consolidated results of operations. Therefore, the Company believes that it is useful to evaluate both measures when reviewing the Company’s financial and operating performance. Each segment’s Adjusted operating earnings before income taxes are calculated by adjusting Income (loss) before income taxes for the following items: • Net investment gains (losses), which are significantly influenced by economic and market conditions, including interest rates and credit spreads, and are not indicative of normal operations. Net investment gains (losses) include gains (losses) on the sale of securities, impairments, changes in the fair value of investments using the FVO unrelated to the implied loan-backed security income recognition for certain mortgage-backed obligations, and changes in the fair value of derivative instruments, excluding gains (losses) associated with swap settlements and accrued interest. It also includes changes in the fair value of derivatives related to managed custody guarantees, net of related reserve increases (decreases), less the estimated cost of these benefits, changes in nonperformance spread, and changes in market risk benefits; • Income (loss) related to businesses exited or to be exited through reinsurance or divestment, which includes gains and (losses) associated with transactions to exit blocks of business, amortization of intangible assets and residual run-off activity. Excluding this activity better reveals trends in the Company's core business and more closely aligns Adjusted operating earnings before income taxes with how the Company manages its segments; • Income (loss) attributable to noncontrolling interests to which the Company is not economically entitled, such as Allianz's stake in the results of VIM Holdings LLC (referred to as redeemable noncontrolling interest or Allianz noncontrolling interest) or the attribution of results from consolidated VIEs or VOEs; • Dividend payments made to preferred shareholders are included as reductions to reflect the Adjusted operating earnings before income taxes that are available to common shareholders; • Other adjustments may include the following items: ◦ Income (loss) related to early extinguishment of debt since the outcome of decisions to restructure debt are not indicative of normal operations; ◦ Impairment of goodwill and intangible assets as these represent losses related to infrequent events and do not reflect normal, cash-settled expenses; ◦ Amortization of acquisition-related intangible assets as well as contingent consideration fair value adjustments incurred in connection with certain acquisitions which are not indicative of current Operating expense fundamentals; ◦ Expected return on plan assets net of interest costs associated with the Company's qualified defined benefit pension plan and immediate recognition of net actuarial gains (losses) related to all of the Company's pension and other postretirement benefit obligations and gains (losses) from plan amendments and curtailments. These amounts do not reflect cash-settled expenses, and are not indicative of current Operating expense fundamentals; and ◦ Other items not indicative of normal operations or performance of the Company's segments or related to events such as capital or organizational restructurings, including certain costs related to debt and equity offerings, acquisition / merger integration expenses, severance and other third-party expenses associated with such activities, and expenses attributable to vacant real estate. These items vary widely in timing, scope and frequency between periods as well as between companies to which the Company is compared. Accordingly, the Company adjusts for these items as management believes that these items distort the ability to make a meaningful evaluation of the current and future performance of the Company's segments. The summary below reconciles Adjusted operating earnings before income taxes for the segments to Income (loss) before income taxes for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Adjusted operating earnings before income taxes by segment: Wealth Solutions $ 211 $ 179 $ 611 $ 485 Health Solutions 23 53 142 271 Investment Management 72 63 189 168 Corporate (60) (52) (178) (175) Total including Allianz noncontrolling interest 245 242 764 749 Less: Earning (loss) attributable to Allianz noncontrolling interest 16 14 40 35 Total $ 230 $ 229 $ 724 $ 715 Adjustments: Net investment gains (losses) (33) 42 50 (4) Income (loss) related to businesses exited or to be exited through reinsurance or divestment (52) (68) (121) (122) Income (loss) attributable to noncontrolling interests (16) (16) 51 107 Dividend payments made to preferred shareholders 16 14 37 32 Other adjustments (28) (28) (63) (150) Total adjustments to income (loss) before income taxes (113) (56) (45) (138) Income (loss) before income taxes $ 116 $ 172 $ 679 $ 576 Adjusted operating revenues is a measure of the Company's segment revenues. Each segment's Operating revenues are calculated by adjusting Total revenues to exclude the following items: • Net investment gains (losses); • Revenues related to businesses exited or to be exited through reinsurance or divestment; • Revenues attributable to noncontrolling interests, which represents the attribution of results from consolidated VIEs or VOEs; and • Other adjustments primarily reflect fee income earned by the Company's broker-dealers for sales of non-proprietary products, which are reflected net of commission expense in the Company's segments’ operating revenues, other items where the income is passed on to third parties and the elimination of intercompany investment expenses included in Adjusted operating revenues. The summary below reconciles Adjusted operating revenues for the segments to Total revenues for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Adjusted operating revenues by segment: Wealth Solutions $ 726 $ 702 $ 2,176 $ 2,090 Health Solutions 892 768 2,689 2,317 Investment Management 243 233 711 688 Corporate 6 14 15 39 Total $ 1,867 $ 1,717 $ 5,591 $ 5,135 Adjustments: Net investment gains (losses) (33) 40 30 (21) Revenues related to businesses exited or to be exited through reinsurance or divestment 52 21 89 53 Revenues attributable to noncontrolling interests 19 22 186 211 Other adjustments 50 24 144 152 Total adjustments to revenues 89 106 449 395 Total revenues $ 1,956 $ 1,823 $ 6,040 $ 5,529 Other Segment Information The Investment Management segment revenues include the following intersegment revenues, primarily consisting of asset-based management and administration fees for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Investment Management intersegment revenues $ 20 $ 21 $ 59 $ 65 The summary below presents Total assets for the Company’s segments as of the dates indicated: September 30, 2024 December 31, 2023 Wealth Solutions $ 131,936 $ 122,318 Health Solutions 3,553 3,336 Investment Management 1,790 1,600 Corporate 25,386 25,527 Total assets, before consolidation (1) 162,665 152,781 Consolidation of investment entities 4,268 4,304 Total assets $ 166,933 $ 157,085 (1) Total assets, before consolidation include the Company's direct investments in CIEs prior to consolidation, which are accounted for using the equity method or fair value option.

Share-based Incentive Compensat

Share-based Incentive Compensation Plans	9 Months Ended
	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Share-based Incentive Compensation Plans	Share-based Incentive Compensation Plans The Company previously offered equity-based compensation awards to its employees and non-employee directors under various employee and non-employee incentive plans (together, the "Omnibus Plans"). On May 23, 2024, the Company's shareholders approved the Voya Financial, Inc. 2024 Omnibus Incentive Plan (the "2024 Omnibus Plan"), which is a successor to the Omnibus Plans, and no further grants shall be made pursuant to the Omnibus Plans. The 2024 Omnibus Plan provides for 8,000,000 shares of common stock to be initially available for issuance as equity-based compensation awards, less one share for every one share granted under the Omnibus Plans after December 31, 2023 and prior to the effective date of the 2024 Omnibus Plan. As of September 30, 2024, common stock reserved and available for issuance under the 2024 Omnibus Plan was 7,048,255 shares. Compensation Cost The following table summarizes share-based compensation expense, which includes expenses related to awards granted under the Omnibus Plans and the 2024 Omnibus Plan for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Restricted Stock Unit (RSU) awards $ 13 $ 14 $ 49 $ 67 Performance Stock Unit (PSU) awards 10 7 36 43 Total share-based compensation expense 23 21 85 110 Income tax benefit 5 4 21 26 After-tax share-based compensation expense $ 18 $ 17 $ 64 $ 84 Awards Outstanding The following table summarizes RSU and PSU awards activity under the Omnibus Plans and the 2024 Omnibus Plan for the period indicated: RSU Awards PSU Awards (awards in millions) Number of Awards Weighted Average Grant Date Fair Value Number of Awards Weighted Average Grant Date Fair Value Outstanding as of January 1, 2024 2.0 $ 67.06 2.2 $ 61.17 Adjustment for PSU performance factor — — (0.1) 46.94 Granted 0.9 67.70 0.7 59.21 Vested (0.8) 64.91 (0.6) 53.53 Forfeited (0.1) 69.42 — * 69.19 Outstanding as of September 30, 2024 2.0 $ 68.06 2.2 $ 63.55 *Less than 0.1 The following table summarizes the number of options under the Omnibus Plans for the period indicated: Stock Options (awards in millions) Number of Awards Weighted Average Exercise Price Outstanding as of January 1, 2024 1.2 $ 44.79 Granted — — Exercised (0.3) 42.55 Forfeited — * 50.03 Outstanding as of September 30, 2024 0.9 $ 45.47 Vested, exercisable, as of September 30, 2024 0.9 $ 45.47 *Less than 0.1

Shareholders' Equity

Shareholders' Equity	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Shareholder's Equity	Shareholders' Equity Common Shares The following table presents the rollforward of common shares used in calculating the weighted average shares utilized in the basic earnings per common share calculation for the periods indicated: Common Shares (shares in millions) Issued Held in Treasury Outstanding Balance, January 1, 2023 97.8 0.6 97.2 Common shares issued 9.7 — 9.7 Common shares acquired - share repurchase — 5.4 (5.4) Share-based compensation 2.1 0.7 1.4 Treasury stock retirement (6.0) (6.0) — Balance, December 31, 2023 103.6 0.7 102.9 Common shares issued 0.1 — 0.1 Common shares acquired - share repurchase — 6.9 (6.9) Share-based compensation 1.7 0.7 1.0 Balance, September 30, 2024 105.4 8.3 97.1 Dividends declared per share of common stock were as follows for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Dividends declared per share of common stock $ 0.45 $ 0.40 $ 1.25 $ 0.80 Share Repurchase Program From time to time, the Company's Board of Directors authorizes the Company to repurchase shares of its common stock. These authorizations permit stock repurchases up to a prescribed dollar amount and generally may be accomplished through various means, including, without limitation, open market transactions, privately negotiated transactions, forward, derivative, or accelerated repurchase, or automatic repurchase transactions, including through 10b5-1 plans, or tender offers. Share repurchase authorizations typically expire if unused by a prescribed date. As of September 30, 2024, the Company's remaining repurchase capacity under the Board's prior authorization was $382. On October 31, 2024, the Company's Board authorized additional share repurchases of $500. The Company's share repurchase authorization expires on December 31, 2025 (unless extended) and does not obligate the Company to purchase any shares. The authorization for the share repurchase program may be terminated, increased or decreased by the Company's Board at any time. The following table presents repurchases of the Company's common stock through share repurchase agreements with third-party financial institutions during the nine months ended September 30, 2024: Execution Date Payment Initial Shares Delivered Closing Date Additional Shares Delivered Total Shares Repurchased September 12, 2024 $ 100 1,061,853 (1) (1) (1) (1) This arrangement is scheduled to terminate no later than December 31, 2024, at which time the Company will settle any positive or negative share balances based on the daily volume-weighted average price of the Company's common stock. The following table presents repurchases of our common stock pursuant to 10b5-1 plans and through open market repurchases for the periods indicated: Nine Months Ended September 30, 2024 2023 Shares of common stock 5,811,158 3,107,195 Payment $ 415 $ 216 Subsequent to September 30, 2024, the Company repurchased 997,994 shares pursuant to a 10b5-1 plan for $81. Preferred Stock As of September 30, 2024 and December 31, 2023, there were 100,000,000 shares of preferred stock authorized. Shares of preferred stock issued and outstanding are as follows: September 30, 2024 December 31, 2023 Series Issued Outstanding Issued Outstanding 7.758% Non-cumulative Preferred Stock, Series A 325,000 325,000 325,000 325,000 5.35% Non-cumulative Preferred Stock, Series B 300,000 300,000 300,000 300,000 Total 625,000 625,000 625,000 625,000 Dividends declared on preferred stock per share and in the aggregate were as follows for the periods indicated: Series A Series B Three Months Ended September 30, Per Share Aggregate Per Share Aggregate 2024 $ 38.790 $ 13 $ 13.375 $ 4 2023 30.625 10 13.375 4 Nine Months Ended September 30, 2024 77.580 25 40.125 12 2023 61.250 20 40.125 12 As of September 30, 2024, there were no preferred stock dividends in arrears.

Earnings per Common Share

Earnings per Common Share	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Earnings per Common Share	Earnings per Common Share The following table presents a reconciliation of Net income (loss) and shares used in calculating basic and diluted net income (loss) per common share for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, (in millions, except for per share data) 2024 2023 2024 2023 Earnings Net income (loss) available to common shareholders: Net income (loss) $ 98 $ 246 $ 621 $ 610 Less: Preferred stock dividends 16 14 37 32 Less: Net income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest (16) (16) 51 107 Net income (loss) available to common shareholders $ 98 $ 248 $ 533 $ 471 Weighted average common shares outstanding Basic 98.2 105.8 100.2 102.2 Dilutive Effects: Warrants (1) — — — 4.3 RSUs 1.1 1.1 1.1 1.1 PSUs 0.7 1.1 0.7 1.2 Stock Options 0.4 0.4 0.4 0.5 Diluted 100.4 108.4 102.4 109.3 Net income (loss) available to Voya Financial, Inc.'s common shareholders per common share (2) Basic $ 1.00 $ 2.35 $ 5.32 $ 4.62 Diluted $ 0.98 $ 2.29 $ 5.20 $ 4.31 (1) See the Shareholders' Equity Note to the Consolidated Financial Statements in Part II, Item 8. of the Company's Annual Report on Form 10-K for the year ended December 31, 2023 for additional information on warrants settled. (2) Basic and diluted earnings per share are calculated using unrounded, actual amounts. Therefore, the components of earnings per share may not sum to its corresponding total. Diluted earnings per share is computed assuming the issuance of restricted stock units, stock options, performance share units and warrants using the treasury stock method.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) Shareholders' equity included the following components of Accumulated other comprehensive income ("AOCI") as of the dates indicated: September 30, 2024 September 30, 2023 Fixed maturities, net of impairment $ (1,648) $ (3,881) Derivatives (1) 34 100 Change in current discount rate (838) (850) Deferred income tax asset (liability) (2) 638 1,096 Total (1,814) (3,535) Pension and other postretirement benefits liability, net of tax 2 2 AOCI $ (1,812) $ (3,533) (1) Gains and losses reported in AOCI from hedge transactions that resulted in the acquisition of an identified asset are reclassified into earnings in the same period or periods during which the asset acquired affects earnings. As of September 30, 2024, the portion of the AOCI that is expected to be reclassified into earnings within the next 12 months is $12. (2) The Company uses the portfolio method to determine when stranded tax benefits (or detriments) are released from AOCI. Changes in AOCI, including the reclassification adjustments recognized in the Condensed Consolidated Statements of Operations, were as follows for the periods indicated: Three Months Ended September 30, 2024 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ 1,047 $ (219) $ 828 Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations (20) 4 (16) Change in unrealized gains/losses on available-for-sale securities 1,027 (215) 812 Derivatives: Derivatives (28) (1) 6 (22) Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (4) 1 (3) Change in unrealized gains/losses on derivatives (32) 7 (25) Change in current discount rate (20) 4 (16) Change in Accumulated other comprehensive income (loss) $ 975 $ (204) $ 771 (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Nine Months Ended September 30, 2024 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ 717 $ (151) $ 566 Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 4 (1) 3 Change in unrealized gains (losses) on available-for-sale securities 721 (152) 569 Derivatives: Derivatives (17) (1) 4 (13) Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (12) 3 (9) Change in unrealized gains (losses) on derivatives (29) 7 (22) Change in current discount rate 52 (11) 41 Change in Accumulated other comprehensive income (loss) $ 744 $ (156) $ 588 (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Three Months Ended September 30, 2023 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (937) $ 197 $ (740) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 18 (4) 14 Change in unrealized gains (losses) on available-for-sale securities (919) 193 (726) Derivatives: Derivatives 7 (1) (2) 5 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (4) 1 (3) Change in unrealized gains (losses) on derivatives 3 (1) 2 Change in current discount rate (23) 5 (18) Change in Accumulated other comprehensive income (loss) $ (939) $ 197 $ (742) (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Nine Months Ended September 30, 2023 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (619) $ 130 $ (489) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 32 (7) 25 Change in unrealized gains (losses) on available-for-sale securities (587) 123 (464) Derivatives: Derivatives (11) (1) 2 (9) Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (14) 3 (11) Change in unrealized gains (losses) on derivatives (25) 5 (20) Change in current discount rate 7 (1) 6 Change in Accumulated other comprehensive income (loss) $ (605) $ 127 $ (478) (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information.

Revenue from Contract with Cust

Revenue from Contract with Customers	9 Months Ended
	Sep. 30, 2024
Revenue from Contract with Customer [Abstract]
Revenue from Contracts with Customers	Revenue from Contracts with Customers Financial services and software subscriptions and services revenue is disaggregated by type of service in the following table: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Wealth Solutions: Advisory and recordkeeping and administration $ 163 $ 125 $ 463 $ 369 Distribution and shareholder servicing 34 29 100 88 Investment Management: Advisory, asset management and recordkeeping and administration 248 236 732 698 Distribution and shareholder servicing 40 36 119 100 Health Solutions: Recordkeeping and administration 7 4 19 15 Software subscriptions and services 50 53 154 167 Corporate: Recordkeeping and administration — 8 2 25 Total financial services and software subscriptions and services revenue 542 491 1,589 1,462 Revenue from other sources (1) 101 79 270 210 Total Fee income and Other revenue $ 643 $ 570 $ 1,859 $ 1,672 (1) Primarily consists of revenue from insurance contracts and financial instruments. Net receivables of $339 are included in Other assets on the Condensed Consolidated Balance Sheets as of September 30, 2024 and December 31, 2023.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company uses the estimated annual effective tax rate method in computing its interim tax provision. Certain items, including changes in the realizability of deferred tax assets and changes in liabilities for uncertain tax positions, are excluded from the estimated annual effective tax rate and the actual tax expense or benefit is reported in the period the related item is incurred. The Company's effective tax rate for the three months ended September 30, 2024 was 15.5%. The effective tax rate differed from the statutory rate of 21% primarily due to the effect of the dividends received deduction ("DRD"), tax credits and noncontrolling interest. The Company's effective tax rate for the nine months ended September 30, 2024 was 8.5%. The effective tax rate differed from the statutory rate of 21% primarily due to the Security Life of Denver Company capital loss carryback as discussed below, the effect of the DRD, noncontrolling interest and tax credits. The Company's effective tax rate for the three months ended September 30, 2023 was (43.0)%. The effective tax rate differed from the statutory rate of 21% primarily due to the Security Life of Denver Company capital loss carryback, the effect of the DRD and tax credits. The Company's effective tax rate for the nine months ended September 30, 2023 was (5.9)%. The effective tax rate differed from the statutory rate of 21% primarily due to the Security Life of Denver Company capital loss carryback, the effect of the DRD, noncontrolling interest and tax credits. On January 4, 2021, the Company completed a series of transactions pursuant to a Master Transaction Agreement with Resolution Life U.S. Holdings Inc. ("Resolution Life US"). As a part of these transactions, Resolution Life US acquired the Company's wholly owned subsidiary, Security Life of Denver Company ("SLD"). SLD generated capital losses in the 2023 and 2022 tax years, which are included in a carryback claim for the Company. The Company recorded a $38 and $92 tax benefit in 2024 and 2023, respectively, resulting in a decrease to the effective tax rate. Valuation allowances are provided when it is considered more likely than not that some portion or all of the deferred tax assets ("DTAs") will not be realized. The Company reviews all available positive and negative evidence to determine if a valuation allowance is recorded, including historical and projected pre-tax book income, tax planning strategies and reversals of temporary differences. As of September 30, 2024, the Company had year-to-date gains on securities of $692 in Other comprehensive income reducing the related DTA. Additionally, income before income taxes available to the Company remained positive for the period and was largely consistent with the 2023 year-end valuation allowance analysis. After evaluating the positive and negative evidence, the Company did not change its judgement regarding the realization of DTAs. For more information related to the valuation allowance, refer to the Income Taxes Note to the Consolidated Financial Statements included in Part II, Item 8. of the Annual Report on Form 10-K . Tax Regulatory Matters For the tax years 2022 through 2024, the Company participates in the Internal Revenue Service ("IRS") Compliance Assurance Process ("CAP"), which is a continuous audit program provided by the IRS. For the 2023 tax year, the Company is in the Compliance Maintenance Bridge ("Bridge") phase of CAP. In the Bridge phase, the IRS did not conduct any review or provide any letters of assurance for that tax year. For the 2024 tax year, the Company is in the Compliance Maintenance Bridge Plus ("Bridge Plus") phase of CAP. In the Bridge Plus phase, the IRS will review the tax return and issue either a full or partial acceptance letter upon completion of review. Tax Legislative Matters In August 2022, the Inflation Reduction Act was signed into law creating the corporate alternative minimum tax ("CAMT"). In September 2024, the Department of Treasury issued proposed regulations providing additional guidance on the CAMT. Based on the proposed regulations, the Company does not expect to be subject to the CAMT for 2024.

Financing Agreements

Financing Agreements	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Financing Agreements	Financing Agreements Short-term and Long-term Debt The following table summarizes the carrying value of the Company’s debt issued or borrowed and outstanding as of the periods indicated: Issuer Maturity September 30, 2024 December 31, 2023 3.976% Senior Notes, due 2025 (2)(3) Voya Financial, Inc. 02/15/2025 $ 397 $ 390 3.65% Senior Notes, due 2026 (2)(3) Voya Financial, Inc. 06/15/2026 446 446 5.0% Senior Notes, due 2034 (2)(3) Voya Financial, Inc. 09/20/2034 395 — 5.7% Senior Notes, due 2043 (2)(3) Voya Financial, Inc. 07/15/2043 396 396 4.8% Senior Notes, due 2046 (2)(3) Voya Financial, Inc. 06/15/2046 297 297 4.7% Fixed-to-Floating Rate Junior Subordinated Notes, due 2048 Voya Financial, Inc. 01/23/2048 336 336 7.625% Voya Holdings Inc. debentures, due 2026 (1) Voya Holdings, Inc. 08/15/2026 139 139 6.97% Voya Holdings Inc. debentures, due 2036 (1) Voya Holdings, Inc. 08/15/2036 79 79 8.42% Equitable of Iowa Companies Capital Trust II Notes, due 2027 Equitable of Iowa Capital Trust II 04/01/2027 13 13 1.00% Windsor Property Loan Voya Retirement Insurance and Annuity Company 06/14/2027 2 2 Subtotal 2,500 2,098 Less: Current portion of long-term debt 397 1 Total $ 2,103 $ 2,097 (1) Guaranteed by ING Group. (2) Interest is paid semi-annually in arrears. (3) Guaranteed by Voya Holdings. As of September 30, 2024, the Company was in compliance with its debt covenants. Senior Notes On September 20, 2024, Voya Financial, Inc. issued $400 of unsecured 5.0% Senior Notes due 2034 (the "2034 Notes"). The 2034 Notes are fully, irrevocably, and unconditionally guaranteed by Voya Holdings Inc. Interest is paid semi-annually in arrears on March 20 and September 20 of each year, commencing on March 20, 2025. The offering resulted in aggregate net proceeds to the Company of $397, after deducting commissions and expenses. The Company intends to use the net proceeds for the repayment at maturity of the $400 outstanding principal amount of its 3.976% Senior Notes due February 15, 2025. Aetna Notes As of September 30, 2024, outstanding principal amount of the 7.625% Voya Holdings Inc. debentures, due 2026 and 6.97% Voya Holdings Inc. debentures, due 2036 (collectively, the "Aetna Notes") was $218, which is guaranteed by ING Group. As of September 30, 2024, the Company provided $231 of collateral benefiting ING Group, comprised of a deposit of $219 to a control account with a third-party collateral agent and $12 of letter of credit. The collateral may be exchanged at any time upon the posting of any other form of acceptable collateral to the account. Credit Facilities The Company uses credit facilities as part of its capital management practices. Total fees associated with credit facilities for the nine months ended September 30, 2024 and 2023 were immaterial. The following table summarizes the Company's credit facilities as of September 30, 2024: Obligor / Applicant Secured / Unsecured Committed / Uncommitted Expiration Capacity Utilization Unused Commitment Voya Financial, Inc. Unsecured Committed 05/01/2028 $ 500 $ — $ 500 Voya Financial, Inc. Unsecured Committed 04/07/2025 12 (2) 12 (1) — Total $ 512 $ 12 $ 500 (1) Amount utilized as collateral for outstanding Aetna Notes. (2) In March of 2024, the Company decreased the capacity of its letter of credit, expiring in 2025, from $200 to $12. This reduction was due to the reduced collateral requirements resulting from the maturity of a portion of the Aetna Notes. Additionally, the full capacity was not expected to be utilized through its expiration. Put Option Agreement for Senior Debt Issuance During 2015, the Company entered into an off-balance sheet 10-year put option agreement with a Delaware trust formed by the Company, in connection with the sale by the trust of pre-capitalized trust securities ("P-Caps"), that provides Voya Financial, Inc. the right, at any time over a 10-year period, to issue up to $500 principal amount of its 3.976% Senior Notes due 2025 ("3.976% Senior Notes") to the trust and receive in exchange a corresponding principal amount of U.S. Treasury securities that are held by the trust. The 3.976% Senior Notes will not be issued unless and until the put option is exercised. In return, the Company pays a semi-annual put premium to the trust at a rate of 1.875% per annum applied to the unexercised portion of the put option and reimburses the trust for its expenses. The put premium and expense reimbursements are recorded in Operating expenses in the Condensed Consolidated Statements of Operations. If and when issued, the 3.976% Senior Notes will be guaranteed by Voya Holdings. Upon an event of default, the put option will be exercised automatically in full. The Company has a one-time right to unwind a prior voluntary exercise of the put option by repurchasing all of the 3.976% Senior Notes then held by the trust for U.S. Treasury securities. If the put option has been fully exercised, the 3.976% Senior Notes issued may be redeemed by the Company prior to their maturity at par or, if greater, at a make-whole redemption price, in each case plus accrued and unpaid interest to the date of redemption. The P-Caps are to be redeemed by the trust on February 15, 2025 or upon any early redemption of the 3.976% Senior Notes. On May 1, 2023, pursuant to the put option agreement, the Company exercised the put option to require the trust to purchase $400 aggregate principal amount of 3.976% Senior Notes in exchange for a corresponding amount of U.S. Treasury securities held by the trust. On May 3, 2023, the Company issued $400 aggregate principal amount of 3.976% Senior Notes to the trust and the Company received approximately $400 of U.S. Treasury securities. The proceeds from the sale of the U.S. Treasury securities were used to redeem the 5.65% Fixed-to-Floating Rate Junior Subordinated Notes due 2053 on May 15, 2023. As of September 30, 2024, the Company may issue up to $100 principal amount of its 3.976% Senior Notes to the trust under the put option agreement. Senior Unsecured Credit Facility Agreement As of September 30, 2024, the Company had a $500 senior unsecured credit facility with a syndicate of banks which expires May 1, 2028. The facility provides $500 of committed capacity for revolving loan borrowings and letters of credit issuances, including a sublimit for swingline (short-term) loans in an aggregate amount of up to $25. As of September 30, 2024, there were no amounts outstanding as revolving credit borrowings, no amounts of LOCs outstanding, and no amounts of swingline loans outstanding under the senior unsecured credit facility. Under the terms of the facility, the Company is required to maintain a minimum net worth of $4.998 billion, which may increase upon any future equity issuances by the Company.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Leases During the three and nine months ended September 30, 2024, there was no impairment on the Company's right-of-use asset associated with leased office space. During the three months ended September 30, 2023, there was no impairment on the Company's right-of-use asset associated with leased office space. During the nine months ended September 30, 2023, the Company recorded an impairment of $14, on its right-of-use asset associated with leased office space. The impairments are included in Operating expenses in the Condensed Consolidated Statements of Operations. Commitments Through the normal course of investment operations, the Company commits to either purchase or sell securities, mortgage loans, or money market instruments, at a specified future date and at a specified price or yield. The inability of counterparties to honor these commitments may result in either a higher or lower replacement cost. Also, there is likely to be a change in the value of the securities underlying the commitments. As of September 30, 2024, the Company had off-balance sheet commitments to acquire mortgage loans of $119 and purchase limited partnerships and private placement investments of $1,169, of which $411 related to consolidated investment entities. Restricted Assets The Company is required to maintain assets on deposit with various regulatory authorities to support its insurance operations. The Company may also post collateral in connection with certain securities lending, repurchase agreements, funding agreements, credit facilities and derivative transactions. The components of the fair value of the restricted assets were as follows as of the dates indicated: September 30, 2024 December 31, 2023 Fixed maturity collateral pledged to FHLB (1) $ 2,176 $ 1,956 FHLB restricted stock (2) 65 64 Fixed maturities-state and other deposits 40 37 Cash and cash equivalents 22 25 Securities pledged (3) 1,463 1,160 Total restricted assets $ 3,766 $ 3,242 (1) Included in Fixed maturities, available for sale, at fair value on the Condensed Consolidated Balance Sheets. (2) Included in Other investments on the Condensed Consolidated Balance Sheets. (3) Includes the fair value of loaned securities of $1,091 and $842 as of September 30, 2024 and December 31, 2023, respectively. In addition, as of September 30, 2024 and December 31, 2023, the Company delivered securities as collateral of $168 and $201, respectively, and repurchase agreements of $204 and $117, respectively. Loaned securities and securities delivered as collateral are included in Securities pledged on the Condensed Consolidated Balance Sheets. Federal Home Loan Bank Funding Agreements The Company is a member of the FHLB of Des Moines and the FHLB of Boston and is required to pledge collateral to back funding agreements issued to the FHLB. As of September 30, 2024 and December 31, 2023, the Company had $1,251 and $1,175, respectively, in non-putable funding agreements, which are included in Contract owner account balances on the Condensed Consolidated Balance Sheets. As of September 30, 2024 and December 31, 2023, assets with a market value of approximately $2,176 and $1,956, respectively, collateralized the FHLB funding agreements. Assets pledged to the FHLB are included in Fixed maturities, available-for-sale, at fair value on the Condensed Consolidated Balance Sheets. Litigation, Regulatory Matters and Contingencies Litigation, regulatory and other loss contingencies arise in connection with the Company's activities as a diversified financial services firm. The Company is a defendant in a number of litigation matters, arising from the conduct of its business, both in the ordinary course and otherwise. In some of these matters, claimants seek to recover very large or indeterminate amounts, including compensatory, punitive, treble and exemplary damages. The variability in pleading requirements and past experience demonstrate that the monetary and other relief that may be requested in a lawsuit or claim often bears little relevance to the merits or potential value of a claim. As with other financial services companies, the Company periodically receives informal and formal requests for information from various state and federal governmental agencies and self-regulatory organizations in connection with inquiries and investigations of the products and practices of the Company or the financial services industry. For example, the Company is cooperating with a publicly reported, industry-wide investigation by the SEC regarding compliance with certain record-keeping requirements for business-related electronic communications on unapproved channels. While it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company's financial position, based on information currently known, management believes that neither the outcome of pending litigation and regulatory matters nor potential liabilities associated with other loss contingencies, are likely to have such an effect. However, given the large and indeterminate amounts sought in certain litigation and the inherent unpredictability of all such matters, it is possible that an adverse outcome in certain of the Company's litigation or regulatory matters, or liabilities arising from other loss contingencies, could, from time to time, have a material adverse effect upon the Company's results of operations or cash flows in a particular quarterly or annual period. For some matters, the Company is able to estimate a possible range of loss. For such matters in which a loss is probable, an accrual has been made. For matters where the Company, however, believes a loss is reasonably possible, but not probable, no accrual is required. For matters for which an accrual has been made, but there remains a reasonably possible range of loss in excess of the amounts accrued or for matters where no accrual is required, the Company develops an estimate of the unaccrued amounts of the reasonably possible range of losses. As of September 30, 2024, the Company estimates the aggregate range of reasonably possible losses, in excess of any amounts accrued for these matters as of such date, to be up to approximately $100. For other matters, the Company is currently not able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from plaintiffs and other parties, investigation of factual allegations, rulings by a court on motions or appeals, analysis by experts and the progress of settlement discussions. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation and regulatory contingencies and updates the Company's accruals, disclosures and reasonably possible losses or ranges of loss based on such reviews. Litigation includes Ravarino, et al. v. Voya Financial, Inc., et al. (USDC District of Connecticut, No. 3:21-cv-01658)(filed December 14, 2021). In this putative class action, the plaintiffs allege that the named defendants breached their fiduciary duties of prudence and loyalty in the administration of the Voya 401(k) Savings Plan. The plaintiffs claim that the named defendants did not exercise proper prudence in their management of allegedly poorly performing investment options, including proprietary funds, and passed excessive investment-management and other administrative fees for proprietary and non-proprietary funds onto plan participants. The plaintiffs also allege that the defendants engaged in self-dealing through the inclusion of the Voya Stable Value Option into the plan offerings and by setting the “crediting rate” for participants’ investment in the Stable Value Fund artificially low in relation to Voya’s general account investment returns in order to maximize the spread and Voya’s profits at the participants’ expense. The complaint seeks disgorgement of unjust profits as well as costs incurred. On June 13, 2023, the Court issued a ruling granting in part and denying in part Voya's motion to dismiss. The court largely dismissed the claims for breach of fiduciary duty. The remaining claims concern allegations of breaches of the ERISA prohibited transactions rule and a claim for failure to monitor the Voya Small Cap Growth fund. The Company continues to deny the allegations, which it believes are without merit, and intends to defend the case vigorously. In November 2022, the Company acquired Czech Asset Management, L.P., pursuant to an agreement that provides for earn-out payments if certain contingencies are met. On March 11, 2024, the Company received from the sellers a demand for arbitration of a claim that the full amount of these earn-outs had become payable. The Company is opposing the claim in arbitration. Contingencies related to Performance-based Capital Allocations on Private Equity Funds Certain performance-based capital allocations related to sponsored private equity funds ("carried interest") are not final until the conclusion of an investment term specified in the relevant asset management contract. As a result, such carried interest, if accrued or paid to the Company during such term, is subject to later adjustment based on subsequent fund performance. If the fund’s cumulative investment return falls below specified investment return hurdles, some or all of the previously accrued carried interest is reversed to the extent that the Company is no longer entitled to the performance-based capital allocation. Should the fund’s cumulative investment return subsequently increase above specified investment return hurdles in future periods, previous reversals could be fully or partially recovered. As of September 30, 2024, approximately $93 of previously accrued carried interest would be subject to full or partial reversal in future periods if cumulative fund performance hurdles are not maintained throughout the remaining life of the affected funds.

Consolidated and Nonconsolidate

Consolidated and Nonconsolidated Investment Entities	9 Months Ended
	Sep. 30, 2024
Consolidated Investment Entities [Abstract]
Consolidated and Nonconsolidated Investment Entities	Consolidated and Nonconsolidated Investment Entities The Company holds variable interests in certain investment entities in the form of debt or equity investments, as well as the right to receive management fees, performance fees, and carried interest. The Company consolidates certain entities under the VIE guidance when it is determined that the Company is the primary beneficiary. Alternatively, certain entities are consolidated under the VOE guidance when control is obtained through voting rights. Refer to the Condensed Consolidated Balance Sheets for the assets and liabilities of the Company's consolidated investment entities. The Company has no right to the benefits from, nor does it bear the risks associated with consolidated investment entities beyond the Company’s direct equity and debt investments in and management fees generated from these entities. Such direct investments amounted to approximately $385 and $316 as of September 30, 2024 and December 31, 2023, respectively. If the Company were to liquidate, the assets held by consolidated investment entities would not be available to the general creditors of the Company as a result of the liquidation. Consolidated VIEs and VOEs Collateral Loan Obligations Entities ("CLOs") The Company is involved in the design, creation, and the ongoing management of CLOs. These entities are created for the purpose of acquiring diversified portfolios of senior secured floating rate leveraged loans, and securitizing these assets by issuing multiple tranches of collateralized debt; thereby providing investors with a broad array of risk and return profiles. Also known as collateralized financing entities under ASC Topic 810, CLOs are variable interest entities by definition. In return for providing collateral management services, the Company earns investment management fees and contingent performance fees. In addition to earning fee income, the Company often invests in the subordinated debt of entities formed to be the issuers of CLO offerings during their warehouse periods. The Company’s investments in these CLOs are repaid when the CLOs’ warehouse periods are closed and the CLO offerings are issued. The Company performs ongoing monitoring of the consolidation assessment for CLOs during and after their warehouse periods to determine if the Company remains the primary beneficiary of the CLOs. The fee income earned and investments held are included in the Company's ongoing consolidation assessment for each CLO. The Company was the primary beneficiary of 7 and 5 CLOs as of September 30, 2024 and December 31, 2023, respectively. Limited Partnerships ("LPs") The Company invests in and manages various limited partnerships, including private equity funds and hedge funds. The LPs generally have a ten-year life and a specified period during which investors can subscribe for limited partnership interests. Once the investors are admitted as limited partners, the investors are required to contribute capital when called by the general partners. The purpose of the LPs is to obtain subscriptions from limited partners and maximize the return to their partners by assembling a diversified portfolio of investments in private equity funds and other securities or assets with similar risk and return characteristics primarily through secondary market purchases. The majority of the investors in the LPs are unrelated parties to the Company. In return for subscriptions, each partner receives an equity interest in the LPs in proportion to its respective investment. These entities have been evaluated by the Company and are determined to be VIEs due to the equity holders, as a group, lacking the characteristics of a controlling financial interest. In return for serving as the general partner of and providing investment management services to these entities, the Company earns management fees and carried interest in the normal course of business. Additionally, the Company often holds an investment in each limited partnership it manages, generally in the form of general partner and limited partner interests. The fee income, carried interest, and investments held are included in the Company’s ongoing consolidation analysis for each limited partnership. The Company consolidated 13 and 11 partnerships as of September 30, 2024 and December 31, 2023, respectively. The noncontrolling interest related to partnerships decreased from $1,685 at December 31, 2023 to $1,665 at September 30, 2024. Changes in market value, consolidations, deconsolidations, contributions, and distributions related to these investments in the funds directly impact the noncontrolling interest component of Shareholders' equity on the Company's Condensed Consolidated Balance Sheets. The change in noncontrolling interest was primarily driven by an increase in net distributions, partially offset by favorable market appreciation in limited partnership investments. The Company records the noncontrolling interest using a lag methodology relying on the most recent financial information available. Fair Value Measurement Upon consolidation, the Company elected to apply the FVO for financial assets and financial liabilities held by CLOs and continued to measure these assets (primarily corporate loans) and liabilities (debt obligations issued by CLOs) at fair value in subsequent periods. The Company has elected the FVO to more closely align its accounting with the economics of its transactions and allows the Company to more effectively align changes in the fair value of CLO assets with a commensurate change in the fair value of CLO liabilities. Investments held by consolidated private equity funds are measured and reported at fair value in the Company's Condensed Consolidated Financial Statements. Changes in the fair value of consolidated investment entities are recorded as a separate line item within Income (loss) related to consolidated investment entities in the Company's Condensed Consolidated Statements of Operations. The methodology for measuring the fair value of financial assets and liabilities of consolidated investment entities, and the classification of these measurements in the fair value hierarchy is consistent with the methodology and classification applied by the Company to its investment portfolio, as discussed within the Fair Value Measurements (excluding Consolidated Investment Entities) Note to these Condensed Consolidated Financial Statements. As discussed in more detail below, the Company utilizes valuations obtained from third-party commercial pricing services, brokers and investment sponsors or third-party administrators that supply NAV (or its equivalent) per share used as a practical expedient. The valuations obtained from brokers and third-party commercial pricing services are non-binding. These valuations are reviewed on a monthly or quarterly basis depending on the entity and its underlying investments. Procedures include, but are not limited to, a review of underlying fund investor reports, review of top and worst performing funds requiring further scrutiny, review of variance from prior periods and review of variance from benchmarks, where applicable. In addition, the Company considers both macro and fund specific events that may impact the latest NAV supplied and determines if further adjustments of value should be made. Such changes, if any, are subject to senior management review. When a price cannot be obtained from a commercial pricing service, independent broker quotes are solicited. Securities priced using independent broker quotes are classified as Level 3. Broker quotes and prices obtained from pricing services are reviewed and validated through an internal valuation committee price variance review, comparisons to internal pricing models, back testing to recent trades or monitoring of trading volumes. Cash and Cash Equivalents The carrying amounts for cash reflect the assets’ fair values. The fair value for cash equivalents is determined based on quoted market prices. These assets are classified as Level 1. CLOs Corporate loans : Corporate loan investments, which comprise the majority of consolidated CLO portfolio collateral, are senior secured corporate loans maturing at various dates between 2024 and 2032, paying interest at SOFR, EURIBOR or PRIME plus a spread of up to 8.8%. As of September 30, 2024 and December 31, 2023, the unpaid principal balance exceeded the fair value of the corporate loans by approximately $23 and $46, respectively. Less than 1.0% of the collateral loans were in default as of September 30, 2024 and December 31, 2023. The fair values for corporate loans are determined using independent commercial pricing services. Fair value measurement based on pricing services may be classified in Level 2 or Level 3 depending on the type, complexity, observability and liquidity of the asset being measured. The inputs used by independent commercial pricing services, such as benchmark yields and credit risk adjustments, are those that are derived principally from or corroborated by observable market data. Hence, the fair value measurement of corporate loans priced by independent pricing service providers is classified within Level 2 of the fair value hierarchy. In addition, there are assets held with CLO portfolios that represent senior level debt of other third party CLOs. These CLO investments are classified within Level 3 of the fair value hierarchy. See description of fair value process for CLO notes below. CLO notes : The CLO notes are backed by diversified loan portfolios consisting primarily of senior secured floating rate leveraged loans. Repayment risk is segmented into tranches with credit ratings of these tranches reflecting both the credit quality of underlying collateral as well as how much protection a given tranche is afforded by tranches that are subordinate to it. The most subordinated tranche bears the first loss and receives the residual payments, if any. The interest rates are generally variable rates based on SOFR or EURIBOR plus a pre-defined spread, which varies from 1.0% for the more senior tranches to 8.8% for the more subordinated tranches. CLO notes mature in 2034 and 2036, and have a weighted average maturity of 11 years as of September 30, 2024. The investors in this debt are not affiliated with the Company and have no recourse to the general credit of the Company for this debt. The fair values of the CLO notes are measured based on the fair value of the CLO's corporate loans, as the Company uses the measurement alternative available under ASU 2014-13 and determined that the inputs for measuring financial assets are more observable. The CLO notes are classified within Level 2 of the fair value hierarchy, consistent with the classification of the majority of the CLO financial assets. The Company reviews the detailed prices including comparisons to prior periods for reasonableness. The Company utilizes a formal pricing challenge process to request a review of any price during which time the vendor examines its assumptions and relevant market inputs to determine if a price change is warranted. The following narrative indicates the sensitivity of inputs: • Default Rate: An increase (decrease) in the expected default rate would likely increase (decrease) the discount margin (increase risk premium) used to value the CLO investments and CLO notes and, as a result, would potentially decrease the value of the CLO investments and CLO notes. • Recovery Rate: A decrease (increase) in the expected recovery of defaulted assets would potentially decrease (increase) the valuation of CLO investments and CLO notes. • Prepayment Rate: A decrease (increase) in the expected rate of collateral prepayments would potentially decrease (increase) the valuation of CLO investments and CLO notes as the expected weighted average life ("WAL") would increase (decrease). • Discount Margin (spread over SOFR): An increase (decrease) in the discount margin used to value the CLO investments and CLO notes would decrease (increase) the value of the CLO investments and CLO notes. Private Equity Funds As prescribed in ASC Topic 820, the unit of account for these investments is the interest in the investee fund. The Company owns an undivided interest in the fund portfolio and does not have the ability to dispose of individual assets and liabilities in the fund portfolio. Rather, the Company would be required to redeem or dispose of its entire interest in the investee fund. There is no current active market for interests in underlying private equity funds. Valuation is generally based on the valuations provided by the fund's general partner or investment manager. The valuations typically reflect the fair value of the Company's capital account balance of each fund investment, including unrealized capital gains (losses), as reported in the financial statements of the respective investee fund as of the respective year end or the latest available date. In circumstances where fair values are not provided, the Company seeks to determine the fair value of fund investments based upon other information provided by the fund's general partner or investment manager or from other sources. The fair value of securities received in-kind from fund investments is determined based on the restrictions around the securities. • Unrestricted, publicly traded securities are valued at the closing public market price on the reporting date; • Restricted, publicly traded securities may be valued at a discount from the closing public market price on the reporting date, depending on the circumstances; and • Privately held securities are valued by the directors/general partner of the investee fund, based on a variety of factors, including the price of recent transactions in the company's securities and the company's earnings, revenue and book value. In the case of direct investments or co-investments in private equity companies, the Company initially recognizes investments at cost and subsequently adjusts investments to fair value. On a quarterly basis, the Company reviews the general partner or lead investor's valuation of the investee company, taking into account other available information, such as indications of a market value through subsequent issues of capital or transactions between third parties, performance of the investee company during the period and public, comparable companies' analysis, where appropriate. Investments in these funds typically may not be fully redeemed at net asset value ("NAV") within 90 days because of inherent restriction on near term redemptions. As of September 30, 2024, certain private equity funds maintained revolving lines of credit of $1,308. As of December 31, 2023, certain private equity funds maintained term loans and revolving lines of credit of $1,330. The term loans were fully paid off during the nine months ended September 30, 2024, and the revolving lines of credit are eligible for renewal every three years; all loans bear interest at EURIBOR or SOFR plus 140 - 240 bps. The lines of credit are used for funding transactions before capital is called from investors, as well as for the financing of certain purchases. As of September 30, 2024 and December 31, 2023, outstanding borrowings amount to $1,180 and $1,198, respectively. The borrowings are reflected in Liabilities related to consolidated investment entities - Other liabilities on the Company's Condensed Consolidated Balance Sheets. The borrowings are carried at an amount equal to the unpaid principal balance. The following table summarizes the fair value hierarchy levels of consolidated investment entities as of September 30, 2024: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 84 $ — $ — $ — $ 84 Corporate loans — 1,345 — — 1,345 Limited partnerships/corporations — — — 3,033 3,033 Other investments (1) — — 23 — 23 VOEs Cash and cash equivalents 4 — — — 4 Other investments (1) — — — 49 49 Total assets $ 88 $ 1,345 $ 23 $ 3,082 $ 4,538 Liabilities VIEs CLO notes $ — $ 1,123 $ — $ — $ 1,123 Total liabilities $ — $ 1,123 $ — $ — $ 1,123 (1) VIEs and VOEs - Other investments are reflected in Assets related to consolidated investment entities - Other assets on the Company's Condensed Consolidated Balance Sheets. The following table summarizes the fair value hierarchy levels of consolidated investment entities as of December 31, 2023: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 181 $ — $ — $ — $ 181 Corporate loans — 1,404 — — 1,404 Limited partnerships/corporations — — — 2,861 2,861 Total assets $ 181 $ 1,404 $ — $ 2,861 $ 4,446 Liabilities VIEs CLO notes $ — $ 1,332 $ — $ — $ 1,332 Total liabilities $ — $ 1,332 $ — $ — $ 1,332 Transfers of investments out of Level 3 and into Level 2 or Level 1, if any, are recorded as of the beginning of the period in which the transfer occurred. For the three and nine months ended September 30, 2024 and 2023, there were no transfers in or out of Level 3 or transfers between Level 1 and Level 2. Deconsolidation of Certain Investment Entities Certain investment entities that have historically been consolidated in the financial statements may require deconsolidation as of the reporting period because: (a) such funds have been liquidated or dissolved; or (b) the Company is no longer deemed to be the primary beneficiary of the VIEs/VOEs as it no longer has a controlling financial interest. The change in CLO’s consolidation status due to the close of the warehouse and the launch of the CLO do not meet the criteria described above as this transaction represents normal business operations of the entity. Refer to the CLO life cycle described above. The Company had no deconsolidation during the three months ended September 30, 2024 and 2023. The Company had two and one deconsolidations during the nine months ended September 30, 2024 and 2023, respectively. Because the Company was no longer deemed to be the primary beneficiary of the VIEs, it no longer had a controlling financial interest in the entities. For deconsolidated investment entities, the Company continues to serve as the general partner and/or investment manager until such entities are fully liquidated. Nonconsolidated VIEs The Company also holds variable interest in certain CLOs and LPs that are not consolidated as it has been determined that the Company is not the primary beneficiary. CLOs As of September 30, 2024 and December 31, 2023, the Company held $454 and $383 ownership interests, respectively, in unconsolidated CLOs, which also represents the Company's maximum exposure to loss. LPs As of September 30, 2024 and December 31, 2023, the Company held $1,736 and $1,621 ownership interests, respectively, in unconsolidated limited partnerships, which also represents the Company's maximum exposure to loss. Securitizations The Company invests in various tranches of securitization entities, including RMBS, CMBS and ABS. Through its investments, the Company is not obligated to provide any financial or other support to these entities. Each of the RMBS, CMBS and ABS entities are thinly capitalized by design and considered VIEs. The Company's involvement with these entities is limited to that of a passive investor. The Company has no unilateral right to appoint or remove the servicer, special servicer or investment manager, which are generally viewed to have the power to direct the activities that most significantly impact the securitization entities' economic performance, in any of these entities, nor does the Company function in any of these roles. The Company, through its investments or other arrangements, does not have the obligation to absorb losses or the right to receive benefits from the entity that could potentially be significant to the entity. Therefore, the Company is not the primary beneficiary and does not consolidate any of the RMBS, CMBS and ABS entities in which it holds investments. These investments are accounted for as investments available-for-sale as described in the Fair Value Measurements (excluding Consolidated Investment Entities) Note to these Condensed Consolidated Financial Statements and unrealized capital gains (losses) on these securities are recorded directly in AOCI, except for certain RMBS which are accounted for under the FVO whose change in fair value is reflected in Net gains (losses) in the Condensed Consolidated Statements of Operations. The Company’s maximum exposure to loss on these structured investments is limited to the amount of its investment. Refer to the Investments (excluding Consolidated Investment Entities) Note to these Condensed Consolidated Financial Statements for details regarding the carrying amounts and classifications of these assets.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill The changes in the carrying amount of goodwill reported in the Company's operating segments were as follows: Wealth Solutions Health Solutions Investment Management Corporate (1) Consolidated Balance as of January 1, 2023 $ 17 $ 24 $ 286 $ — $ 327 Additions from business combinations (2) — 319 — 102 421 Balance as of December 31, 2023 $ 17 $ 343 $ 286 $ 102 $ 748 Additions from business combinations — — — — — Balance as of September 30, 2024 $ 17 $ 343 $ 286 $ 102 $ 748 (1) Corporate includes goodwill that was acquired by the parent company and not pushed to a subsidiary within the Company’s reportable segments. The carrying value of goodwill within Corporate is allocated to Wealth Solutions, Health Solutions, and Investment Management reporting units as $72, $20 and $10, respectively. (2) See the Business, Basis of Presentation and Significant Accounting Policies Note for information on business combinations. Other Intangible Assets The following table presents other intangible assets as of the dates indicated: Weighted September 30, 2024 December 31, 2023 Gross Accumulated Net Gross Accumulated Net Indefinite-life intangibles: Management contract rights N/A $ 350 $ — $ 350 $ 350 $ — $ 350 Total indefinite-life intangibles $ 350 $ — $ 350 $ 350 $ — $ 350 Finite-life intangibles: Management contract rights 15 years $ 153 $ 20 $ 133 $ 153 $ 11 $ 142 Customer relationship lists 17 years 325 141 184 325 128 197 Trademarks 8 years 15 3 12 15 2 13 Computer software 5 years 419 236 183 501 346 155 Total intangible assets $ 1,262 $ 400 $ 862 $ 1,344 $ 487 $ 857 Amortization expense related to intangible assets was $70 and $63 for the nine months ended September 30, 2024 and 2023, respectively. Fully amortized computer software of $156 was written-off during the nine months ended September 30, 2024.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 114	$ 262	$ 570	$ 503

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	9 Months Ended
	Sep. 30, 2024 shares	Sep. 30, 2024 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Trevor Ogle [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		Name and title of director or officer Date of adoption of trading arrangement Duration of trading arrangement Aggregate number of securities to be sold or purchased under trading arrangement Trevor Ogle, EVP, Chief Strategy, M&A, and Corporate Transaction Officer September 16, 2024 December 16, 2024 to November 6, 2025 15,950 shares to be sold
Name	Trevor Ogle
Title	EVP, Chief Strategy, M&A, and Corporate Transaction Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 16, 2024
Expiration Date	11/6/2025
Arrangement Duration	325 days
Aggregate Available	15,950	15,950

Business, Basis of Presentati_2

Business, Basis of Presentation and Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Adoption of New Pronouncements and Future Adoption of Accounting Pronouncements	Adoption of New Pronouncements Equity Securities Subject to Contractual Sale Restrictions In June 2022, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2022-03, "Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions" ("ASU 2022-03"), which clarifies that contractual restrictions on equity security sales are not considered part of the security unit of account and, therefore, are not considered in measuring the fair value. In addition, the restrictions cannot be recognized and measured as separate units of account. Disclosures on such restrictions are also required. The provisions of ASU 2022-03 were adopted prospectively on January 1, 2024. The adoption did not have an impact on the Company's financial condition, results of operations, or cash flows. Future Adoption of Accounting Pronouncements Profits Interest and Similar Awards In March 2024, the FASB issued ASU 2024-01, "Compensation - Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards" ("ASU 2024-01"), which adds incremental clarity for how profits interests should be accounted. ASU 2024-01 is effective for annual periods beginning after December 15, 2024 and interim periods within those annual periods with early adoption permitted. The Company intends to adopt ASU 2024-01 as of January 1, 2025 on a prospective basis, and does not expect this ASU to have a material impact on the Company's financial condition, results of operations, or cash flows. Income Tax Disclosures In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures" ("ASU 2023-09"), which requires: • A tabular rate reconciliation of (1) reported income tax expense/benefit from continuing operations, to (2) the product of the income/loss from continuing operations before income taxes and the statutory federal income tax rate, using specific categories, as well as disclosure of certain reconciling items based on a 5% threshold. • Year-to-date net income taxes paid, disaggregated by federal, state, and foreign, as well as disaggregated information on net income taxes paid to an individual jurisdiction based on a 5% threshold. The amendments are effective for annual periods beginning after December 15, 2024 and should be applied prospectively, with retrospective application permitted. Early adoption is also permitted. The Company is currently in the process of determining the disclosures that may be required by the adoption of the provisions of ASU 2023-09. Segment Disclosures In November 2023, the FASB issued ASU 2023-07 "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" ("ASU 2023-07"), which requires all current annual disclosures about segment profit/loss and assets to be reported in interim periods, as well as enhanced disclosures about significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods beginning after December 15, 2024, and are required to be applied retrospectively. Restated prior period disclosures should be based on the significant segment expense categories disclosed in the period of adoption. The Company is currently in the process of determining the disclosures that may be required by the adoption of the provisions of ASU 2023-07. Climate Related Disclosures In March 2024, the SEC adopted a final rule under SEC Release No. 33-11275, The Enhancement and Standardization of Climate-Related Disclosures for Investors, to enhance and standardize climate-related disclosures. The rule will require companies to disclose material Scope 1 and Scope 2 greenhouse gas emissions; climate-related risks, governance, and oversight; and the financial effects of severe weather events and other natural conditions. These disclosures will be phased in beginning with the Company's annual report for the year ending December 31, 2025. While the implementation of this rule is pending the outcome of legal challenges, the Company is currently assessing the disclosures that may be required by the adoption in the event that the stay is lifted.
Derivatives	The Company primarily enters into the following types of derivatives: Interest rate swaps: Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and/or liabilities. Interest rate swaps are also used to hedge the interest rate risk associated with the value of assets it owns or in an anticipation of acquiring them. Using interest rate swaps, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest payments, calculated by reference to an agreed upon notional principal amount. These transactions are entered into pursuant to master agreements that provide for a single net payment to be made to/from the counterparty at each due date. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Foreign exchange swaps: The Company uses foreign exchange or currency swaps to reduce the risk of change in the value, yield or cash flows associated with certain foreign denominated invested assets. Foreign exchange swaps represent contracts that require the exchange of foreign currency cash flows against U.S. dollar cash flows at regular periods, typically quarterly or semi-annually. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Total return swaps: The Company uses total return swaps as a hedge of interest related risks within various Legacy Annuity and Retirement products. Total return swaps are also used as a hedge of other corporate liabilities. Using total return swaps, the Company agrees with another party to exchange, at specified intervals, the difference between the economic performance of assets or a market index and a fixed or variable funding multiplied by reference to an agreed upon notional amount. No cash is exchanged at the onset of the contracts. Cash is paid and received over the life of the contract based upon the terms of the swaps. The Company utilizes these contracts in non-qualifying hedging relationships. Futures: Futures contracts are used to hedge against a decrease in certain equity indices. The Company also uses interest rate futures contracts to hedge its exposure to market risks due to changes in interest rates. The Company enters into exchange traded futures with regulated futures commissions that are members of the exchange. The Company also posts initial and variation margins, with the exchange, on a daily basis. The Company utilizes exchange-traded futures in non-qualifying hedging relationships. Embedded derivatives: The Company also invests in certain fixed maturity instruments and has issued certain products that contain embedded derivatives for which market value is at least partially determined by, among other things, levels of or changes in domestic and/or foreign interest rates (short-term or long-term), exchange rates, prepayment rates, equity rates or credit ratings/spreads. In addition, the Company has entered into coinsurance with funds withheld arrangements, which contain embedded derivatives. The Company utilizes derivative contracts mainly to hedge exposure to variability in cash flows, interest rate risk, credit risk, foreign exchange risk and equity market risk. The majority of derivatives used by the Company are designated as product hedges, which hedge the exposure arising from insurance liabilities or guarantees embedded in the contracts the Company offers through various product lines. The Company also uses derivatives contracts to hedge its exposure to various risks associated with the investment portfolio. The Company also uses credit default swaps coupled with other investments in order to produce the investment characteristics of otherwise permissible investments. Based on the notional amounts, a substantial portion of the Company’s derivative positions was not designated or did not qualify for hedge accounting as part of a hedging relationship as outlined in ASC Topic 815 as of September 30, 2024 and December 31, 2023.
Income Tax	The Company uses the estimated annual effective tax rate method in computing its interim tax provision. Certain items, including changes in the realizability of deferred tax assets and changes in liabilities for uncertain tax positions, are excluded from the estimated annual effective tax rate and the actual tax expense or benefit is reported in the period the related item is incurred.

Investments (excluding Consol_2

Investments (excluding Consolidated Investment Entities) (Tables)	9 Months Ended
	Sep. 30, 2024
Investments, Debt and Equity Securities [Abstract]
Fixed Maturities	Available-for-sale and fair value option ("FVO") fixed maturities were as follows as of September 30, 2024: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Allowance for credit losses Fair Value Fixed maturities: U.S. Treasuries $ 388 $ 6 $ 20 $ — $ — $ 374 U.S. Government agencies and authorities 29 2 — — — 31 State, municipalities and political subdivisions 717 — 82 — — 635 U.S. corporate public securities 7,826 207 780 — — 7,253 U.S. corporate private securities 5,162 75 236 — 6 4,995 Foreign corporate public securities and foreign governments (1) 2,686 71 206 — 2 2,549 Foreign corporate private securities (1) 2,761 48 96 — 1 2,712 Residential mortgage-backed securities 3,974 42 200 3 — 3,819 Commercial mortgage-backed securities 3,890 3 483 — 17 3,393 Other asset-backed securities 2,787 41 37 — 6 2,785 Total fixed maturities, including securities pledged 30,220 495 2,140 3 32 28,546 Less: Securities pledged 1,543 — 80 — — 1,463 Total fixed maturities $ 28,677 $ 495 $ 2,060 $ 3 $ 32 $ 27,083 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Net gains (losses) in the Condensed Consolidated Statements of Operations. Available-for-sale and FVO fixed maturities were as follows as of December 31, 2023: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Allowance for credit losses Fair Value Fixed maturities: U.S. Treasuries $ 417 $ 7 $ 21 $ — $ — $ 403 U.S. Government agencies and authorities 54 3 1 — — 56 State, municipalities and political subdivisions 871 1 101 — — 771 U.S. corporate public securities 8,402 168 904 — — 7,666 U.S. corporate private securities 5,040 44 324 — — 4,760 Foreign corporate public securities and foreign governments (1) 2,928 47 270 — 3 2,702 Foreign corporate private securities (1) 2,916 27 129 — 2 2,812 Residential mortgage-backed securities 3,695 36 257 2 — 3,476 Commercial mortgage-backed securities 4,147 1 644 — 9 3,495 Other asset-backed securities 2,528 16 71 — 3 2,470 Total fixed maturities, including securities pledged 30,998 350 2,722 2 17 28,611 Less: Securities pledged 1,232 — 72 — — 1,160 Total fixed maturities $ 29,766 $ 350 $ 2,650 $ 2 $ 17 $ 27,451 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Net gains (losses) in the Condensed Consolidated Statements of Operations.
Investments Classified by Contractual Maturity Date	The amortized cost and fair value of fixed maturities, including securities pledged, as of September 30, 2024, are shown below by contractual maturity. Actual maturities may differ from contractual maturities as securities may be restructured, called or prepaid. Mortgage-backed securities ("MBS") and Other asset-backed securities ("ABS") are shown separately because they are not due at a single maturity date. Amortized Cost Fair Value Due to mature: One year or less $ 610 $ 593 After one year through five years 3,848 3,798 After five years through ten years 3,664 3,655 After ten years 11,447 10,503 Mortgage-backed securities 7,864 7,212 Other asset-backed securities 2,787 2,785 Fixed maturities, including securities pledged $ 30,220 $ 28,546
Schedule of Securities Pledged	The following table presents Securities pledged as of the dates indicated: September 30, 2024 December 31, 2023 Securities pledged/obligations under repurchase agreements (1) $ 204 $ 117 Securities loaned to lending agent (2) 1,091 842 Securities pledged as collateral (2)(3) 168 201 Total $ 1,463 $ 1,160 (1) Comprised of other asset-backed securities and included in Securities pledged and Payables under securities loan and repurchase agreements, including collateral held on the Condensed Consolidated Balance Sheets. (2) Included in Securities pledged on the Condensed Consolidated Balance Sheets. (3) See Collateral within the Derivatives Note to these Condensed Consolidated Financial Statements for more information.
Schedule of Securities Borrowed Under Securities Lending Transactions	The following table presents collateral held by asset class that the Company pledged under securities lending as of the dates indicated: September 30, 2024 December 31, 2023 U.S. Treasuries $ 13 $ 14 U.S. corporate public securities 649 568 Short-term investments 155 55 Foreign corporate public securities and foreign governments 315 238 Total (1) $ 1,132 $ 875 (1) As of September 30, 2024 and December 31, 2023, liabilities to return cash collateral were $925 and $660, respectively, and included in Payables under securities loan and repurchase agreements, including collateral held on the Condensed Consolidated Balance Sheets.
Fixed Maturities, Allowance for Credit Losses	The following tables presents a rollforward of the allowance for credit losses on available-for-sale fixed maturity securities for the periods presented: Nine Months Ended September 30, 2024 U.S. corporate private securities Commercial mortgage-backed securities Foreign corporate public securities and foreign governments Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ — $ 9 $ 3 $ 2 $ 3 $ 17 Credit losses on securities for which credit losses were not previously recorded 6 9 — — 1 16 Reductions for securities sold during the period — — (1) — — (1) Increase (decrease) on securities with allowance recorded in previous period — (1) — (1) 2 — Balance as of September 30 $ 6 $ 17 $ 2 $ 1 $ 6 $ 32 Year Ended December 31, 2023 U.S. corporate private securities Commercial mortgage-backed securities Foreign corporate public securities and foreign governments Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ — $ — $ 9 $ 2 $ 1 $ 12 Credit losses on securities for which credit losses were not previously recorded — 9 — — 2 11 Reductions for securities sold during the period — — (5) — — (5) Increase (decrease) on securities with allowance recorded in previous period — — (1) — — (1) Balance as of December 31 $ — $ 9 $ 3 $ 2 $ 3 $ 17
Schedule of Unrealized Loss on Investments	The following tables present available-for-sale fixed maturities, including securities pledged, for which an allowance for credit losses has not been recorded by investment category and duration as of the dates indicated: As of September 30, 2024 Twelve Months or Less More Than Twelve Months Below Amortized Cost Total Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses U.S. Treasuries $ 66 $ 1 $ 150 $ 19 $ 216 $ 20 State, municipalities and political subdivisions 1 — 618 82 619 82 U.S. corporate public securities 96 8 4,573 772 4,669 780 U.S. corporate private securities 178 2 3,061 234 3,239 236 Foreign corporate public securities and foreign governments 47 2 1,367 204 1,414 206 Foreign corporate private securities 10 — 1,605 96 1,615 96 Residential mortgage-backed 19 — 1,290 200 1,309 200 Commercial mortgage-backed 32 — 3,091 483 3,123 483 Other asset-backed 34 1 371 36 405 37 Total $ 483 $ 14 $ 16,126 $ 2,126 $ 16,609 $ 2,140 As of December 31, 2023 Twelve Months or Less More Than Twelve Months Below Amortized Cost Total Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses Fair Value Unrealized Capital Losses U.S. Treasuries $ 99 $ 3 $ 109 $ 18 $ 208 $ 21 U.S. Government agencies and authorities — — 3 1 3 1 State, municipalities and political subdivisions 20 — 731 101 751 101 U.S. corporate public securities 321 17 5,101 887 5,422 904 U.S. corporate private securities 176 7 3,365 317 3,541 324 Foreign corporate public securities and foreign governments 82 2 1,749 268 1,831 270 Foreign corporate private securities 189 5 2,101 124 2,290 129 Residential mortgage-backed 114 3 1,354 254 1,468 257 Commercial mortgage-backed 84 2 3,269 642 3,353 644 Other asset-backed 136 3 1,156 68 1,292 71 Total $ 1,221 $ 42 $ 18,938 $ 2,680 $ 20,159 $ 2,722
Mortgage Loans by Loan to Value Ratio	The following tables present commercial mortgage loans by year of origination and LTV ratio as of the dates indicated. The information is updated as of September 30, 2024 and December 31, 2023, respectively. As of September 30, 2024 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2024 $ 129 $ 83 $ 15 $ — $ — $ 227 2023 117 222 39 — — 378 2022 231 295 105 — — 631 2021 238 196 115 — — 549 2020 186 86 — — — 272 Prior 2,570 185 16 — 18 2,789 Total $ 3,471 $ 1,067 $ 290 $ — $ 18 $ 4,846 As of December 31, 2023 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% -70% >70% - 80% >80% and above Total 2023 $ 150 $ 222 $ — $ — $ — $ 372 2022 252 326 73 — — 651 2021 244 214 209 — — 667 2020 168 112 — 10 16 306 2019 238 68 28 — — 334 Prior 2,586 280 4 — 18 2,888 Total $ 3,638 $ 1,222 $ 314 $ 10 $ 34 $ 5,218
Mortgage Loans by Debt Service Coverage Ratio	The following tables present commercial mortgage loans by year of origination and DSC ratio as of the dates indicated. The information is updated as of September 30, 2024 and December 31, 2023, respectively. As of September 30, 2024 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2024 $ 96 $ 91 $ 33 $ 7 $ 227 2023 114 74 179 11 378 2022 271 76 84 200 631 2021 259 12 83 195 549 2020 209 19 20 24 272 Prior 2,109 228 350 102 2,789 Total $ 3,058 $ 500 $ 749 $ 539 $ 4,846 *No commercial mortgage loans were secured by land or construction loans As of December 31, 2023 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2023 $ 189 $ 116 $ 67 $ — $ 372 2022 204 68 192 187 651 2021 260 14 64 329 667 2020 211 24 21 50 306 2019 203 26 84 21 334 Prior 2,216 264 255 153 2,888 Total $ 3,283 $ 512 $ 683 $ 740 $ 5,218 *No commercial mortgage loans were secured by land or construction loans
Mortgage Loans by Geographic Location of Collateral	The following tables present the commercial mortgage loans by year of origination and U.S. region as of the dates indicated. The information is updated as of September 30, 2024 and December 31, 2023, respectively. As of September 30, 2024 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2024 $ 28 $ 80 $ 34 $ 44 $ 20 $ 1 $ 8 $ 3 $ 9 $ 227 2023 69 84 12 102 39 40 3 26 3 378 2022 140 132 49 98 94 92 5 1 20 631 2021 96 51 116 93 97 47 9 40 — 549 2020 62 134 17 10 12 15 — 7 15 272 Prior 721 657 665 178 228 136 58 117 29 2,789 Total $ 1,116 $ 1,138 $ 893 $ 525 $ 490 $ 331 $ 83 $ 194 $ 76 $ 4,846 As of December 31, 2023 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2023 $ 69 $ 77 $ 12 $ 101 $ 39 $ 42 $ 3 $ 26 $ 3 $ 372 2022 140 132 47 100 113 93 5 1 20 651 2021 96 63 124 148 111 75 9 40 1 667 2020 63 155 17 10 12 26 — 7 16 306 2019 53 100 10 74 45 4 14 13 21 334 Prior 734 605 765 189 214 171 47 144 19 2,888 Total $ 1,155 $ 1,132 $ 975 $ 622 $ 534 $ 411 $ 78 $ 231 $ 80 $ 5,218
Mortgage Loans by Property Type of Collateral	The following tables present the commercial mortgage loans by year of origination and property type as of the dates indicated. The information is updated as of September 30, 2024 and December 31, 2023, respectively. As of September 30, 2024 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2024 $ 25 $ 130 $ 57 $ 15 $ — $ — $ — $ 227 2023 125 171 33 17 32 — — 378 2022 79 262 236 34 10 10 — 631 2021 35 131 245 111 — 18 9 549 2020 56 48 71 97 — — — 272 Prior 676 727 672 442 68 157 47 2,789 Total $ 996 $ 1,469 $ 1,314 $ 716 $ 110 $ 185 $ 56 $ 4,846 As of December 31, 2023 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2023 $ 125 $ 164 $ 33 $ 18 $ 32 $ — $ — $ 372 2022 79 263 255 34 10 10 — 651 2021 36 145 335 123 — 18 10 667 2020 57 49 72 128 — — — 306 2019 45 82 160 36 11 — — 334 Prior 780 755 618 463 60 163 49 2,888 Total $ 1,122 $ 1,458 $ 1,473 $ 802 $ 113 $ 191 $ 59 $ 5,218
Commercial Mortgage Loans, Allowance for Credit Losses	The following table summarizes the activity in the allowance for losses for commercial mortgage loans for the periods indicated: September 30, 2024 December 31, 2023 Allowance for credit losses, beginning of period $ 26 $ 18 Credit losses on mortgage loans for which credit losses were not previously recorded — 2 Increase (decrease) on mortgage loans with an allowance recorded in a previous period 1 9 Provision for expected credit losses 27 29 Write-offs (3) (3) Recoveries of amounts previously written-off — — Allowance for credit losses, end of period $ 24 $ 26
Mortgage Loans, Past Due	The following table presents the payment status of commercial mortgage loans as of the dates indicated: September 30, 2024 December 31, 2023 Current $ 4,808 $ 5,202 30-59 days past due — — 60-89 days past due 12 — Greater than 90 days past due 26 16 Total $ 4,846 $ 5,218
Net Investment Income	The following table summarizes Net investment income by investment type for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Fixed maturities $ 420 $ 438 $ 1,252 $ 1,336 Equity securities 7 3 16 17 Mortgage loans on real estate 58 64 179 187 Policy loans 6 5 16 16 Short-term investments and cash equivalents 11 10 31 28 Limited partnerships and other 26 44 116 106 Gross investment income 528 564 1,610 1,690 Less: Investment expenses 22 17 57 53 Net investment income $ 506 $ 547 $ 1,553 $ 1,637
Realized Gain (Loss) on Investments	Net gains (losses) were as follows for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Fixed maturities, available-for-sale, including securities pledged $ 15 $ (24) $ (19) $ (41) Fixed maturities, at fair value option 96 (135) (15) (243) Equity securities, at fair value 7 (3) 11 (6) Derivatives (128) 134 48 199 Embedded derivatives - fixed maturities 3 (3) 1 (4) Other derivatives 1 — 1 — Standalone derivatives (1) 1 — 1 Managed custody guarantees 6 (15) 6 (12) Stabilizer (6) (9) (7) (9) Mortgage loans (4) (1) (1) (11) Other investments (3) 48 — 47 Net gains (losses) $ (14) $ (7) $ 25 $ (79)
Proceeds and Gross Gains and Gross Losses on Investments	Proceeds from the sale of fixed maturities, available-for-sale and equity securities and the related gross realized gains and losses, before tax, were as follows for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Proceeds on sales $ 753 $ 862 $ 2,199 $ 4,499 Gross gains 18 11 37 54 Gross losses 13 14 49 69

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Notional Amounts of Outstanding Derivative Positions	The notional amounts and fair values of derivatives were as follows as of the dates indicated: September 30, 2024 December 31, 2023 Notional Asset Fair Value Liability Notional Asset Fair Value Liability Derivatives: Qualifying for hedge accounting (1) Fair value hedges: Interest rate contracts $ 200 $ — $ 7 $ — $ — $ — Foreign exchange contracts 100 — 2 98 — 4 Cash flow hedges: Interest rate contracts 12 — — 12 — — Foreign exchange contracts 655 21 11 718 33 7 Derivatives: Non-qualifying for hedge accounting (1) Interest rate contracts 15,005 195 331 16,773 270 354 Foreign exchange contracts 173 2 3 183 4 2 Equity contracts 286 7 3 255 4 2 Credit contracts 126 — 2 137 — 2 Embedded derivatives and Managed custody guarantees ("MCGs"): Within fixed maturity investments (2) N/A 3 — N/A 2 — Within reinsurance agreements (4) N/A 40 45 N/A 61 49 MCGs (3) N/A — 2 N/A — 8 Stabilizers (3) N/A — 8 N/A — 1 Total $ 268 $ 414 $ 374 $ 429 (1) Open derivative contracts are reported as Derivatives assets or liabilities at fair value on the Condensed Consolidated Balance Sheets. (2) Included in Fixed maturities, available-for-sale, at fair value on the Condensed Consolidated Balance Sheets. (3) Included in Contract owner account balances on the Condensed Consolidated Balance Sheets. (4) Included in Other liabilities, Other assets and Premium receivable and reinsurance recoverable on the Condensed Consolidated Balance Sheets. N/A - Not applicable
Offsetting Assets and Liabilities	The Company does not offset any derivative assets and liabilities in the Condensed Consolidated Balance Sheets. The disclosures set out in the table below include the fair values of Over-The-Counter (“OTC”) and cleared derivatives excluding exchange traded contracts subject to master netting agreements or similar agreements as of the dates indicated: Gross Amount Recognized (1) Counterparty Netting (2) Cash Collateral Netting (2) Securities Collateral Netting (2) Net Receivables/ Payables September 30, 2024 Derivative assets $ 224 $ (193) $ (25) $ (2) $ 4 Derivative liabilities 359 (193) (158) (5) 3 December 31, 2023 Derivative assets 311 (216) (76) (8) 11 Derivative liabilities 370 (216) (150) (3) 1 (1) As of September 30, 2024, gross amounts exclude asset and liability exchange traded contracts of $1 and $0, respectively. As of December 31, 2023, gross amounts exclude asset and liability exchange traded contracts of $0 and $1, respectively. (2) Represents the netting of receivable with payable balances, net of collateral, for the same counterparty under eligible netting agreements.
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance	The location and effect of derivatives qualifying for hedge accounting on the Condensed Consolidated Statements of Operations and Condensed Consolidated Statements of Comprehensive Income are as follows for the periods indicated: 2024 2023 Interest Rate Contracts Foreign Exchange Contracts Interest Rate Contracts Foreign Exchange Contracts Location of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income into Income Net investment income Net investment income and Net gains (losses) Net investment income Net investment income and Net gains (losses) Three Months Ended September 30, Amount of Gain (Loss) Recognized in Other Comprehensive Income $ — $ (29) $ — $ 7 Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income — 5 — 3 Nine Months Ended September 30, Amount of Gain (Loss) Recognized in Other Comprehensive Income $ — $ (18) $ — $ (11) Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income — 11 — 8 The location and amount of gain (loss) recognized in the Condensed Consolidated Statements of Operations for derivatives qualifying for hedge accounting are as follows for the periods indicated: 2024 2023 Net investment income Net gains (losses) Net investment income Net gains (losses) Three Months Ended September 30, Total amounts of line items presented in the statements of operations in which the effects of fair value or cash flow hedges are recorded $ 506 $ (14) $ 547 $ (7) Fair value hedges: Interest rate contracts: Hedged items — 7 — — Derivatives designated as hedging instruments — (7) — — Foreign exchange contracts: Hedged items — 3 — (3) Derivatives designated as hedging instruments (1) — (4) — 4 Cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income 2 3 3 — Nine Months Ended September 30, Total amounts of line items presented in the statements of operations in which the effects of fair value or cash flow hedges are recorded $ 1,553 $ 25 $ 1,637 $ (79) Fair value hedges: Interest rate contracts: Hedged items — 8 Derivatives designated as hedging instruments — (8) Foreign exchange contracts: Hedged items — 1 — (1) Derivatives designated as hedging instruments (1) — — — 3 Cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income 7 4 8 — (1) The change in derivative instruments designated and qualifying as fair value hedges of $0 and $1 were excluded from the assessment of hedge effectiveness and recognized currently in earnings for the three and nine months ended September 30, 2024, respectively. The change in derivative instruments designated and qualifying as fair value hedges of $1 and $2 were excluded from the assessment of hedge effectiveness and recognized currently in earnings for three and nine months ended September 30, 2023, respectively. The location and effect of derivatives not designated as hedging instruments on the Condensed Consolidated Statements of Operations are as follows for the periods indicated: Location of Gain (Loss) Recognized on Derivative Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Derivatives: Non-qualifying for hedge accounting Interest rate contracts Net gains (losses) $ (129) $ 138 $ 36 $ 196 Foreign exchange contracts Net gains (losses) (1) (2) (4) (1) Equity contracts Net gains (losses) 8 (7) 19 1 Credit contracts Net gains (losses) 1 1 — — Embedded derivatives and Managed custody guarantees: Within fixed maturity investments Net gains (losses) 3 (3) 1 (4) Within reinsurance agreements (1) Policyholder benefits (27) 29 (23) 11 MCGs Net gains (losses) 6 (15) 6 (12) Stabilizers Net gains (losses) (6) (9) (7) (9) Total $ (145) $ 132 $ 28 $ 182 (1) For the three months ended September 30, 2024, the amount excluded gains (losses) of $(1) from standalone derivatives recognized in Net gains (losses). For the nine months ended September 30, 2024, the amount excluded gains (losses) of $0 from standalone derivatives recognized in Net gains (losses). For the three and nine months ended September 30, 2023, the amount excluded gains (losses) of $1 from standalone derivatives recognized in Net gains (losses).

Fair Value Measurements (excl_2

Fair Value Measurements (excluding Consolidated Investment Entities) (Tables)	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of September 30, 2024: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 319 $ 55 $ — $ 374 U.S. Government agencies and authorities — 31 — 31 State, municipalities and political subdivisions — 635 — 635 U.S. corporate public securities — 7,242 11 7,253 U.S. corporate private securities — 3,550 1,445 4,995 Foreign corporate public securities and foreign governments (1) — 2,539 10 2,549 Foreign corporate private securities (1) — 2,244 468 2,712 Residential mortgage-backed securities — 3,753 66 3,819 Commercial mortgage-backed securities — 3,393 — 3,393 Other asset-backed securities — 2,751 34 2,785 Total fixed maturities, including securities pledged 319 26,193 2,034 28,546 Equity securities 149 — 102 251 Derivatives: Interest rate contracts 2 193 — 195 Foreign exchange contracts — 23 — 23 Equity contracts — 7 — 7 Embedded derivative on reinsurance — 40 — 40 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,808 14 — 2,822 Assets held in separate accounts 97,372 5,812 348 103,532 Total assets $ 100,650 $ 32,282 $ 2,484 $ 135,416 Liabilities: Contingent consideration $ — $ — $ 35 $ 35 Stabilizer and MCGs — — 10 10 Derivatives: Interest rate contracts 1 337 — 338 Foreign exchange contracts — 16 — 16 Equity contracts — 3 — 3 Credit contracts — 2 — 2 Embedded derivative on reinsurance — (7) (2) 52 45 Total liabilities $ 1 $ 351 $ 97 $ 449 (1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within liabilities given the underlying nature of the balance and the right-of-offset. The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of December 31, 2023: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 346 $ 57 $ — $ 403 U.S. Government agencies and authorities — 55 1 56 State, municipalities and political subdivisions — 771 — 771 U.S. corporate public securities — 7,648 18 7,666 U.S. corporate private securities — 3,234 1,526 4,760 Foreign corporate public securities and foreign governments (1) — 2,702 — 2,702 Foreign corporate private securities (1) — 2,376 436 2,812 Residential mortgage-backed securities — 3,419 57 3,476 Commercial mortgage-backed securities — 3,495 — 3,495 Other asset-backed securities — 2,418 52 2,470 Total fixed maturities, including securities pledged 346 26,175 2,090 28,611 Equity securities 140 — 96 236 Derivatives: Interest rate contracts 7 263 — 270 Foreign exchange contracts — 37 — 37 Equity contracts — 4 — 4 Embedded derivative on reinsurance — 61 — 61 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,148 17 — 2,165 Assets held in separate accounts 87,180 5,605 348 93,133 Total assets $ 89,821 $ 32,162 $ 2,534 $ 124,517 Liabilities: Contingent consideration $ — $ — $ 51 $ 51 Stabilizer and MCGs — — 9 9 Derivatives: Interest rate contracts — 354 — 354 Foreign exchange contracts — 13 — 13 Equity contracts — 2 — 2 Credit contracts — 2 — 2 Embedded derivative on reinsurance — (9) (2) 58 49 Total liabilities $ — $ 362 $ 118 $ 480 (1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within liabilities given the underlying nature of the balance and the right-of-offset.
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation	The following tables summarize the change in fair value of the Company's Level 3 assets and liabilities and transfers in and out of Level 3 for the periods indicated: Three Months Ended September 30, 2024 Fair Value as of July 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of September 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. corporate public securities 12 — (1) — — — — — — 11 — (1) U.S. corporate private securities 1,464 (4) 58 118 — (3) (81) — (107) 1,445 2 54 Foreign corporate public securities and foreign governments (1) 17 — 1 10 — (18) — — — 10 — — Foreign corporate private securities (1) 444 2 2 22 — — (2) — — 468 1 3 Residential mortgage-backed securities 49 4 — 13 — — — — — 66 5 — Other asset-backed securities 24 — — 12 — — (2) — — 34 — — Total fixed maturities, including securities pledged 2,010 2 60 175 — (21) (85) — (107) 2,034 8 56 Equity securities, at fair value 98 4 — — — — — — — 102 4 — Contingent consideration (49) — — — — — 14 — — (35) — — Stabilizer and MCGs (2) (10) — — — — — — — — (10) — — Embedded derivatives on reinsurance (57) (1) — — — — 6 — — (52) — — Assets held in separate accounts (4) 363 11 — 12 — (9) — — (29) 348 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of September 30 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Nine Months Ended September 30, 2024 Fair Value as of January 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of September 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. Government agencies and authorities $ 1 $ — $ — $ — $ — $ — $ — $ — $ (1) $ — $ — $ — U.S. corporate public securities 18 — — — — — (7) — — 11 — (1) U.S. corporate private securities 1,526 (5) 36 240 — (9) (196) — (147) 1,445 1 29 Foreign corporate public securities and foreign governments (1) — — — 10 — — — — — 10 — — Foreign corporate private securities (1) 436 2 (9) 43 — (9) (46) 51 — 468 1 (9) Residential mortgage-backed securities 57 — — 13 — — — — (4) 66 1 — Other asset-backed securities 52 — — 12 — — (5) — (25) 34 — — Total fixed maturities, including securities pledged 2,090 (3) 27 318 — (18) (254) 51 (177) 2,034 3 19 Equity securities, at fair value 96 6 — — — — — — — 102 6 — Contingent consideration (51) — — — — — 16 — — (35) — — Stabilizer and MCGs (2) (9) — — — (1) — — — — (10) — — Embedded derivatives on reinsurance (58) — — — — — 6 — — (52) — — Assets held in separate accounts (4) 348 12 — 47 — (24) — 5 (40) 348 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of September 30 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Three Months Ended September 30, 2023 Fair Value as of July 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of September 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. Government agencies and authorities $ 1 $ — $ — $ — $ — $ — $ — $ — $ — $ 1 $ — $ — U.S. corporate public securities 20 — 1 — — — — — (3) 18 — — U.S. corporate private securities 1,732 — (49) 24 — — (46) 63 (256) 1,468 — (49) Foreign corporate private securities (1) 413 (2) (6) 58 — — (20) 53 (21) 475 (2) (6) Residential mortgage-backed securities 57 (3) — 3 — — — 6 — 63 (3) — Other asset-backed securities 45 — — 10 — — (1) — (4) 50 — — Total fixed maturities, including securities pledged 2,268 (5) (54) 95 — — (67) 122 (284) 2,075 (5) (55) Equity securities, at fair value 192 (2) — — — — — — — 190 (2) — Contingent consideration (112) — — — — — — — — (112) — — Stabilizer and MCGs (2) (3) (24) — — — — — — — (27) — — Embedded derivatives on reinsurance (58) 1 — — — — — — — (57) — — Assets held in separate accounts (4) 344 (5) — 1 — (4) — 6 (1) 341 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of September 30 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Nine Months Ended September 30, 2023 Fair Value as of January 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of September 30 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. Government agencies and authorities $ 1 $ — $ — $ — $ — $ — $ — $ — $ — $ 1 $ — $ — U.S. corporate public securities 20 — — — — — 1 — (3) 18 — — U.S. corporate private securities 1,801 — (46) 104 — (3) (137) 45 (296) 1,468 — (48) Foreign corporate public securities and foreign governments (1) 3 — — — — — — — (3) — — — Foreign corporate private securities (1) 432 1 1 115 — — (197) 130 (7) 475 1 — Residential mortgage-backed securities 28 (6) — 37 — — — 4 — 63 (6) — Other asset-backed securities 64 — (1) 10 — — (1) — (22) 50 — (1) Total fixed maturities, including securities pledged 2,349 (5) (46) 266 — (3) (334) 179 (331) 2,075 (5) (49) Equity securities, at fair value 196 (10) — — — — — 4 — 190 (10) — Contingent consideration (112) — — — — — — — — (112) — — Stabilizer and MCGs (2) (6) (20) — — (1) — — — — (27) — — Embedded derivatives on reinsurance (58) 1 — — — — — — — (57) — — Assets held in separate accounts (4) 347 (9) — 8 — (13) — 9 (1) 341 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of September 30 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company.
Fair Value, by Balance Sheet Grouping	The carrying values and estimated fair values of the Company's financial instruments as of the dates indicated: September 30, 2024 December 31, 2023 Carrying Fair Carrying Fair Assets: Fixed maturities, including securities pledged $ 28,546 $ 28,546 $ 28,611 $ 28,611 Equity securities 251 251 236 236 Mortgage loans on real estate 4,846 4,702 5,218 4,941 Policy loans 345 345 352 352 Cash, cash equivalents, short-term investments and short-term investments under securities loan agreements 2,822 2,822 2,165 2,165 Derivatives 225 225 311 311 Embedded derivatives on reinsurance 40 40 61 61 Other investments 66 66 64 64 Assets held in separate accounts 103,532 103,532 93,133 93,133 Liabilities: Investment contract liabilities: Funding agreements without fixed maturities and deferred annuities (1) $ 31,403 $ 34,625 $ 32,848 $ 34,856 Funding agreements with fixed maturities 1,251 1,207 1,175 1,178 Supplementary contracts, immediate annuities and other 582 539 628 571 Stabilizer and MCGs 10 10 9 9 Derivatives 359 359 371 371 Embedded derivative on reinsurance 45 45 49 49 Short-term debt 397 396 1 1 Long-term debt 2,103 2,083 2,097 1,998 (1) Certain amounts included in Funding agreements without fixed maturities and deferred annuities are also reflected within the Stabilizer and MCGs section of the table above. The following table summarizes the fair value hierarchy levels of consolidated investment entities as of September 30, 2024: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 84 $ — $ — $ — $ 84 Corporate loans — 1,345 — — 1,345 Limited partnerships/corporations — — — 3,033 3,033 Other investments (1) — — 23 — 23 VOEs Cash and cash equivalents 4 — — — 4 Other investments (1) — — — 49 49 Total assets $ 88 $ 1,345 $ 23 $ 3,082 $ 4,538 Liabilities VIEs CLO notes $ — $ 1,123 $ — $ — $ 1,123 Total liabilities $ — $ 1,123 $ — $ — $ 1,123 (1) VIEs and VOEs - Other investments are reflected in Assets related to consolidated investment entities - Other assets on the Company's Condensed Consolidated Balance Sheets. The following table summarizes the fair value hierarchy levels of consolidated investment entities as of December 31, 2023: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 181 $ — $ — $ — $ 181 Corporate loans — 1,404 — — 1,404 Limited partnerships/corporations — — — 2,861 2,861 Total assets $ 181 $ 1,404 $ — $ 2,861 $ 4,446 Liabilities VIEs CLO notes $ — $ 1,332 $ — $ — $ 1,332 Total liabilities $ — $ 1,332 $ — $ — $ 1,332
Financial Instruments Not Carried at Fair Value	The following table presents the classification of financial instruments which are not carried at fair value on the Condensed Consolidated Balance Sheets: Financial Instrument Classification Mortgage loans on real estate Level 3 Policy loans Level 2 Other investments Level 2 Funding agreements without fixed maturities and deferred annuities Level 3 Funding agreements with fixed maturities Level 2 Supplementary contracts, immediate annuities and other Level 3 Short-term debt and Long-term debt Level 2

Deferred Policy Acquisition C_2

Deferred Policy Acquisition Costs and Value of Business Acquired (Tables)	9 Months Ended
	Sep. 30, 2024
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net [Abstract]
Deferred Policy Acquisition Costs and Value of Business Acquired	The following table presents a rollforward of deferred policy acquisition costs ("DAC") and value of business acquired ("VOBA") for the periods indicated: DAC VOBA (1) Wealth Solutions Deferred and Individual Annuities Health Solutions Voluntary (2) Businesses exited Balance as of January 1, 2023 $ 691 $ 171 $ 1,043 $ 439 Deferrals of commissions and expenses 59 54 — 4 Amortization expense (55) (32) (105) (37) Balance as of December 31, 2023 $ 695 $ 193 $ 938 $ 406 Deferrals of commissions and expenses 45 42 — 3 Amortization expense (41) (25) (76) (25) Balance as of September 30, 2024 $ 699 $ 210 $ 862 $ 384 (1) There was no loss recognition related to VOBA during the periods presented. (2) During the second quarter of 2024, the Company reclassified certain insurance products within the Health Solutions segment from Group to Voluntary. As a result, the rollforward above and the reconciliation table below have been updated for 2023 to reflect this change. The following table shows a reconciliation of DAC and VOBA balances to the Condensed Consolidated Balance Sheets for the periods indicated: September 30, 2024 December 31, 2023 DAC: Wealth Solutions Deferred and Individual Annuities $ 699 $ 695 Health Solutions Voluntary 210 193 Businesses exited 862 938 Other 18 18 VOBA 384 406 Total $ 2,173 $ 2,250

Reserves for Future Policy Be_2

Reserves for Future Policy Benefits and Contract Owner Account Balances (Tables)	9 Months Ended
	Sep. 30, 2024
Reserves for Future Policy Benefits and Contract Owner Balances [Abstract]
Liability for Future Policy Benefit, Activity	The following tables present the balances and changes in the liability for future policy benefits for Health Solutions Group, Health Solutions Voluntary and Businesses Exited as of September 30, 2024 and December 31, 2023. Health Solutions Group Health Solutions Voluntary Businesses Exited 2024 2023 2024 2023 2024 2023 Present Value of Expected Net Premiums: Balance at January 1 $ 68 $ 77 $ 101 $ 97 $ 3,145 $ 4,244 Beginning balance at original discount rate 71 84 102 100 2,992 4,128 Reclassifications (2) (65) — 65 — — — Effect of change in cash flow assumptions (1) (6) (1) 6 (5) (921) Effect of actual variances from expected experience — 11 33 8 (105) (91) Adjusted balance at January 1 5 89 199 114 2,882 3,116 Interest accrual — 2 6 4 119 196 Net premiums collected (1) (1) (20) (25) (16) (234) (320) Ending balance at original discount rate 4 71 180 102 2,767 2,992 Effects of changes in discount rate assumptions — (3) (2) (1) 162 153 Balance at end of period $ 4 $ 68 $ 178 $ 101 $ 2,929 $ 3,145 Present Value of Expected Future Policy Benefits: Balance at January 1 $ 899 $ 881 $ 307 $ 285 $ 7,538 $ 8,639 Beginning balance at original discount rate 918 913 307 294 7,404 8,644 Reclassifications (2) (150) — 150 — — — Effect of change in cash flow assumptions (12) (8) (1) 13 10 (805) Effect of actual variances from expected experience (2) (16) 44 9 (91) (123) Adjusted balance at January 1 754 889 500 316 7,323 7,716 Issuances 94 136 — — 11 17 Interest accrual 16 24 14 14 278 412 Benefit payments (90) (131) (32) (23) (550) (741) Ending balance at original discount rate 774 918 482 307 7,062 7,404 Effects of changes in discount rate assumptions (7) (19) (2) — 191 134 Balance at end of period $ 767 $ 899 $ 480 $ 307 $ 7,253 $ 7,538 Net liability for future policy benefits $ 763 $ 831 $ 302 $ 206 $ 4,324 $ 4,392 Less: Reinsurance recoverable 328 315 9 — 4,237 4,342 Net liability for future policy benefits, after reinsurance recoverable $ 435 $ 516 $ 293 $ 206 $ 87 $ 50 (1) Net Premiums collected represent the portion of gross premiums collected from policyholders that is used to fund expected benefit payments. (2) During the second quarter 2024, the Company reclassified certain insurance products within the Health Solutions from Group to Voluntary. The table was not updated to reflect the reclassification impact on the comparative information and the impacts were primarily related to Net premiums collected and Benefit payments of $(17) and $(17), respectively. The following table presents a rollforward of the additional reserve liability for Businesses exited for the periods indicated: Businesses exited September 30, 2024 December 31, 2023 Balance at beginning of period $ 2,001 $ 2,107 Effect of change in cash flow assumptions (38) (44) Effect of actual variances from expected experience (12) (100) Adjusted balance at January 1 1,951 1,963 Interest accrual 62 84 Excess Benefits (304) (417) Assessments 201 371 Balance at end of period 1,910 2,001 Less: Reinsurance recoverable 1,858 1,950 Net additional liability, after reinsurance recoverable $ 52 $ 51 The reconciliation of the net liability for future policy benefits to the liability for future policy benefits in the Condensed Consolidated Balance Sheets is presented below: September 30, 2024 December 31, 2023 Health Solutions Group $ 763 $ 831 Health Solutions Voluntary 302 206 Businesses Exited - Future policy benefits 4,324 4,392 Businesses Exited - Additional liability 1,910 2,001 Business Exited - Other 1,305 1,335 Other (1) 939 795 Total $ 9,543 $ 9,560 (1) Primarily consists of short-duration contracts. The amount of undiscounted expected gross premiums and future benefit payments is presented in the table below: September 30, 2024 December 31, 2023 Undiscounted Discounted Undiscounted Discounted Health Solutions Group Expected future benefit payments $ 967 $ 774 $ 1,144 $ 918 Expected future gross premiums 11 9 271 214 Health Solutions Voluntary Expected future benefit payments 865 482 668 307 Expected future gross premiums 631 445 341 213 The following table presents the weighted average duration of the liability for future policy benefits and the weighted average interest rates for the periods indicated: Health Solutions Group Health Solutions Voluntary Businesses Exited September 30, 2024 December 31, 2023 September 30, 2024 December 31, 2023 September 30, 2024 December 31, 2023 Weighted average duration (in years) (1) 7 7 14 14 8 8 Interest accretion rate 4.0 % 4.0 % 5.1 % 5.2 % 5.0 % 4.9 % Current discount rate 4.8 % 4.9 % 5.1 % 5.1 % 5.0 % 5.1 % (1) Weighted average duration (in years) for Businesses Exited includes additional liability.
Policyholder Account Balance	The following table presents a rollforward of Contract owner account balances for the periods indicated: Wealth Solutions Deferred Group and Individual Annuity Businesses Exited September 30, 2024 December 31, 2023 September 30, 2024 December 31, 2023 Balance at January 1 $ 31,139 $ 33,622 $ 4,635 $ 5,146 Deposits 1,837 2,309 214 288 Fee income (36) (9) (275) (373) Surrenders, withdrawals and benefits (3,780) (5,663) (430) (577) Net transfers (from) to the general account (1) 105 (5) 4 10 Interest credited 635 885 130 141 Ending Balance $ 29,900 $ 31,139 $ 4,278 $ 4,635 Weighted-average crediting rate 2.8 % 2.8 % 3.9 % 2.5 % Net amount at risk (2) $ 96 $ 123 $ 686 $ 734 Cash surrender value $ 29,441 $ 30,676 $ 1,284 $ 1,491 (1) Net transfers (from) to the general account for Wealth Solutions includes transfers of $(866) and $(523) for 2024 and 2023, respectively, related to Voya-managed institutional/mutual fund plan assets in trust that are not reflected on the Condensed Consolidated Balance Sheets. (2) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date and is calculated at a contract level. When a contract has both a living benefit and a death benefit, the Company calculates NAR at a contract level and aggregates the higher of the two values together. The following table presents a reconciliation of the Contract owner account balances to the Condensed Consolidated Balance Sheets for the periods indicated: September 30, 2024 December 31, 2023 Wealth Solutions Deferred group and individual annuity $ 29,900 $ 31,139 Businesses exited 4,278 4,635 Non-puttable funding agreements 1,251 1,175 Business exited - Other 1,188 1,275 Other (1) 896 950 Total $ 37,513 $ 39,174 (1) Primarily consists of universal life contracts. The following table summarizes detail on the differences between the interest rate being credited to contract holders as of the periods indicated, and the respective guaranteed minimum interest rates ("GMIRs"): Account Value (1) Excess of crediting rate over GMIR At GMIR Up to .50% Above GMIR 0.51% - 1.00% 1.01% - 1.50% Above GMIR 1.51% - 2.00% Above GMIR More than 2.00% Above GMIR Total As of September 30, 2024 Up to 1.00% $ 90 $ 4,544 $ 3,676 $ 1,731 $ 1,478 $ 870 $ 12,389 1.01% - 2.00% 452 118 50 7 3 6 636 2.01% - 3.00% 10,331 96 65 105 — 4 10,601 3.01% - 4.00% 8,492 151 — 11 — — 8,654 4.01% and Above 1,492 80 — — — — 1,572 Renewable beyond 12 months (2) 377 — — — 2 — 379 Total discretionary rate setting products $ 21,234 $ 4,989 $ 3,791 $ 1,854 $ 1,483 $ 880 $ 34,231 As of December 31, 2023 Up to 1.00% $ 120 $ 5,070 $ 3,460 $ 2,215 $ 863 $ 800 $ 12,528 1.01% - 2.00% 527 131 50 8 3 6 725 2.01% - 3.00% 11,225 93 63 108 — 3 11,492 3.01% - 4.00% 8,873 152 — 6 — — 9,031 4.01% and Above 1,566 83 — — — — 1,649 Renewable beyond 12 months (2) 428 — — — 3 — 431 Total discretionary rate setting products $ 22,739 $ 5,529 $ 3,573 $ 2,337 $ 869 $ 809 $ 35,856 (1) Includes only the account values for investment spread products with GMIRs and discretionary crediting rates, net of policy loans. Excludes Stabilizer products, which are fee based. (2) Represents multi year guaranteed annuity ("MYGA") contracts with renewal dates after September 30, 2024 and December 31, 2023 on which we are required to credit interest above the contractual GMIR for the next twelve months.

Reinsurance (Tables)

Reinsurance (Tables)	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Effects of Reinsurance	Information regarding the effect of reinsurance on the Condensed Consolidated Balance Sheets is as follows as of the periods indicated: Direct Assumed Ceded Total, Net of Reinsurance September 30, 2024 Assets Premiums receivable $ 208 $ 11 $ (235) $ (16) Reinsurance recoverable, net of allowance for credit losses — — 11,502 11,502 Total $ 208 $ 11 $ 11,267 $ 11,486 Liabilities Future policy benefits and contract owner account balances $ 46,150 $ 906 $ — $ 47,056 Liability for funds withheld under reinsurance agreements 108 — — 108 Total $ 46,258 $ 906 $ — $ 47,164 December 31, 2023 Assets Premiums receivable $ 193 $ 9 $ (219) $ (17) Reinsurance recoverable, net of allowance for credit losses — — 11,999 11,999 Total $ 193 $ 9 $ 11,780 $ 11,982 Liabilities Future policy benefits and contract owner account balances $ 47,781 $ 953 $ — $ 48,734 Liability for funds withheld under reinsurance agreements 103 — — 103 Total $ 47,884 $ 953 $ — $ 48,837 Information regarding the effect of reinsurance on the Condensed Consolidated Statements of Operations is as follows for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Premiums: Direct premiums $ 1,016 $ 896 $ 3,070 $ 2,706 Reinsurance assumed 6 5 17 20 Reinsurance ceded (226) (219) (701) (682) Net premiums $ 796 $ 682 $ 2,386 $ 2,044 Fee income: Gross fee income $ 634 $ 585 $ 1,854 $ 1,718 Reinsurance assumed 4 4 12 13 Reinsurance ceded (98) (100) (296) (304) Net fee income $ 540 $ 489 $ 1,570 $ 1,427 Interest credited and other benefits to contract owners / policyholders: Direct interest credited and other benefits to contract owners / policyholders $ 1,233 $ 1,099 $ 3,571 $ 3,221 Reinsurance assumed 7 21 43 51 Reinsurance ceded (302) (321) (982) (1,040) Net interest credited and other benefits to contract owners / policyholders $ 938 $ 799 $ 2,632 $ 2,232

Separate Accounts (Tables)

Separate Accounts (Tables)	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Separate Account, Liability	The following tables present a rollforward of separate account liabilities for the Wealth Solutions stabilizer and deferred annuity business, including a reconciliation to the Condensed Consolidated Balance Sheets, for the periods indicated: September 30, 2024 December 31, 2023 Wealth Solutions Stabilizer Deferred Annuity Total Stabilizer Deferred Annuity Total Balance at January 1 $ 7,175 $ 82,310 $ 89,485 $ 7,196 $ 69,152 $ 76,348 Premiums and deposits 702 7,510 8,212 940 10,052 10,992 Fee income (25) (358) (383) (34) (426) (460) Surrenders, withdrawals and benefits (1,019) (8,999) (10,018) (1,342) (9,631) (10,973) Net transfers (from) to the separate account — (971) (971) — (518) (518) Investment performance 384 12,846 13,230 415 13,681 14,096 Balance at end of period $ 7,217 $ 92,338 $ 99,555 $ 7,175 $ 82,310 $ 89,485 Reconciliation to Condensed Consolidated Balance Sheets: Other 3,977 3,648 Total Separate Account liabilities $ 103,532 $ 93,133
Fair Value, Separate Account Investment	The aggregate fair value of assets, by major investment asset category, supporting separate accounts was as follows for the periods indicated: September 30, 2024 December 31, 2023 U.S. Treasury securities and obligations of U.S. government corporations and agencies $ 886 $ 1,015 Corporate and foreign debt securities 2,756 2,528 Mortgage-backed securities 3,191 3,231 Equity securities (including mutual funds) 96,257 85,916 Cash, cash equivalents and short-term investments 300 399 Receivable for securities and accruals 142 44 Total $ 103,532 $ 93,133

Segments (Tables)

Segments (Tables)	9 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
Reconciliation of Operating Earnings Before Income Taxes from Segments to Consolidated	The summary below reconciles Adjusted operating earnings before income taxes for the segments to Income (loss) before income taxes for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Adjusted operating earnings before income taxes by segment: Wealth Solutions $ 211 $ 179 $ 611 $ 485 Health Solutions 23 53 142 271 Investment Management 72 63 189 168 Corporate (60) (52) (178) (175) Total including Allianz noncontrolling interest 245 242 764 749 Less: Earning (loss) attributable to Allianz noncontrolling interest 16 14 40 35 Total $ 230 $ 229 $ 724 $ 715 Adjustments: Net investment gains (losses) (33) 42 50 (4) Income (loss) related to businesses exited or to be exited through reinsurance or divestment (52) (68) (121) (122) Income (loss) attributable to noncontrolling interests (16) (16) 51 107 Dividend payments made to preferred shareholders 16 14 37 32 Other adjustments (28) (28) (63) (150) Total adjustments to income (loss) before income taxes (113) (56) (45) (138) Income (loss) before income taxes $ 116 $ 172 $ 679 $ 576
Reconciliation of Revenue from Segments to Total Revenues	The summary below reconciles Adjusted operating revenues for the segments to Total revenues for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Adjusted operating revenues by segment: Wealth Solutions $ 726 $ 702 $ 2,176 $ 2,090 Health Solutions 892 768 2,689 2,317 Investment Management 243 233 711 688 Corporate 6 14 15 39 Total $ 1,867 $ 1,717 $ 5,591 $ 5,135 Adjustments: Net investment gains (losses) (33) 40 30 (21) Revenues related to businesses exited or to be exited through reinsurance or divestment 52 21 89 53 Revenues attributable to noncontrolling interests 19 22 186 211 Other adjustments 50 24 144 152 Total adjustments to revenues 89 106 449 395 Total revenues $ 1,956 $ 1,823 $ 6,040 $ 5,529
Schedule of Intersegment Revenues Included in Investment Management Segment	The Investment Management segment revenues include the following intersegment revenues, primarily consisting of asset-based management and administration fees for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Investment Management intersegment revenues $ 20 $ 21 $ 59 $ 65
Summary of Financial Information for Segments	The summary below presents Total assets for the Company’s segments as of the dates indicated: September 30, 2024 December 31, 2023 Wealth Solutions $ 131,936 $ 122,318 Health Solutions 3,553 3,336 Investment Management 1,790 1,600 Corporate 25,386 25,527 Total assets, before consolidation (1) 162,665 152,781 Consolidation of investment entities 4,268 4,304 Total assets $ 166,933 $ 157,085 (1) Total assets, before consolidation include the Company's direct investments in CIEs prior to consolidation, which are accounted for using the equity method or fair value option.

Share-based Incentive Compens_2

Share-based Incentive Compensation Plans (Tables)	9 Months Ended
	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Share-based Compensation Expense	The following table summarizes share-based compensation expense, which includes expenses related to awards granted under the Omnibus Plans and the 2024 Omnibus Plan for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Restricted Stock Unit (RSU) awards $ 13 $ 14 $ 49 $ 67 Performance Stock Unit (PSU) awards 10 7 36 43 Total share-based compensation expense 23 21 85 110 Income tax benefit 5 4 21 26 After-tax share-based compensation expense $ 18 $ 17 $ 64 $ 84
Schedule of Share-based Compensation, Activity	The following table summarizes RSU and PSU awards activity under the Omnibus Plans and the 2024 Omnibus Plan for the period indicated: RSU Awards PSU Awards (awards in millions) Number of Awards Weighted Average Grant Date Fair Value Number of Awards Weighted Average Grant Date Fair Value Outstanding as of January 1, 2024 2.0 $ 67.06 2.2 $ 61.17 Adjustment for PSU performance factor — — (0.1) 46.94 Granted 0.9 67.70 0.7 59.21 Vested (0.8) 64.91 (0.6) 53.53 Forfeited (0.1) 69.42 — * 69.19 Outstanding as of September 30, 2024 2.0 $ 68.06 2.2 $ 63.55 *Less than 0.1
Schedule of Share-based Compensation, Stock Options, Activity	The following table summarizes the number of options under the Omnibus Plans for the period indicated: Stock Options (awards in millions) Number of Awards Weighted Average Exercise Price Outstanding as of January 1, 2024 1.2 $ 44.79 Granted — — Exercised (0.3) 42.55 Forfeited — * 50.03 Outstanding as of September 30, 2024 0.9 $ 45.47 Vested, exercisable, as of September 30, 2024 0.9 $ 45.47 *Less than 0.1

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Schedule of Common Stock Outstanding Roll Forward	The following table presents the rollforward of common shares used in calculating the weighted average shares utilized in the basic earnings per common share calculation for the periods indicated: Common Shares (shares in millions) Issued Held in Treasury Outstanding Balance, January 1, 2023 97.8 0.6 97.2 Common shares issued 9.7 — 9.7 Common shares acquired - share repurchase — 5.4 (5.4) Share-based compensation 2.1 0.7 1.4 Treasury stock retirement (6.0) (6.0) — Balance, December 31, 2023 103.6 0.7 102.9 Common shares issued 0.1 — 0.1 Common shares acquired - share repurchase — 6.9 (6.9) Share-based compensation 1.7 0.7 1.0 Balance, September 30, 2024 105.4 8.3 97.1
Schedule of Dividends Declared	Dividends declared per share of common stock were as follows for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Dividends declared per share of common stock $ 0.45 $ 0.40 $ 1.25 $ 0.80 Series A Series B Three Months Ended September 30, Per Share Aggregate Per Share Aggregate 2024 $ 38.790 $ 13 $ 13.375 $ 4 2023 30.625 10 13.375 4 Nine Months Ended September 30, 2024 77.580 25 40.125 12 2023 61.250 20 40.125 12
Schedule of Preferred Stock Issued and Outstanding	Shares of preferred stock issued and outstanding are as follows: September 30, 2024 December 31, 2023 Series Issued Outstanding Issued Outstanding 7.758% Non-cumulative Preferred Stock, Series A 325,000 325,000 325,000 325,000 5.35% Non-cumulative Preferred Stock, Series B 300,000 300,000 300,000 300,000 Total 625,000 625,000 625,000 625,000
Schedule of Share Repurchases	The following table presents repurchases of the Company's common stock through share repurchase agreements with third-party financial institutions during the nine months ended September 30, 2024: Execution Date Payment Initial Shares Delivered Closing Date Additional Shares Delivered Total Shares Repurchased September 12, 2024 $ 100 1,061,853 (1) (1) (1) (1) This arrangement is scheduled to terminate no later than December 31, 2024, at which time the Company will settle any positive or negative share balances based on the daily volume-weighted average price of the Company's common stock. The following table presents repurchases of our common stock pursuant to 10b5-1 plans and through open market repurchases for the periods indicated: Nine Months Ended September 30, 2024 2023 Shares of common stock 5,811,158 3,107,195 Payment $ 415 $ 216

Earnings per Common Share (Tabl

Earnings per Common Share (Tables)	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table presents a reconciliation of Net income (loss) and shares used in calculating basic and diluted net income (loss) per common share for the periods indicated: Three Months Ended September 30, Nine Months Ended September 30, (in millions, except for per share data) 2024 2023 2024 2023 Earnings Net income (loss) available to common shareholders: Net income (loss) $ 98 $ 246 $ 621 $ 610 Less: Preferred stock dividends 16 14 37 32 Less: Net income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest (16) (16) 51 107 Net income (loss) available to common shareholders $ 98 $ 248 $ 533 $ 471 Weighted average common shares outstanding Basic 98.2 105.8 100.2 102.2 Dilutive Effects: Warrants (1) — — — 4.3 RSUs 1.1 1.1 1.1 1.1 PSUs 0.7 1.1 0.7 1.2 Stock Options 0.4 0.4 0.4 0.5 Diluted 100.4 108.4 102.4 109.3 Net income (loss) available to Voya Financial, Inc.'s common shareholders per common share (2) Basic $ 1.00 $ 2.35 $ 5.32 $ 4.62 Diluted $ 0.98 $ 2.29 $ 5.20 $ 4.31 (1) See the Shareholders' Equity Note to the Consolidated Financial Statements in Part II, Item 8. of the Company's Annual Report on Form 10-K for the year ended December 31, 2023 for additional information on warrants settled. (2) Basic and diluted earnings per share are calculated using unrounded, actual amounts. Therefore, the components of earnings per share may not sum to its corresponding total. Diluted earnings per share is computed assuming the issuance of restricted stock units, stock options, performance share units and warrants using the treasury stock method.

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income	Shareholders' equity included the following components of Accumulated other comprehensive income ("AOCI") as of the dates indicated: September 30, 2024 September 30, 2023 Fixed maturities, net of impairment $ (1,648) $ (3,881) Derivatives (1) 34 100 Change in current discount rate (838) (850) Deferred income tax asset (liability) (2) 638 1,096 Total (1,814) (3,535) Pension and other postretirement benefits liability, net of tax 2 2 AOCI $ (1,812) $ (3,533) (1) Gains and losses reported in AOCI from hedge transactions that resulted in the acquisition of an identified asset are reclassified into earnings in the same period or periods during which the asset acquired affects earnings. As of September 30, 2024, the portion of the AOCI that is expected to be reclassified into earnings within the next 12 months is $12. (2)
Schedule of Amounts Recognized in Other Comprehensive Income (Loss)	Changes in AOCI, including the reclassification adjustments recognized in the Condensed Consolidated Statements of Operations, were as follows for the periods indicated: Three Months Ended September 30, 2024 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ 1,047 $ (219) $ 828 Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations (20) 4 (16) Change in unrealized gains/losses on available-for-sale securities 1,027 (215) 812 Derivatives: Derivatives (28) (1) 6 (22) Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (4) 1 (3) Change in unrealized gains/losses on derivatives (32) 7 (25) Change in current discount rate (20) 4 (16) Change in Accumulated other comprehensive income (loss) $ 975 $ (204) $ 771 (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Nine Months Ended September 30, 2024 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ 717 $ (151) $ 566 Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 4 (1) 3 Change in unrealized gains (losses) on available-for-sale securities 721 (152) 569 Derivatives: Derivatives (17) (1) 4 (13) Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (12) 3 (9) Change in unrealized gains (losses) on derivatives (29) 7 (22) Change in current discount rate 52 (11) 41 Change in Accumulated other comprehensive income (loss) $ 744 $ (156) $ 588 (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Three Months Ended September 30, 2023 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (937) $ 197 $ (740) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 18 (4) 14 Change in unrealized gains (losses) on available-for-sale securities (919) 193 (726) Derivatives: Derivatives 7 (1) (2) 5 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (4) 1 (3) Change in unrealized gains (losses) on derivatives 3 (1) 2 Change in current discount rate (23) 5 (18) Change in Accumulated other comprehensive income (loss) $ (939) $ 197 $ (742) (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Nine Months Ended September 30, 2023 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (619) $ 130 $ (489) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 32 (7) 25 Change in unrealized gains (losses) on available-for-sale securities (587) 123 (464) Derivatives: Derivatives (11) (1) 2 (9) Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (14) 3 (11) Change in unrealized gains (losses) on derivatives (25) 5 (20) Change in current discount rate 7 (1) 6 Change in Accumulated other comprehensive income (loss) $ (605) $ 127 $ (478) (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information.

Revenue from Contracts with Cus

Revenue from Contracts with Customers (Tables)	9 Months Ended
	Sep. 30, 2024
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	Financial services and software subscriptions and services revenue is disaggregated by type of service in the following table: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Wealth Solutions: Advisory and recordkeeping and administration $ 163 $ 125 $ 463 $ 369 Distribution and shareholder servicing 34 29 100 88 Investment Management: Advisory, asset management and recordkeeping and administration 248 236 732 698 Distribution and shareholder servicing 40 36 119 100 Health Solutions: Recordkeeping and administration 7 4 19 15 Software subscriptions and services 50 53 154 167 Corporate: Recordkeeping and administration — 8 2 25 Total financial services and software subscriptions and services revenue 542 491 1,589 1,462 Revenue from other sources (1) 101 79 270 210 Total Fee income and Other revenue $ 643 $ 570 $ 1,859 $ 1,672 (1) Primarily consists of revenue from insurance contracts and financial instruments.

Financing Agreements (Tables)

Financing Agreements (Tables)	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	The following table summarizes the carrying value of the Company’s debt issued or borrowed and outstanding as of the periods indicated: Issuer Maturity September 30, 2024 December 31, 2023 3.976% Senior Notes, due 2025 (2)(3) Voya Financial, Inc. 02/15/2025 $ 397 $ 390 3.65% Senior Notes, due 2026 (2)(3) Voya Financial, Inc. 06/15/2026 446 446 5.0% Senior Notes, due 2034 (2)(3) Voya Financial, Inc. 09/20/2034 395 — 5.7% Senior Notes, due 2043 (2)(3) Voya Financial, Inc. 07/15/2043 396 396 4.8% Senior Notes, due 2046 (2)(3) Voya Financial, Inc. 06/15/2046 297 297 4.7% Fixed-to-Floating Rate Junior Subordinated Notes, due 2048 Voya Financial, Inc. 01/23/2048 336 336 7.625% Voya Holdings Inc. debentures, due 2026 (1) Voya Holdings, Inc. 08/15/2026 139 139 6.97% Voya Holdings Inc. debentures, due 2036 (1) Voya Holdings, Inc. 08/15/2036 79 79 8.42% Equitable of Iowa Companies Capital Trust II Notes, due 2027 Equitable of Iowa Capital Trust II 04/01/2027 13 13 1.00% Windsor Property Loan Voya Retirement Insurance and Annuity Company 06/14/2027 2 2 Subtotal 2,500 2,098 Less: Current portion of long-term debt 397 1 Total $ 2,103 $ 2,097 (1) Guaranteed by ING Group. (2) Interest is paid semi-annually in arrears. (3) Guaranteed by Voya Holdings.
Schedule of Line of Credit Facilities	The following table summarizes the Company's credit facilities as of September 30, 2024: Obligor / Applicant Secured / Unsecured Committed / Uncommitted Expiration Capacity Utilization Unused Commitment Voya Financial, Inc. Unsecured Committed 05/01/2028 $ 500 $ — $ 500 Voya Financial, Inc. Unsecured Committed 04/07/2025 12 (2) 12 (1) — Total $ 512 $ 12 $ 500 (1) Amount utilized as collateral for outstanding Aetna Notes. (2) In March of 2024, the Company decreased the capacity of its letter of credit, expiring in 2025, from $200 to $12. This reduction was due to the reduced collateral requirements resulting from the maturity of a portion of the Aetna Notes. Additionally, the full capacity was not expected to be utilized through its expiration.

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Restricted Assets	Restricted Assets The Company is required to maintain assets on deposit with various regulatory authorities to support its insurance operations. The Company may also post collateral in connection with certain securities lending, repurchase agreements, funding agreements, credit facilities and derivative transactions. The components of the fair value of the restricted assets were as follows as of the dates indicated: September 30, 2024 December 31, 2023 Fixed maturity collateral pledged to FHLB (1) $ 2,176 $ 1,956 FHLB restricted stock (2) 65 64 Fixed maturities-state and other deposits 40 37 Cash and cash equivalents 22 25 Securities pledged (3) 1,463 1,160 Total restricted assets $ 3,766 $ 3,242 (1) Included in Fixed maturities, available for sale, at fair value on the Condensed Consolidated Balance Sheets. (2) Included in Other investments on the Condensed Consolidated Balance Sheets. (3) Includes the fair value of loaned securities of $1,091 and $842 as of September 30, 2024 and December 31, 2023, respectively. In addition, as of September 30, 2024 and December 31, 2023, the Company delivered securities as collateral of $168 and $201, respectively, and repurchase agreements of $204 and $117, respectively. Loaned securities and securities delivered as collateral are included in Securities pledged on the Condensed Consolidated Balance Sheets.

Consolidated and Nonconsolida_2

Consolidated and Nonconsolidated Investment Entities (Tables)	9 Months Ended
	Sep. 30, 2024
Consolidated Investment Entities [Abstract]
Fair Value, by Balance Sheet Grouping	The carrying values and estimated fair values of the Company's financial instruments as of the dates indicated: September 30, 2024 December 31, 2023 Carrying Fair Carrying Fair Assets: Fixed maturities, including securities pledged $ 28,546 $ 28,546 $ 28,611 $ 28,611 Equity securities 251 251 236 236 Mortgage loans on real estate 4,846 4,702 5,218 4,941 Policy loans 345 345 352 352 Cash, cash equivalents, short-term investments and short-term investments under securities loan agreements 2,822 2,822 2,165 2,165 Derivatives 225 225 311 311 Embedded derivatives on reinsurance 40 40 61 61 Other investments 66 66 64 64 Assets held in separate accounts 103,532 103,532 93,133 93,133 Liabilities: Investment contract liabilities: Funding agreements without fixed maturities and deferred annuities (1) $ 31,403 $ 34,625 $ 32,848 $ 34,856 Funding agreements with fixed maturities 1,251 1,207 1,175 1,178 Supplementary contracts, immediate annuities and other 582 539 628 571 Stabilizer and MCGs 10 10 9 9 Derivatives 359 359 371 371 Embedded derivative on reinsurance 45 45 49 49 Short-term debt 397 396 1 1 Long-term debt 2,103 2,083 2,097 1,998 (1) Certain amounts included in Funding agreements without fixed maturities and deferred annuities are also reflected within the Stabilizer and MCGs section of the table above. The following table summarizes the fair value hierarchy levels of consolidated investment entities as of September 30, 2024: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 84 $ — $ — $ — $ 84 Corporate loans — 1,345 — — 1,345 Limited partnerships/corporations — — — 3,033 3,033 Other investments (1) — — 23 — 23 VOEs Cash and cash equivalents 4 — — — 4 Other investments (1) — — — 49 49 Total assets $ 88 $ 1,345 $ 23 $ 3,082 $ 4,538 Liabilities VIEs CLO notes $ — $ 1,123 $ — $ — $ 1,123 Total liabilities $ — $ 1,123 $ — $ — $ 1,123 (1) VIEs and VOEs - Other investments are reflected in Assets related to consolidated investment entities - Other assets on the Company's Condensed Consolidated Balance Sheets. The following table summarizes the fair value hierarchy levels of consolidated investment entities as of December 31, 2023: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 181 $ — $ — $ — $ 181 Corporate loans — 1,404 — — 1,404 Limited partnerships/corporations — — — 2,861 2,861 Total assets $ 181 $ 1,404 $ — $ 2,861 $ 4,446 Liabilities VIEs CLO notes $ — $ 1,332 $ — $ — $ 1,332 Total liabilities $ — $ 1,332 $ — $ — $ 1,332

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The changes in the carrying amount of goodwill reported in the Company's operating segments were as follows: Wealth Solutions Health Solutions Investment Management Corporate (1) Consolidated Balance as of January 1, 2023 $ 17 $ 24 $ 286 $ — $ 327 Additions from business combinations (2) — 319 — 102 421 Balance as of December 31, 2023 $ 17 $ 343 $ 286 $ 102 $ 748 Additions from business combinations — — — — — Balance as of September 30, 2024 $ 17 $ 343 $ 286 $ 102 $ 748 (1) Corporate includes goodwill that was acquired by the parent company and not pushed to a subsidiary within the Company’s reportable segments. The carrying value of goodwill within Corporate is allocated to Wealth Solutions, Health Solutions, and Investment Management reporting units as $72, $20 and $10, respectively. (2) See the Business, Basis of Presentation and Significant Accounting Policies Note for information on business combinations.
Schedule of Indefinite-Lived Intangible Assets	The following table presents other intangible assets as of the dates indicated: Weighted September 30, 2024 December 31, 2023 Gross Accumulated Net Gross Accumulated Net Indefinite-life intangibles: Management contract rights N/A $ 350 $ — $ 350 $ 350 $ — $ 350 Total indefinite-life intangibles $ 350 $ — $ 350 $ 350 $ — $ 350 Finite-life intangibles: Management contract rights 15 years $ 153 $ 20 $ 133 $ 153 $ 11 $ 142 Customer relationship lists 17 years 325 141 184 325 128 197 Trademarks 8 years 15 3 12 15 2 13 Computer software 5 years 419 236 183 501 346 155 Total intangible assets $ 1,262 $ 400 $ 862 $ 1,344 $ 487 $ 857
Schedule of Finite-Lived Intangible Assets	The following table presents other intangible assets as of the dates indicated: Weighted September 30, 2024 December 31, 2023 Gross Accumulated Net Gross Accumulated Net Indefinite-life intangibles: Management contract rights N/A $ 350 $ — $ 350 $ 350 $ — $ 350 Total indefinite-life intangibles $ 350 $ — $ 350 $ 350 $ — $ 350 Finite-life intangibles: Management contract rights 15 years $ 153 $ 20 $ 133 $ 153 $ 11 $ 142 Customer relationship lists 17 years 325 141 184 325 128 197 Trademarks 8 years 15 3 12 15 2 13 Computer software 5 years 419 236 183 501 346 155 Total intangible assets $ 1,262 $ 400 $ 862 $ 1,344 $ 487 $ 857

Business, Basis of Presentati_3

Business, Basis of Presentation and Significant Accounting Policies - Narrative (Details) $ in Millions		9 Months Ended
	Jan. 24, 2023 USD ($)	Sep. 30, 2024 USD ($) segment	Sep. 30, 2023 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Number of operating segments | segment		3
Payments for business acquisitions, net of cash acquired		$ 0	$ 584
Goodwill acquired		748		$ 748	$ 327
Benefitfocus
Total purchase consideration	$ 595
Cash purchase consideration	583
Payments for business acquisitions, net of cash acquired	558
Cash acquired from acquisition	25
Cash acquired	49
Goodwill acquired	319
Intangible assets acquired	275
Deferred tax assets acquired	45
Lease liabilities assumed	91
Customer Relationships | Benefitfocus
Finite-lived intangible assets acquired	$ 190
Acquired finite-lived intangible assets, useful life	15 years
Software | Benefitfocus
Finite-lived intangible assets acquired	$ 70
Acquired finite-lived intangible assets, useful life	5 years
VFI SLK
Cash purchase consideration		53
OneAmerica
Cash purchase consideration		50
Other cash payments for acquisition		160
Voya India
Goodwill acquired		$ 102
Voya India
Noncontrolling interest, ownership percentage by parent		49%
SLK
Noncontrolling interest, ownership percentage by noncontrolling owners		51%

Investments (excluding Consol_3

Investments (excluding Consolidated Investment Entities) - Fixed Maturities (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, including securities pledged, Amortized Cost	$ 26,668	$ 27,690
Securities pledged, Amortized Cost	1,543	1,232
Fixed maturities, allowance for credit losses	32	17	$ 12
Collateral Pledged
Schedule of Available for Sale, including Securities Pledged [Line Items]
Securities pledged	1,463	1,160
U.S. Treasuries
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, including securities pledged, Amortized Cost	388	417
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	6	7
Fixed maturities, including securities pledged, Gross Unrealized Capital Losses	20	21
Embedded Derivatives	0	0
Fixed maturities, allowance for credit losses	0	0
Fixed maturities, including securities pledged, Fair Value	374	403
U.S. Government agencies and authorities
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, including securities pledged, Amortized Cost	29	54
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	2	3
Fixed maturities, including securities pledged, Gross Unrealized Capital Losses	0	1
Embedded Derivatives	0	0
Fixed maturities, allowance for credit losses	0	0
Fixed maturities, including securities pledged, Fair Value	31	56
State, municipalities and political subdivisions
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, including securities pledged, Amortized Cost	717	871
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	0	1
Fixed maturities, including securities pledged, Gross Unrealized Capital Losses	82	101
Embedded Derivatives	0	0
Fixed maturities, allowance for credit losses	0	0
Fixed maturities, including securities pledged, Fair Value	635	771
U.S. corporate public securities
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, including securities pledged, Amortized Cost	7,826	8,402
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	207	168
Fixed maturities, including securities pledged, Gross Unrealized Capital Losses	780	904
Embedded Derivatives	0	0
Fixed maturities, allowance for credit losses	0	0
Fixed maturities, including securities pledged, Fair Value	7,253	7,666
U.S. corporate private securities
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, including securities pledged, Amortized Cost	5,162	5,040
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	75	44
Fixed maturities, including securities pledged, Gross Unrealized Capital Losses	236	324
Embedded Derivatives	0	0
Fixed maturities, allowance for credit losses	6	0	0
Fixed maturities, including securities pledged, Fair Value	4,995	4,760
Foreign corporate public securities and foreign governments
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, including securities pledged, Amortized Cost	2,686	2,928
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	71	47
Fixed maturities, including securities pledged, Gross Unrealized Capital Losses	206	270
Embedded Derivatives	0	0
Fixed maturities, allowance for credit losses	2	3	9
Fixed maturities, including securities pledged, Fair Value	2,549	2,702
Foreign corporate private securities
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, including securities pledged, Amortized Cost	2,761	2,916
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	48	27
Fixed maturities, including securities pledged, Gross Unrealized Capital Losses	96	129
Embedded Derivatives	0	0
Fixed maturities, allowance for credit losses	1	2	2
Fixed maturities, including securities pledged, Fair Value	2,712	2,812
Residential mortgage-backed
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, including securities pledged, Amortized Cost	3,974	3,695
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	42	36
Fixed maturities, including securities pledged, Gross Unrealized Capital Losses	200	257
Embedded Derivatives	(3)	(2)
Fixed maturities, allowance for credit losses	0	0
Fixed maturities, including securities pledged, Fair Value	3,819	3,476
Commercial mortgage-backed securities
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, including securities pledged, Amortized Cost	3,890	4,147
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	3	1
Fixed maturities, including securities pledged, Gross Unrealized Capital Losses	483	644
Embedded Derivatives	0	0
Fixed maturities, allowance for credit losses	17	9	$ 0
Fixed maturities, including securities pledged, Fair Value	3,393	3,495
Other asset-backed securities
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, including securities pledged, Amortized Cost	2,787	2,528
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	41	16
Fixed maturities, including securities pledged, Gross Unrealized Capital Losses	37	71
Embedded Derivatives	0	0
Fixed maturities, allowance for credit losses	6	3
Fixed maturities, including securities pledged, Fair Value	2,785	2,470
Fixed maturities
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, including securities pledged, Amortized Cost	30,220	30,998
Total fixed maturities, less securities pledged, Amortized Cost	28,677	29,766
Fixed maturities, including securities pledged, Gross Unrealized Capital Gains	495	350
Total fixed maturities, less securities pledged, Gross Unrealized Capital Gains	495	350
Fixed maturities, including securities pledged, Gross Unrealized Capital Losses	2,140	2,722
Total fixed maturities, less securities pledged, Gross Unrealized Capital Losses	2,060	2,650
Embedded Derivatives	(3)	(2)
Fixed maturities, allowance for credit losses	32	17
Fixed maturities, including securities pledged, Fair Value	28,546	28,611
Total fixed maturities, less securities pledged, Fair Value	27,083	27,451
Fixed maturities | Collateral Pledged
Schedule of Available for Sale, including Securities Pledged [Line Items]
Securities pledged, Amortized Cost	1,543	1,232
Securities pledged, Gross Unrealized Capital Gains	0	0
Securities pledged, Gross Unrealized Capital Losses	80	72
Embedded Derivatives	0	0
Fixed maturities, allowance for credit losses	0	0
Securities pledged	$ 1,463	$ 1,160

Investments (excluding Consol_4

Investments (excluding Consolidated Investment Entities) - Debt Maturities (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	$ 26,668,000,000	$ 27,690,000,000
Single issuer in excess of total equity	0
Fixed maturities
Available-for-sale Securities, Including Securities Pledged [Line Items]
One year or less, Amortized Cost	610,000,000
After one year through five years, Amortized Cost	3,848,000,000
After five years through ten years, Amortized Cost	3,664,000,000
After ten years, Amortized Cost	11,447,000,000
Fixed maturities, amortized cost	30,220,000,000	30,998,000,000
One year or less, Fair Value	593,000,000
After one year through five years, Fair Value	3,798,000,000
After five years through ten years, Fair Value	3,655,000,000
After ten years, Fair Value	10,503,000,000
Fixed maturities, fair value	28,546,000,000	28,611,000,000
Mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Without single maturity date, Amortized Cost	7,864,000,000
Without single maturity date, Fair Value	7,212,000,000
Other asset-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Without single maturity date, Amortized Cost	2,787,000,000
Fixed maturities, amortized cost	2,787,000,000	2,528,000,000
Without single maturity date, Fair Value	2,785,000,000
Fixed maturities, fair value	$ 2,785,000,000	$ 2,470,000,000

Investments (excluding Consol_5

Investments (excluding Consolidated Investment Entities) - Repurchase Agreements and Securities Pledged (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Securities Financing Transaction [Line Items]
Initial collateral required, percent of market value of loaned securities	102%
Payables under securities loan and repurchase agreements, including collateral held	$ 1,368	$ 1,121
U.S. Treasuries
Securities Financing Transaction [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	13	14
U.S. corporate public securities
Securities Financing Transaction [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	649	568
Short-term Investments
Securities Financing Transaction [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	155	55
Foreign corporate public securities and foreign governments
Securities Financing Transaction [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	315	238
Total collateral held
Securities Financing Transaction [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	1,132	875
Collateral Pledged
Securities Financing Transaction [Line Items]
Securities sold under agreements to repurchase, asset	0	0
Securities pledged	1,463	1,160
Collateral Pledged | Fixed maturities
Securities Financing Transaction [Line Items]
Securities pledged	1,463	1,160
Securities pledged
Securities Financing Transaction [Line Items]
Securities pledged/obligations under repurchase agreements	204	117
Securities loaned to lending agent	1,091	842
Securities pledged as collateral	168	201
Short-term Investments
Securities Financing Transaction [Line Items]
Securities received as collateral	$ 925	$ 660

Investments (excluding Consol_6

Investments (excluding Consolidated Investment Entities) - Allowance for Credit Losses on Available-for-sale Fixed Maturity Securities (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	$ 17	$ 12
Credit losses on securities for which credit losses were not previously recorded	16	11
Reductions for securities sold during the period	(1)	(5)
Increase (decrease) on securities with allowance recorded in previous period	0	(1)
Ending Balance	32	17
U.S. corporate private securities
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	0	0
Credit losses on securities for which credit losses were not previously recorded	6	0
Reductions for securities sold during the period	0	0
Increase (decrease) on securities with allowance recorded in previous period	0	0
Ending Balance	6	0
Commercial mortgage-backed securities
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	9	0
Credit losses on securities for which credit losses were not previously recorded	9	9
Reductions for securities sold during the period	0	0
Increase (decrease) on securities with allowance recorded in previous period	(1)	0
Ending Balance	17	9
Foreign corporate public securities and foreign governments
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	3	9
Credit losses on securities for which credit losses were not previously recorded	0	0
Reductions for securities sold during the period	(1)	(5)
Increase (decrease) on securities with allowance recorded in previous period	0	(1)
Ending Balance	2	3
Foreign corporate private securities
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	2	2
Credit losses on securities for which credit losses were not previously recorded	0	0
Reductions for securities sold during the period	0	0
Increase (decrease) on securities with allowance recorded in previous period	(1)	0
Ending Balance	1	2
Other asset-backed securities
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	3	1
Credit losses on securities for which credit losses were not previously recorded	1	2
Reductions for securities sold during the period	0	0
Increase (decrease) on securities with allowance recorded in previous period	2	0
Ending Balance	$ 6	$ 3

Investments (excluding Consol_7

Investments (excluding Consolidated Investment Entities) - Unrealized Capital Losses (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 483	$ 1,221
Twelve months or less below amortized cost, Unrealized Capital Loss	14	42
More than twelve months below amortized cost, Fair Value	16,126	18,938
More than twelve months below amortized cost, Unrealized Capital Loss	2,126	2,680
Total, Fair Value	16,609	20,159
Total Unrealized Capital Losses	$ 2,140	2,722
Minimum
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities average duration	6 years
Maximum
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities average duration	6 years 6 months
U.S. Treasuries
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 66	99
Twelve months or less below amortized cost, Unrealized Capital Loss	1	3
More than twelve months below amortized cost, Fair Value	150	109
More than twelve months below amortized cost, Unrealized Capital Loss	19	18
Total, Fair Value	216	208
Total Unrealized Capital Losses	20	21
U.S. Government agencies and authorities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value		0
Twelve months or less below amortized cost, Unrealized Capital Loss		0
More than twelve months below amortized cost, Fair Value		3
More than twelve months below amortized cost, Unrealized Capital Loss		1
Total, Fair Value		3
Total Unrealized Capital Losses		1
State, municipalities and political subdivisions
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	1	20
Twelve months or less below amortized cost, Unrealized Capital Loss	0	0
More than twelve months below amortized cost, Fair Value	618	731
More than twelve months below amortized cost, Unrealized Capital Loss	82	101
Total, Fair Value	619	751
Total Unrealized Capital Losses	82	101
U.S. corporate public securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	96	321
Twelve months or less below amortized cost, Unrealized Capital Loss	8	17
More than twelve months below amortized cost, Fair Value	4,573	5,101
More than twelve months below amortized cost, Unrealized Capital Loss	772	887
Total, Fair Value	4,669	5,422
Total Unrealized Capital Losses	780	904
U.S. corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	178	176
Twelve months or less below amortized cost, Unrealized Capital Loss	2	7
More than twelve months below amortized cost, Fair Value	3,061	3,365
More than twelve months below amortized cost, Unrealized Capital Loss	234	317
Total, Fair Value	3,239	3,541
Total Unrealized Capital Losses	236	324
Foreign corporate public securities and foreign governments
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	47	82
Twelve months or less below amortized cost, Unrealized Capital Loss	2	2
More than twelve months below amortized cost, Fair Value	1,367	1,749
More than twelve months below amortized cost, Unrealized Capital Loss	204	268
Total, Fair Value	1,414	1,831
Total Unrealized Capital Losses	206	270
Foreign corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	10	189
Twelve months or less below amortized cost, Unrealized Capital Loss	0	5
More than twelve months below amortized cost, Fair Value	1,605	2,101
More than twelve months below amortized cost, Unrealized Capital Loss	96	124
Total, Fair Value	1,615	2,290
Total Unrealized Capital Losses	96	129
Residential mortgage-backed
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	19	114
Twelve months or less below amortized cost, Unrealized Capital Loss	0	3
More than twelve months below amortized cost, Fair Value	1,290	1,354
More than twelve months below amortized cost, Unrealized Capital Loss	200	254
Total, Fair Value	1,309	1,468
Total Unrealized Capital Losses	200	257
Commercial mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	32	84
Twelve months or less below amortized cost, Unrealized Capital Loss	0	2
More than twelve months below amortized cost, Fair Value	3,091	3,269
More than twelve months below amortized cost, Unrealized Capital Loss	483	642
Total, Fair Value	3,123	3,353
Total Unrealized Capital Losses	483	644
Other asset-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	34	136
Twelve months or less below amortized cost, Unrealized Capital Loss	1	3
More than twelve months below amortized cost, Fair Value	371	1,156
More than twelve months below amortized cost, Unrealized Capital Loss	36	68
Total, Fair Value	405	1,292
Total Unrealized Capital Losses	$ 37	$ 71

Investments (excluding Consol_8

Investments (excluding Consolidated Investment Entities) - Evaluating Securities for Impairments and Debt Modifications (Narrative) (Details) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) loan	Sep. 30, 2023 USD ($) loan
Financing Receivable, Troubled Debt Restructuring [Line Items]
Intent impairments | $	$ 1	$ 18	$ 6	$ 25
Commercial mortgage loans
Financing Receivable, Troubled Debt Restructuring [Line Items]
Debt modifcations, number of contracts | loan			0	0

Investments (excluding Consol_9

Investments (excluding Consolidated Investment Entities) - Loans by Loan to Value (Details) - USD ($) $ in Millions	6 Months Ended	9 Months Ended
	Jun. 30, 2024	Sep. 30, 2024	Dec. 31, 2023
Schedule of Loans by Loan to Value Ratio [Line Items]
Targeted maximum amount of mortgage loans lended, percent of estimated fair value of underlying real estate		75%
0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	0%
Loan to value ratio, maximum	50%
50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	50%
Loan to value ratio, maximum	60%
60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	60%
Loan to value ratio, maximum	70%
70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	70%
Loan to value ratio, maximum	80%
80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	80%
Year of Origination 2024 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		$ 129
Year of Origination 2024 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		83
Year of Origination 2024 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		15
Year of Origination 2024 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0
Year of Origination 2024 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0
Year of Origination 2023 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		117	$ 150
Year of Origination 2023 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		222	222
Year of Origination 2023 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		39	0
Year of Origination 2023 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	0
Year of Origination 2023 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	0
Year of Origination 2022 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		231	252
Year of Origination 2022 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		295	326
Year of Origination 2022 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		105	73
Year of Origination 2022 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	0
Year of Origination 2022 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	0
Year of Origination 2021 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		238	244
Year of Origination 2021 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		196	214
Year of Origination 2021 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		115	209
Year of Origination 2021 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	0
Year of Origination 2021 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	0
Year of Origination 2020 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		186	168
Year of Origination 2020 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		86	112
Year of Origination 2020 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	0
Year of Origination 2020 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	10
Year of Origination 2020 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	16
Year of Origination 2019 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		2,570	238
Year of Origination 2019 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		185	68
Year of Origination 2019 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		16	28
Year of Origination 2019 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	0
Year of Origination 2019 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		18	0
Year of Origination 2018 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans			2,586
Year of Origination 2018 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans			280
Year of Origination 2018 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans			4
Year of Origination 2018 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans			0
Year of Origination 2018 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans			18
Total | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		3,471	3,638
Total | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		1,067	1,222
Total | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		290	314
Total | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		0	10
Total | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans		$ 18	$ 34

Investments (excluding Conso_10

Investments (excluding Consolidated Investment Entities) - Loans by Debt Service Coverage Ratio (Details) $ in Millions	9 Months Ended
	Sep. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)
>1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, minimum	1.5
>1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, minimum	1.25
Debt Service Coverage Ratio, maximum	1.5
>1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, minimum	1
Debt Service Coverage Ratio, maximum	1.25
Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, maximum	1
Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	$ 4,846	$ 5,218
Year of Origination 2024 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	96
Year of Origination 2024 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	91
Year of Origination 2024 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	33
Year of Origination 2024 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	7
Year of Origination 2024 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	227
Year of Origination 2023 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	114	189
Year of Origination 2023 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	74	116
Year of Origination 2023 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	179	67
Year of Origination 2023 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	11	0
Year of Origination 2023 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	378	372
Year of Origination 2022 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	271	204
Year of Origination 2022 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	76	68
Year of Origination 2022 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	84	192
Year of Origination 2022 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	200	187
Year of Origination 2022 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	631	651
Year of Origination 2021 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	259	260
Year of Origination 2021 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	12	14
Year of Origination 2021 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	83	64
Year of Origination 2021 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	195	329
Year of Origination 2021 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	549	667
Year of Origination 2020 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	209	211
Year of Origination 2020 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	19	24
Year of Origination 2020 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	20	21
Year of Origination 2020 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	24	50
Year of Origination 2020 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	272	306
Year of Origination 2019 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	2,109	203
Year of Origination 2019 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	228	26
Year of Origination 2019 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	350	84
Year of Origination 2019 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	102	21
Year of Origination 2019 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	2,789	334
Year of Origination 2018 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans		2,216
Year of Origination 2018 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans		264
Year of Origination 2018 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans		255
Year of Origination 2018 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans		153
Year of Origination 2018 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans		2,888
Total | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	3,058	3,283
Total | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	500	512
Total | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	749	683
Total | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	539	740
Total | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	$ 4,846	$ 5,218

Investments (excluding Conso_11

Investments (excluding Consolidated Investment Entities) - Loans by U.S. Region (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Year of Origination 2024 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	$ 28
Year of Origination 2024 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	80
Year of Origination 2024 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	34
Year of Origination 2024 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	44
Year of Origination 2024 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	20
Year of Origination 2024 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1
Year of Origination 2024 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	8
Year of Origination 2024 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	3
Year of Origination 2024 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	9
Year of Origination 2024 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	227
Year of Origination 2023 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	69	$ 69
Year of Origination 2023 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	84	77
Year of Origination 2023 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	12	12
Year of Origination 2023 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	102	101
Year of Origination 2023 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	39	39
Year of Origination 2023 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	40	42
Year of Origination 2023 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	3	3
Year of Origination 2023 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	26	26
Year of Origination 2023 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	3	3
Year of Origination 2023 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	378	372
Year of Origination 2022 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	140	140
Year of Origination 2022 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	132	132
Year of Origination 2022 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	49	47
Year of Origination 2022 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	98	100
Year of Origination 2022 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	94	113
Year of Origination 2022 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	92	93
Year of Origination 2022 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	5	5
Year of Origination 2022 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1	1
Year of Origination 2022 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	20	20
Year of Origination 2022 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	631	651
Year of Origination 2021 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	96	96
Year of Origination 2021 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	51	63
Year of Origination 2021 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	116	124
Year of Origination 2021 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	93	148
Year of Origination 2021 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	97	111
Year of Origination 2021 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	47	75
Year of Origination 2021 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	9	9
Year of Origination 2021 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	40	40
Year of Origination 2021 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	1
Year of Origination 2021 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	549	667
Year of Origination 2020 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	62	63
Year of Origination 2020 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	134	155
Year of Origination 2020 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	17	17
Year of Origination 2020 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2020 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	12	12
Year of Origination 2020 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	15	26
Year of Origination 2020 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	7	7
Year of Origination 2020 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	15	16
Year of Origination 2020 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	272	306
Year of Origination 2019 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	721	53
Year of Origination 2019 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	657	100
Year of Origination 2019 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	665	10
Year of Origination 2019 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	178	74
Year of Origination 2019 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	228	45
Year of Origination 2019 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	136	4
Year of Origination 2019 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	58	14
Year of Origination 2019 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	117	13
Year of Origination 2019 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	29	21
Year of Origination 2019 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	2,789	334
Year of Origination 2018 | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		734
Year of Origination 2018 | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		605
Year of Origination 2018 | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		765
Year of Origination 2018 | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		189
Year of Origination 2018 | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		214
Year of Origination 2018 | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		171
Year of Origination 2018 | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		47
Year of Origination 2018 | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		144
Year of Origination 2018 | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		19
Year of Origination 2018 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		2,888
Total | Pacific
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1,116	1,155
Total | South Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1,138	1,132
Total | Middle Atlantic
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	893	975
Total | West South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	525	622
Total | Mountain
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	490	534
Total | East North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	331	411
Total | New England
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	83	78
Total | West North Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	194	231
Total | East South Central
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	76	80
Total | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	$ 4,846	$ 5,218

Investments (excluding Conso_12

Investments (excluding Consolidated Investment Entities) - Loans by Property Type (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Year of Origination 2024 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	$ 25
Year of Origination 2024 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	130
Year of Origination 2024 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	57
Year of Origination 2024 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	15
Year of Origination 2024 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0
Year of Origination 2024 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0
Year of Origination 2024 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0
Year of Origination 2024 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	227
Year of Origination 2023 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	125	$ 125
Year of Origination 2023 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	171	164
Year of Origination 2023 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	33	33
Year of Origination 2023 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	17	18
Year of Origination 2023 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	32	32
Year of Origination 2023 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2023 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2023 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	378	372
Year of Origination 2022 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	79	79
Year of Origination 2022 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	262	263
Year of Origination 2022 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	236	255
Year of Origination 2022 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	34	34
Year of Origination 2022 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2022 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2022 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2022 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	631	651
Year of Origination 2021 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	35	36
Year of Origination 2021 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	131	145
Year of Origination 2021 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	245	335
Year of Origination 2021 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	111	123
Year of Origination 2021 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2021 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	18	18
Year of Origination 2021 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	9	10
Year of Origination 2021 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	549	667
Year of Origination 2020 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	56	57
Year of Origination 2020 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	48	49
Year of Origination 2020 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	71	72
Year of Origination 2020 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	97	128
Year of Origination 2020 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	272	306
Year of Origination 2019 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	676	45
Year of Origination 2019 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	727	82
Year of Origination 2019 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	672	160
Year of Origination 2019 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	442	36
Year of Origination 2019 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	68	11
Year of Origination 2019 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	157	0
Year of Origination 2019 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	47	0
Year of Origination 2019 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	2,789	334
Year of Origination 2018 | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		780
Year of Origination 2018 | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		755
Year of Origination 2018 | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		618
Year of Origination 2018 | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		463
Year of Origination 2018 | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		60
Year of Origination 2018 | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		163
Year of Origination 2018 | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		49
Year of Origination 2018 | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans		2,888
Total | Retail
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	996	1,122
Total | Industrial
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1,469	1,458
Total | Apartments
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	1,314	1,473
Total | Office
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	716	802
Total | Hotel/Motel
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	110	113
Total | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	185	191
Total | Mixed Use
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	56	59
Total | Total
Financing Receivable, Credit Quality Indicator [Line Items]
Commercial mortgage loans	$ 4,846	$ 5,218

Investments (excluding Conso_13

Investments (excluding Consolidated Investment Entities) - Allowance for Losses for Commercial Mortgage Loans (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	$ 26
Ending Balance	24	$ 26
Commercial Portfolio Segment
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	26	18
Credit losses on mortgage loans for which credit losses were not previously recorded	0	2
Increase (decrease) on mortgage loans with an allowance recorded in a previous period	1	9
Provision for expected credit losses	27	29
Write-offs	(3)	(3)
Recoveries of amounts previously written-off	0	0
Ending Balance	$ 24	$ 26

Investments (excluding Conso_14

Investments (excluding Consolidated Investment Entities) - Past due commercial mortgage loans (Details) - USD ($)	3 Months Ended	9 Months Ended
	Mar. 31, 2024	Sep. 30, 2024	Dec. 31, 2023
Financing Receivable, Past Due [Line Items]
Loans on non-accrual status		$ 38,000,000	$ 16,000,000
Nonaccrual, interest income	$ 0	$ 0
Private placement debt
Financing Receivable, Past Due [Line Items]
Threshold period past due, nonaccrual		90 days
Private placement debt | Current
Financing Receivable, Past Due [Line Items]
Commercial mortgage loans		$ 4,808,000,000	5,202,000,000
Private placement debt | 30-59 days past due
Financing Receivable, Past Due [Line Items]
Commercial mortgage loans		0	0
Private placement debt | 60-89 days past due
Financing Receivable, Past Due [Line Items]
Commercial mortgage loans		12,000,000	0
Private placement debt | Greater than 90 days past due
Financing Receivable, Past Due [Line Items]
Commercial mortgage loans		26,000,000	16,000,000
Private placement debt | Total
Financing Receivable, Past Due [Line Items]
Commercial mortgage loans		$ 4,846,000,000	$ 5,218,000,000

Investments (excluding Conso_15

Investments (excluding Consolidated Investment Entities) - Net Investment Income (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Net Investment Income [Line Items]
Gross investment income	$ 528,000,000	$ 564,000,000	$ 1,610,000,000	$ 1,690,000,000
Less: Investment expenses	22,000,000	17,000,000	57,000,000	53,000,000
Net investment income	506,000,000	547,000,000	1,553,000,000	1,637,000,000
Fixed maturity securities on non-accrual status	38,000,000		38,000,000		$ 16,000,000
Fixed maturities
Net Investment Income [Line Items]
Gross investment income	420,000,000	438,000,000	1,252,000,000	1,336,000,000
Fixed maturity securities on non-accrual status	6,000,000		6,000,000		$ 10,000,000
Equity securities
Net Investment Income [Line Items]
Gross investment income	7,000,000	3,000,000	16,000,000	17,000,000
Mortgage loans on real estate
Net Investment Income [Line Items]
Gross investment income	58,000,000	64,000,000	179,000,000	187,000,000
Policy loans
Net Investment Income [Line Items]
Gross investment income	6,000,000	5,000,000	16,000,000	16,000,000
Short-term investments and cash equivalents
Net Investment Income [Line Items]
Gross investment income	11,000,000	10,000,000	31,000,000	28,000,000
Limited partnerships and other
Net Investment Income [Line Items]
Gross investment income	$ 26,000,000	$ 44,000,000	$ 116,000,000	$ 106,000,000

Investments (excluding Conso_16

Investments (excluding Consolidated Investment Entities) - Net Gains (Losses) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Realized Gain/(Losses) [Line Items]
Net gains (losses)	$ (14)	$ (7)	$ 25	$ (79)
Fixed maturities
Realized Gain/(Losses) [Line Items]
Net gains (losses)	3	(3)	1	(4)
Other derivatives, net
Realized Gain/(Losses) [Line Items]
Net gains (losses)	1	0	1	0
Standalone derivatives
Realized Gain/(Losses) [Line Items]
Net gains (losses)	(1)	1	0	1
Managed Custody Guarantees
Realized Gain/(Losses) [Line Items]
Net gains (losses)	6	(15)	6	(12)
Managed custody guarantees
Realized Gain/(Losses) [Line Items]
Net gains (losses)	(6)	(9)	(7)	(9)
Derivatives
Realized Gain/(Losses) [Line Items]
Net gains (losses)	(128)	134	48	199
Mortgage loans on real estate
Realized Gain/(Losses) [Line Items]
Net gains (losses)	(4)	(1)	(1)	(11)
Other investments
Realized Gain/(Losses) [Line Items]
Net gains (losses)	(3)	48	0	47
Fixed maturities, available-for-sale, including securities pledged
Realized Gain/(Losses) [Line Items]
Net gains (losses)	15	(24)	(19)	(41)
Fixed maturities, at fair value option
Realized Gain/(Losses) [Line Items]
Net gains (losses)	96	(135)	(15)	(243)
Equity securities, at fair value
Realized Gain/(Losses) [Line Items]
Net gains (losses)	$ 7	$ (3)	$ 11	$ (6)

Investments (excluding Conso_17

Investments (excluding Consolidated Investment Entities) - Proceeds and Gross Gains/(Losses) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Proceeds on sales	$ 753	$ 862	$ 2,199	$ 4,499
Gross gains	18	11	37	54
Gross losses	$ 13	$ 14	$ 49	$ 69

Derivative Financial Instrume_3

Derivative Financial Instruments - Notional and Fair Values (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	$ 268	$ 374
Derivative Liability, Fair Value, Gross Liability	414	429
Not Designated as Hedging Instrument | Credit contracts
Derivative [Line Items]
Notional Amount	126	137
Not Designated as Hedging Instrument | Derivatives | Credit contracts
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	2	2
Interest rate contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	15,005	16,773
Interest rate contracts | Not Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	195	270
Derivative Liability, Fair Value, Gross Liability	331	354
Interest rate contracts | Fair Value Hedging | Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	200	0
Interest rate contracts | Fair Value Hedging | Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	7	0
Interest rate contracts | Cash Flow Hedging | Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	12	12
Interest rate contracts | Cash Flow Hedging | Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	0	0
Foreign exchange contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	173	183
Foreign exchange contracts | Not Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	2	4
Derivative Liability, Fair Value, Gross Liability	3	2
Foreign exchange contracts | Fair Value Hedging | Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	100	98
Foreign exchange contracts | Fair Value Hedging | Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	2	4
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	655	718
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	21	33
Derivative Liability, Fair Value, Gross Liability	11	7
Equity contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	286	255
Equity contracts | Not Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	7	4
Derivative Liability, Fair Value, Gross Liability	3	2
Fixed maturities | Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	3	2
Derivative Liability, Fair Value, Gross Liability	0	0
Embedded derivative on reinsurance | Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative Asset, Not Subject to Master Netting Arrangement	40	61
Derivative Liability, Not Subject to Master Netting Arrangement	45	49
Managed Custody Guarantees | Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	2	8
Managed custody guarantees | Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	$ 8	$ 1

Derivative Financial Instrume_4

Derivative Financial Instruments - Offsetting Assets and Liabilities (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Gross amount recognized, Assets	$ 224,000,000	$ 311,000,000
Gross amount recognized, Liabilities	359,000,000	370,000,000
Counterparty netting, Assets	(193,000,000)	(216,000,000)
Counterparty netting, Liabilities	(193,000,000)	(216,000,000)
Cash collateral netting, Assets	(25,000,000)	(76,000,000)
Cash collateral netting, Liabilities	(158,000,000)	(150,000,000)
Securities collateral netting, Assets	(2,000,000)	(8,000,000)
Securities collateral netting, Liabilities	(5,000,000)	(3,000,000)
Net receivables/payables, Assets	4,000,000	11,000,000
Net receivables/payables, Liabilities	3,000,000	1,000,000
Excluded asset exchange traded contract	1,000,000	0
Excluded liability exchange traded contracts	$ 0	$ 1,000,000

Derivative Financial Instrume_5

Derivative Financial Instruments - Collateral and Credit Default Swaps (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Securities pledged as collateral
Derivatives, Fair Value [Line Items]
Securities held as collateral	$ 3	$ 11
Securities pledged as collateral	168	201
Over the counter | Cash collateral, included in Payables
Derivatives, Fair Value [Line Items]
Securities held as collateral	25	84
Cleared derivative contract | Cash collateral, included in Payables
Derivatives, Fair Value [Line Items]
Securities held as collateral	$ 159	$ 147

Derivative Financial Instrume_6

Derivative Financial Instruments - Effect of Derivatives (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Net investment income	$ 506	$ 547	$ 1,553	$ 1,637
Net gains (losses)	(14)	(7)	25	(79)
Gain (loss) on derivative, net	(145)	132	28	182
Not Designated as Hedging Instrument | Credit contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	1	1	0	0
Interest rate contracts | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	(129)	138	36	196
Interest rate contracts | Cash Flow Hedging | Designated as Hedging Instrument | Other Comprehensive Income (Loss)
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income	0	0	0	0
Interest rate contracts | Cash Flow Hedging | Designated as Hedging Instrument | Net investment income
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income	0	0	0	0
Interest rate contracts | Fair Value Hedging | Net investment income
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	0	0	0
Interest rate contracts | Fair Value Hedging | Net gains (losses)
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	7	0	8
Interest rate contracts | Fair Value Hedging | Designated as Hedging Instrument | Net investment income
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	0	0	0
Interest rate contracts | Fair Value Hedging | Designated as Hedging Instrument | Net gains (losses)
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	(7)	0	(8)
Foreign exchange contracts | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	(1)	(2)	(4)	(1)
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument | Other Comprehensive Income (Loss)
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income	(29)	7	(18)	(11)
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument | Net investment income
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income	5	3	11	8
Gain (loss) on derivative, net	2	3	7	8
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument | Net gains (losses)
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	3	0	4	0
Foreign exchange contracts | Fair Value Hedging | Net investment income
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	0	0	0	0
Foreign exchange contracts | Fair Value Hedging | Net gains (losses)
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	3	(3)	1	(1)
Foreign exchange contracts | Fair Value Hedging | Designated as Hedging Instrument | Net investment income
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	0	0	0	0
Foreign exchange contracts | Fair Value Hedging | Designated as Hedging Instrument | Net gains (losses)
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	(4)	4	0	3
Embedded derivative on reinsurance
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	(27)	29	(23)	11
Embedded derivative on reinsurance | Level 3 | Measured at fair value on a recurring basis
Derivative Instruments, Gain (Loss) [Line Items]
Change in derivative instruments excluded from assessment of hedge effectiveness and recognized in earnings	0	1	1	2
Gains (losses) from standalone derivatives recognized in Net gains (losses)	(1)	1	0	1
Equity contracts | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	8	(7)	19	1
Fixed maturities
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses)	3	(3)	1	(4)
Gain (loss) on derivative, net	3	(3)	1	(4)
Managed Custody Guarantees
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses)	6	(15)	6	(12)
Gain (loss) on derivative, net	6	(15)	6	(12)
Managed custody guarantees
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses)	(6)	(9)	(7)	(9)
Gain (loss) on derivative, net	(6)	(9)	$ (7)	$ (9)
Managed custody guarantees | Level 3 | Measured at fair value on a recurring basis
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) from standalone derivatives recognized in Net gains (losses)	$ 0	$ (24)

Fair Value Measurements (excl_3

Fair Value Measurements (excluding Consolidated Investment Entities) - Fair Value Measurement (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held in separate accounts	$ 103,532	$ 93,133
Total assets	166,933	157,085
Derivatives	359	371
Total liabilities	160,351	151,032
Fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	28,546	28,611
U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	374	403
U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	31	56
State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	635	771
U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	7,253	7,666
U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	4,995	4,760
Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	2,549	2,702
Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	2,712	2,812
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	3,819	3,476
Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	3,393	3,495
Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	2,785	2,470
Measured at fair value on a recurring basis
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,822	2,165
Assets held in separate accounts	103,532	93,133
Total assets	135,416	124,517
Contingent consideration	35	51
Total liabilities	449	480
Measured at fair value on a recurring basis | Stabilizer and MCGs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	10	9
Measured at fair value on a recurring basis | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	195	270
Derivatives	338	354
Measured at fair value on a recurring basis | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	23	37
Derivatives	16	13
Measured at fair value on a recurring basis | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	7	4
Derivatives	3	2
Measured at fair value on a recurring basis | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	40	61
Embedded derivative on reinsurance	45	49
Measured at fair value on a recurring basis | Credit contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	2	2
Measured at fair value on a recurring basis | Fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	28,546	28,611
Measured at fair value on a recurring basis | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	374	403
Measured at fair value on a recurring basis | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	31	56
Measured at fair value on a recurring basis | State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	635	771
Measured at fair value on a recurring basis | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	7,253	7,666
Measured at fair value on a recurring basis | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	4,995	4,760
Measured at fair value on a recurring basis | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	2,549	2,702
Measured at fair value on a recurring basis | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	2,712	2,812
Measured at fair value on a recurring basis | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	3,819	3,476
Measured at fair value on a recurring basis | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	3,393	3,495
Measured at fair value on a recurring basis | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	2,785	2,470
Measured at fair value on a recurring basis | Equity securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	251	236
Measured at fair value on a recurring basis | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,808	2,148
Assets held in separate accounts	97,372	87,180
Total assets	100,650	89,821
Contingent consideration	0	0
Total liabilities	1	0
Measured at fair value on a recurring basis | Level 1 | Stabilizer and MCGs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	0	0
Measured at fair value on a recurring basis | Level 1 | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	2	7
Derivatives	1	0
Measured at fair value on a recurring basis | Level 1 | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 1 | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 1 | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Embedded derivative on reinsurance	0	0
Measured at fair value on a recurring basis | Level 1 | Credit contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Measured at fair value on a recurring basis | Level 1 | Fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	319	346
Measured at fair value on a recurring basis | Level 1 | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	319	346
Measured at fair value on a recurring basis | Level 1 | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Measured at fair value on a recurring basis | Level 1 | State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Measured at fair value on a recurring basis | Level 1 | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Measured at fair value on a recurring basis | Level 1 | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Measured at fair value on a recurring basis | Level 1 | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Measured at fair value on a recurring basis | Level 1 | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Measured at fair value on a recurring basis | Level 1 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Measured at fair value on a recurring basis | Level 1 | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Measured at fair value on a recurring basis | Level 1 | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Measured at fair value on a recurring basis | Level 1 | Equity securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	149	140
Measured at fair value on a recurring basis | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	14	17
Assets held in separate accounts	5,812	5,605
Total assets	32,282	32,162
Contingent consideration	0	0
Total liabilities	351	362
Measured at fair value on a recurring basis | Level 2 | Stabilizer and MCGs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	0	0
Measured at fair value on a recurring basis | Level 2 | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	193	263
Derivatives	337	354
Measured at fair value on a recurring basis | Level 2 | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	23	37
Derivatives	16	13
Measured at fair value on a recurring basis | Level 2 | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	7	4
Derivatives	3	2
Measured at fair value on a recurring basis | Level 2 | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	40	61
Embedded derivative on reinsurance	(7)	(9)
Measured at fair value on a recurring basis | Level 2 | Credit contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	2	2
Measured at fair value on a recurring basis | Level 2 | Fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	26,193	26,175
Measured at fair value on a recurring basis | Level 2 | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	55	57
Measured at fair value on a recurring basis | Level 2 | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	31	55
Measured at fair value on a recurring basis | Level 2 | State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	635	771
Measured at fair value on a recurring basis | Level 2 | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	7,242	7,648
Measured at fair value on a recurring basis | Level 2 | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	3,550	3,234
Measured at fair value on a recurring basis | Level 2 | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	2,539	2,702
Measured at fair value on a recurring basis | Level 2 | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	2,244	2,376
Measured at fair value on a recurring basis | Level 2 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	3,753	3,419
Measured at fair value on a recurring basis | Level 2 | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	3,393	3,495
Measured at fair value on a recurring basis | Level 2 | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	2,751	2,418
Measured at fair value on a recurring basis | Level 2 | Equity securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	0	0
Measured at fair value on a recurring basis | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	0	0
Assets held in separate accounts	348	348
Total assets	2,484	2,534
Contingent consideration	35	51
Total liabilities	97	118
Measured at fair value on a recurring basis | Level 3 | Stabilizer and MCGs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	10	9
Measured at fair value on a recurring basis | Level 3 | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 3 | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 3 | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 3 | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Embedded derivative on reinsurance	52	58
Measured at fair value on a recurring basis | Level 3 | Credit contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Measured at fair value on a recurring basis | Level 3 | Fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	2,034	2,090
Measured at fair value on a recurring basis | Level 3 | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Measured at fair value on a recurring basis | Level 3 | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	1
Measured at fair value on a recurring basis | Level 3 | State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Measured at fair value on a recurring basis | Level 3 | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	11	18
Measured at fair value on a recurring basis | Level 3 | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	1,445	1,526
Measured at fair value on a recurring basis | Level 3 | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	10	0
Measured at fair value on a recurring basis | Level 3 | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	468	436
Measured at fair value on a recurring basis | Level 3 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	66	57
Measured at fair value on a recurring basis | Level 3 | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	0	0
Measured at fair value on a recurring basis | Level 3 | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	34	52
Measured at fair value on a recurring basis | Level 3 | Equity securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	$ 102	$ 96

Fair Value Measurements (excl_4

Fair Value Measurements (excluding Consolidated Investment Entities) - Level 3 Financial Instruments (Details) - Measured at fair value on a recurring basis - Level 3 - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Managed custody guarantees
Derivatives Rollforward:
Fair Value, Derivatives, beginning balance	$ (10)	$ (3)
Gains (losses) from standalone derivatives recognized in Net gains (losses)	0	(24)
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0
Purchases	0	0
Issuances	0	0
Sales	0	0
Settlements	0	0
Transfers in to Level 3	0	0
Transfers out of Level 3	0	0
Fair Value, Derivatives, ending balance	(10)	(27)	$ (10)	$ (27)
Change In Unrealized Gains (Losses) Included in Earnings	0	0
Change In Unrealized Gains (Losses) Included in OCI	0	0
Embedded derivative on reinsurance
Derivatives Rollforward:
Fair Value, Derivatives, beginning balance	(57)	(58)	(58)	(58)
Gains (losses) from standalone derivatives recognized in Net gains (losses)	(1)	1	0	1
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0	0	0
Purchases	0	0	0	0
Issuances	0	0	0	0
Sales	0	0	0	0
Settlements	6	0	6	0
Transfers in to Level 3	0	0	0	0
Transfers out of Level 3	0	0	0	0
Fair Value, Derivatives, ending balance	(52)	(57)	(52)	(57)
Change In Unrealized Gains (Losses) Included in Earnings	0	0	0	0
Change In Unrealized Gains (Losses) Included in OCI	0	0	0	0
Fixed maturities
Assets Rollforward:
Fair Value, Assets, beginning balance	2,010	2,268	2,090	2,349
Total Realized/Unrealized Gains (Losses) Included in Net income	2	(5)	(3)	(5)
Total Realized/Unrealized Gains (Losses) Included in OCI	60	(54)	27	(46)
Purchases	175	95	318	266
Issuances	0	0	0	0
Sales	(21)	0	(18)	(3)
Settlements	(85)	(67)	(254)	(334)
Transfers in to Level 3	0	122	51	179
Transfers out of Level 3	(107)	(284)	(177)	(331)
Fair Value, Assets, ending balance	2,034	2,075	2,034	2,075
Change In Unrealized Gains (Losses) Included in Earnings	8	(5)	3	(5)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	56	(55)	19	(49)
US Government Agencies Debt Securities
Assets Rollforward:
Fair Value, Assets, beginning balance			1	1
Total Realized/Unrealized Gains (Losses) Included in Net income			0	0
Total Realized/Unrealized Gains (Losses) Included in OCI			0	0
Purchases			0	0
Issuances			0	0
Sales			0	0
Settlements			0	0
Transfers in to Level 3			0	0
Transfers out of Level 3		0	(1)	0
Fair Value, Assets, ending balance	0	1	0	1
Change In Unrealized Gains (Losses) Included in Earnings			0	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		0	0	0
U.S. corporate public securities
Assets Rollforward:
Fair Value, Assets, beginning balance	12	20	18	20
Total Realized/Unrealized Gains (Losses) Included in Net income	0	0	0	0
Total Realized/Unrealized Gains (Losses) Included in OCI	(1)	1	0	0
Purchases	0	0	0	0
Issuances	0	0	0	0
Sales	0	0	0	0
Settlements	0	0	(7)	1
Transfers in to Level 3	0	0	0	0
Transfers out of Level 3	0	(3)	0	(3)
Fair Value, Assets, ending balance	11	18	11	18
Change In Unrealized Gains (Losses) Included in Earnings	0	0	0	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	(1)	0	(1)	0
U.S. corporate private securities
Assets Rollforward:
Fair Value, Assets, beginning balance	1,464	1,732	1,526	1,801
Total Realized/Unrealized Gains (Losses) Included in Net income	(4)	0	(5)	0
Total Realized/Unrealized Gains (Losses) Included in OCI	58	(49)	36	(46)
Purchases	118	24	240	104
Issuances	0	0	0	0
Sales	(3)	0	(9)	(3)
Settlements	(81)	(46)	(196)	(137)
Transfers in to Level 3	0	63	0	45
Transfers out of Level 3	(107)	(256)	(147)	(296)
Fair Value, Assets, ending balance	1,445	1,468	1,445	1,468
Change In Unrealized Gains (Losses) Included in Earnings	2	0	1	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	54	(49)	29	(48)
Foreign corporate public securities and foreign governments
Assets Rollforward:
Fair Value, Assets, beginning balance	17		0	3
Total Realized/Unrealized Gains (Losses) Included in Net income	0		0	0
Total Realized/Unrealized Gains (Losses) Included in OCI	1		0	0
Purchases	10		10	0
Issuances	0		0	0
Sales	(18)		0	0
Settlements	0		0	0
Transfers in to Level 3	0		0	0
Transfers out of Level 3	0		0	(3)
Fair Value, Assets, ending balance	10	0	10	0
Change In Unrealized Gains (Losses) Included in Earnings	0		0	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0		0	0
Foreign corporate private securities
Assets Rollforward:
Fair Value, Assets, beginning balance	444	413	436	432
Total Realized/Unrealized Gains (Losses) Included in Net income	2	(2)	2	1
Total Realized/Unrealized Gains (Losses) Included in OCI	2	(6)	(9)	1
Purchases	22	58	43	115
Issuances	0	0	0	0
Sales	0	0	(9)	0
Settlements	(2)	(20)	(46)	(197)
Transfers in to Level 3	0	53	51	130
Transfers out of Level 3	0	(21)	0	(7)
Fair Value, Assets, ending balance	468	475	468	475
Change In Unrealized Gains (Losses) Included in Earnings	1	(2)	1	1
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	3	(6)	(9)	0
Residential mortgage-backed securities
Assets Rollforward:
Fair Value, Assets, beginning balance	49	57	57	28
Total Realized/Unrealized Gains (Losses) Included in Net income	4	(3)	0	(6)
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0	0	0
Purchases	13	3	13	37
Issuances	0	0	0	0
Sales	0	0	0	0
Settlements	0	0	0	0
Transfers in to Level 3	0	6	0	4
Transfers out of Level 3	0	0	(4)	0
Fair Value, Assets, ending balance	66	63	66	63
Change In Unrealized Gains (Losses) Included in Earnings	5	(3)	1	(6)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0	0	0	0
Other asset-backed securities
Assets Rollforward:
Fair Value, Assets, beginning balance	24	45	52	64
Total Realized/Unrealized Gains (Losses) Included in Net income	0	0	0	0
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0	0	(1)
Purchases	12	10	12	10
Issuances	0	0	0	0
Sales	0	0	0	0
Settlements	(2)	(1)	(5)	(1)
Transfers in to Level 3	0	0	0	0
Transfers out of Level 3	0	(4)	(25)	(22)
Fair Value, Assets, ending balance	34	50	34	50
Change In Unrealized Gains (Losses) Included in Earnings	0	0	0	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0	0	0	(1)
Equity securities, at fair value
Assets Rollforward:
Fair Value, Assets, beginning balance	98	192	96	196
Total Realized/Unrealized Gains (Losses) Included in Net income	4	(2)	6	(10)
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0	0	0
Purchases	0	0	0	0
Issuances	0	0	0	0
Sales	0	0	0	0
Settlements	0	0	0	0
Transfers in to Level 3	0	0	0	4
Transfers out of Level 3	0	0	0	0
Fair Value, Assets, ending balance	102	190	102	190
Change In Unrealized Gains (Losses) Included in Earnings	4	(2)	6	(10)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0	0	0	0
Contingent Consideration
Liabilities Rollforward:
Fair Value, Liabilities, Ending Balance	(49)	(112)	(51)	(112)
Total Realized/Unrealized Gains (Losses) Included in Net income	0	0	0	0
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0	0	0
Purchases	0	0	0	0
Issuances	0	0	0	0
Sales	0	0	0	0
Settlements	14	0	16	0
Transfers into Level 3	0	0	0	0
Transfers out of Level 3	0	0	0	0
Fair Value, Liabilities, Ending Balance	(35)	(112)	(35)	(112)
Change In Unrealized Gains (Losses) Included in Earnings	0	0	0	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0	0	0	0
Managed custody guarantees
Liabilities Rollforward:
Fair Value, Liabilities, Ending Balance			(9)	(6)
Total Realized/Unrealized Gains (Losses) Included in Net income			0	(20)
Total Realized/Unrealized Gains (Losses) Included in OCI			0	0
Purchases			0	0
Issuances			(1)	(1)
Sales			0	0
Settlements			0	0
Transfers into Level 3			0	0
Transfers out of Level 3			0	0
Fair Value, Liabilities, Ending Balance	(10)	(27)	(10)	(27)
Change In Unrealized Gains (Losses) Included in Earnings			0	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI			0	0
Assets held in separate accounts
Assets Rollforward:
Fair Value, Assets, beginning balance	363	344	348	347
Total Realized/Unrealized Gains (Losses) Included in Net income	11	(5)	12	(9)
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0	0	0
Purchases	12	1	47	8
Issuances	0	0	0	0
Sales	(9)	(4)	(24)	(13)
Settlements	0	0	0	0
Transfers in to Level 3	0	6	5	9
Transfers out of Level 3	(29)	(1)	(40)	(1)
Fair Value, Assets, ending balance	348	341	348	341
Change In Unrealized Gains (Losses) Included in Earnings	0	0	0	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	$ 0	$ 0	$ 0	$ 0

Fair Value Measurements (excl_5

Fair Value Measurements (excluding Consolidated Investment Entities) - Other Financial Instruments (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held in separate accounts	$ 103,532	$ 93,133
Derivatives	359	371
Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	28,546	28,611
Equity securities	251	236
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,822	2,165
Derivatives	225	311
Other investments	66	64
Assets held in separate accounts	103,532	93,133
Short-term debt	397	1
Long-term debt	2,103	2,097
Carrying Value | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	40	61
Derivatives	45	49
Carrying Value | Stabilizer and MCGs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	10	9
Carrying Value | Derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	359	371
Carrying Value | Funding agreements without fixed maturities and deferred annuities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	31,403	32,848
Carrying Value | Funding agreements with fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	1,251	1,175
Carrying Value | Supplementary contracts, immediate annuities and other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	582	628
Carrying Value | Mortgage loans on real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Corporate loans	4,846	5,218
Carrying Value | Policy loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Corporate loans	345	352
Estimate of Fair Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	28,546	28,611
Equity securities	251	236
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,822	2,165
Derivatives	225	311
Other investments	66	64
Assets held in separate accounts	103,532	93,133
Short-term debt	396	1
Long-term debt	2,083	1,998
Estimate of Fair Value Measurement | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	40	61
Derivatives	45	49
Estimate of Fair Value Measurement | Stabilizer and MCGs
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	10	9
Estimate of Fair Value Measurement | Derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	359	371
Estimate of Fair Value Measurement | Funding agreements without fixed maturities and deferred annuities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	34,625	34,856
Estimate of Fair Value Measurement | Funding agreements with fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	1,207	1,178
Estimate of Fair Value Measurement | Supplementary contracts, immediate annuities and other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	539	571
Estimate of Fair Value Measurement | Mortgage loans on real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Corporate loans	4,702	4,941
Estimate of Fair Value Measurement | Policy loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Corporate loans	$ 345	$ 352

Deferred Policy Acquisition C_3

Deferred Policy Acquisition Costs and Value of Business Acquired - DAC and VOBA Activity (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Mar. 31, 2024	Sep. 30, 2024
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance		$ 2,250	$ 2,250
Ending balance	$ 2,173		2,173
VOBA
Beginning balance		406	406
Deferrals of commissions and expenses		4	3
Net amortization included in Condensed Consolidated Statements of Operations	(25)	(37)
Ending balance	384		384
Loss recognition related to VOBA		0	0
Wealth Solutions
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance		695	695
Deferrals of commissions and expenses	45	59
Net amortization included in the Consolidated Statements of Operations	(41)	(55)
Ending balance	699		699
Health Solutions
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance		193	193
Deferrals of commissions and expenses	42	54
Net amortization included in the Consolidated Statements of Operations	(25)	(32)
Ending balance	210		210
Businesses Exited
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance		938	938
Deferrals of commissions and expenses		0	0
Net amortization included in the Consolidated Statements of Operations	(76)	$ (105)
Ending balance	$ 862		$ 862

Deferred Policy Acquisition C_4

Deferred Policy Acquisition Costs and Value of Business Acquired - Reconciliation of DAC and VOBA (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Deferred Acquisition Cost and Value of Business Acquired [Line Items]
DAC	$ 2,173	$ 2,250
VOBA	384	406	$ 439
Wealth Solutions
Deferred Acquisition Cost and Value of Business Acquired [Line Items]
DAC	699	695	691
Health Solutions
Deferred Acquisition Cost and Value of Business Acquired [Line Items]
DAC	210	193	171
Businesses Exited
Deferred Acquisition Cost and Value of Business Acquired [Line Items]
DAC	862	938	$ 1,043
Other
Deferred Acquisition Cost and Value of Business Acquired [Line Items]
DAC	$ 18	$ 18

Reserves for Future Policy Be_3

Reserves for Future Policy Benefits and Contract Owner Account Balances - Liability for Future Policy Benefits (Details) $ in Millions	3 Months Ended		9 Months Ended	12 Months Ended
	Jun. 30, 2024 USD ($)	Mar. 31, 2024 USD ($)	Sep. 30, 2024 USD ($) yr	Dec. 31, 2023 USD ($) yr
Present Value of Expected Future Policy Benefits:
Net liability for future policy benefits			$ 9,543	$ 9,560
Current discount rate			4.30%	4.20%
Health Solutions Group
Present Value of Expected Net Premiums:
Balance at beginning of period		$ 68	$ 68	$ 77
Beginning balance at original discount rate		71	71	84
Reclassifications			(65)
Effect of change in cash flow assumptions			(1)	(6)
Effect of actual variances from expected experience			0	11
Adjusted balance at January 1			5	89
Interest accrual		2	0
Net premiums collected		(20)	(1)
Ending balance at original discount rate			4	71
Effects of changes in discount rate assumptions			0	(3)
Balance at end of period			4	68
Present Value of Expected Future Policy Benefits:
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change		899	899	881
Beginning balance at original discount rate		918	918	913
Reclassifications			(150)
Effect of change in cash flow assumptions			(12)	(8)
Effect of actual variances from expected experience			(2)	(16)
Adjusted balance at January 1			754	889
Issuances			94	136
Interest accrual			16	24
Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment			(90)	(131)
Ending balance at original discount rate			774	918
Effects of changes in discount rate assumptions			(7)	(19)
Balance at end of period			767	899
Net liability for future policy benefits			763	831
Less: Reinsurance recoverable			328	315
Net additional liability, after reinsurance recoverable			435	516
Net premium reclassification (from) to	$ (17)
Benefit payment reclassification (from) to	(17)
Expected future benefit payments, Undiscounted			967	1,144
Expected future gross premiums, Undiscounted			11	271
Expected future benefit payments, Discounted			774	918
Expected future gross premiums, Discounted			$ 9	$ 214
Weighted average duration (in years) | yr			7	7
Interest accretion rate			4%	4%
Current discount rate			4.80%	4.90%
Health Solutions Voluntary
Present Value of Expected Net Premiums:
Balance at beginning of period		101	$ 101	$ 97
Beginning balance at original discount rate		102	102	100
Reclassifications			65
Effect of change in cash flow assumptions			(1)	6
Effect of actual variances from expected experience			33	8
Adjusted balance at January 1			199	114
Interest accrual		4	6
Net premiums collected		(16)	(25)
Ending balance at original discount rate			180	102
Effects of changes in discount rate assumptions			(2)	(1)
Balance at end of period			178	101
Present Value of Expected Future Policy Benefits:
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change		307	307	285
Beginning balance at original discount rate		307	307	294
Reclassifications			150
Effect of change in cash flow assumptions			(1)	13
Effect of actual variances from expected experience			44	9
Adjusted balance at January 1			500	316
Issuances			0	0
Interest accrual			14	14
Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment			(32)	(23)
Ending balance at original discount rate			482	307
Effects of changes in discount rate assumptions			(2)	0
Balance at end of period			480	307
Net liability for future policy benefits			302	206
Less: Reinsurance recoverable			9	0
Net additional liability, after reinsurance recoverable			293	206
Net premium reclassification (from) to	17
Benefit payment reclassification (from) to	$ 17
Expected future benefit payments, Undiscounted			865	668
Expected future gross premiums, Undiscounted			631	341
Expected future benefit payments, Discounted			482	307
Expected future gross premiums, Discounted			$ 445	$ 213
Weighted average duration (in years) | yr			14,000,000	14,000,000
Interest accretion rate			5.10%	5.20%
Current discount rate			5.10%	5.10%
Businesses Exited
Present Value of Expected Net Premiums:
Balance at beginning of period		3,145	$ 3,145	$ 4,244
Beginning balance at original discount rate		2,992	2,992	4,128
Effect of change in cash flow assumptions			(5)	(921)
Effect of actual variances from expected experience			(105)	(91)
Adjusted balance at January 1			2,882	3,116
Interest accrual		196	119
Net premiums collected		(320)	(234)
Ending balance at original discount rate			2,767	2,992
Effects of changes in discount rate assumptions			162	153
Balance at end of period			2,929	3,145
Present Value of Expected Future Policy Benefits:
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change		7,538	7,538	8,639
Beginning balance at original discount rate		7,404	7,404	8,644
Effect of change in cash flow assumptions			10	(805)
Effect of actual variances from expected experience			(91)	(123)
Adjusted balance at January 1			7,323	7,716
Issuances			11	17
Interest accrual			278	412
Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment			(550)	(741)
Ending balance at original discount rate			7,062	7,404
Effects of changes in discount rate assumptions			191	134
Balance at end of period			7,253	7,538
Net liability for future policy benefits			4,324	4,392
Less: Reinsurance recoverable			4,237	4,342
Net additional liability, after reinsurance recoverable			87	50
Expected future benefit payments, Discounted			$ 7,062	$ 7,404
Weighted average duration (in years) | yr			8,000,000	8,000,000
Interest accretion rate			5%	4.90%
Current discount rate			5%	5.10%
Businesses Exited - Additional liability
Present Value of Expected Future Policy Benefits:
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change		$ 2,107	$ 2,107
Effect of change in cash flow assumptions			(38)	$ (44)
Effect of actual variances from expected experience			(12)	(100)
Adjusted balance at January 1			1,951	1,963
Interest accrual			62	84
Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment			(304)	(417)
Assessments			201	371
Balance at end of period			2,001	2,107
Net liability for future policy benefits			1,910	2,001
Less: Reinsurance recoverable			1,858	1,950
Net additional liability, after reinsurance recoverable			52	51
Business Exited - Other
Present Value of Expected Future Policy Benefits:
Net liability for future policy benefits			1,305	1,335
Other
Present Value of Expected Future Policy Benefits:
Net liability for future policy benefits			$ 939	$ 795

Reserves for Future Policy Be_4

Reserves for Future Policy Benefits and Contract Owner Account Balances - Contract Owner Account Balances (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended	9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Jun. 30, 2024	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Policyholder Account Balance [Roll Forward]
Beginning Balance			$ 39,174	$ 39,174
Interest credited	$ 257	$ 328		748	$ 813
Ending Balance	37,513			37,513		$ 39,174
Net transfers (from) to the separate account			(523)	(866)
Wealth Solutions
Policyholder Account Balance [Roll Forward]
Beginning Balance			31,139	31,139	33,622	33,622
Deposits				1,837		2,309
Fee income				(36)		(9)
Surrenders, withdrawals and benefits				(3,780)		(5,663)
Net transfers (from) to the general account				105		(5)
Interest credited				635		885
Ending Balance	$ 29,900			$ 29,900		$ 31,139
Weighted-average crediting rate	2.80%			2.80%		2.80%
Net amount at risk	$ 96			$ 96		$ 123
Cash surrender value	29,441			29,441		30,676
Net transfers (from) to the separate account				(971)		(518)
Businesses Exited
Policyholder Account Balance [Roll Forward]
Beginning Balance			4,635	4,635	$ 5,146	5,146
Deposits				214		288
Fee income				(275)		(373)
Surrenders, withdrawals and benefits				(430)		(577)
Net transfers (from) to the general account				4		10
Interest credited				130		141
Ending Balance	$ 4,278			$ 4,278		$ 4,635
Weighted-average crediting rate	3.90%			3.90%		2.50%
Net amount at risk	$ 686			$ 686		$ 734
Cash surrender value	1,284			1,284		1,491
Non-puttable funding agreement
Policyholder Account Balance [Roll Forward]
Beginning Balance			1,175	1,175
Ending Balance	1,251			1,251		1,175
Business Exited Excluded
Policyholder Account Balance [Roll Forward]
Beginning Balance			1,275	1,275
Ending Balance	1,188			1,188		1,275
Other
Policyholder Account Balance [Roll Forward]
Beginning Balance			$ 950	950
Ending Balance	$ 896			$ 896		$ 950

Reserves for Future Policy Be_5

Reserves for Future Policy Benefits and Contract Owner Account Balances - GMIR (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	$ 37,513	$ 39,174
Up to 1.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	12,389	12,528
1.01% - 2.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	636	725
2.01% - 3.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	10,601	11,492
3.01% - 4.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	8,654	9,031
4.01% and Above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	1,572	1,649
Renewable beyond 12 months (MYGA)
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	379	431
Total discretionary rate setting products
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	34,231	35,856
At GMIR
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	21,234	22,739
At GMIR | Up to 1.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	90	120
At GMIR | 1.01% - 2.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	452	527
At GMIR | 2.01% - 3.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	10,331	11,225
At GMIR | 3.01% - 4.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	8,492	8,873
At GMIR | 4.01% and Above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	1,492	1,566
At GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	377	428
Up to .50% Above GMIR
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	4,989	5,529
Up to .50% Above GMIR | Up to 1.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	4,544	5,070
Up to .50% Above GMIR | 1.01% - 2.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	118	131
Up to .50% Above GMIR | 2.01% - 3.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	96	93
Up to .50% Above GMIR | 3.01% - 4.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	151	152
Up to .50% Above GMIR | 4.01% and Above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	80	83
Up to .50% Above GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	0	0
0.51% - 1.00% Above GMIR
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	3,791	3,573
0.51% - 1.00% Above GMIR | Up to 1.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	3,676	3,460
0.51% - 1.00% Above GMIR | 1.01% - 2.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	50	50
0.51% - 1.00% Above GMIR | 2.01% - 3.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	65	63
0.51% - 1.00% Above GMIR | 3.01% - 4.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	0	0
0.51% - 1.00% Above GMIR | 4.01% and Above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	0	0
0.51% - 1.00% Above GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	0	0
1.01% - 1.50% Above GMIR
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	1,854	2,337
1.01% - 1.50% Above GMIR | Up to 1.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	1,731	2,215
1.01% - 1.50% Above GMIR | 1.01% - 2.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	7	8
1.01% - 1.50% Above GMIR | 2.01% - 3.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	105	108
1.01% - 1.50% Above GMIR | 3.01% - 4.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	11	6
1.01% - 1.50% Above GMIR | 4.01% and Above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	0	0
1.01% - 1.50% Above GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	0	0
1.51% - 2.00% Above GMIR
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	1,483	869
1.51% - 2.00% Above GMIR | Up to 1.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	1,478	863
1.51% - 2.00% Above GMIR | 1.01% - 2.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	3	3
1.51% - 2.00% Above GMIR | 2.01% - 3.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	0	0
1.51% - 2.00% Above GMIR | 3.01% - 4.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance		0
1.51% - 2.00% Above GMIR | 4.01% and Above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	0	0
1.51% - 2.00% Above GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	2	3
More than 2.00% Above GMIR
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	880	809
More than 2.00% Above GMIR | Up to 1.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	870	800
More than 2.00% Above GMIR | 1.01% - 2.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	6	6
More than 2.00% Above GMIR | 2.01% - 3.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	4	3
More than 2.00% Above GMIR | 3.01% - 4.00%
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	0	0
More than 2.00% Above GMIR | 4.01% and Above
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	0	0
More than 2.00% Above GMIR | Renewable beyond 12 months (MYGA)
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items]
Policyholder Account Balance	$ 0	$ 0

Reinsurance - Assets and Liabil

Reinsurance - Assets and Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Assets
Premiums receivable, direct	$ 208	$ 193
Premiums Receivable, assumed	11	9
Premiums receivable, ceded	(235)	(219)
Premiums receivable, net of reinsurance	(16)	(17)
Reinsurance recoverable, net of allowance for credit losses, ceded	11,502	11,999
Reinsurance recoverable, net of allowance for credit losses, net	11,502	11,999
Total assets, direct	208	193
Total assets, assumed	11	9
Total assets, ceded	11,267	11,780
Premiums Receivable And Reinsurance Recoverables, Including Reinsurance Premium Paid	11,486	11,982
Liabilities
Future policy benefits and contract owner account balances, direct	46,150	47,781
Future policy benefits and contract owner account balances, assumed	906	953
Future policy benefits and contract owner account balances, net	47,056	48,734
Liability for funds withheld under reinsurance agreements, direct	108	103
Liability for funds withheld under reinsurance agreements, net	108	103
Total liabilities, direct	46,258	47,884
Total liabilities, assumed	906	953
Total liabilities, net	$ 47,164	$ 48,837

Reinsurance - Effect of Reinusa

Reinsurance - Effect of Reinusance (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Premiums:
Direct premiums	$ 1,016	$ 896	$ 3,070	$ 2,706
Reinsurance assumed	6	5	17	20
Reinsurance ceded	226	219	701	682
Premiums	796	682	2,386	2,044
Fee income:
Gross fee income	634	585	1,854	1,718
Reinsurance assumed	4	4	12	13
Reinsurance ceded	98	100	296	304
Net fee income	540	489	1,570	1,427
Interest credited and other benefits to contract owners / policyholders:
Direct interest credited and other benefits to contract owners / policyholders	1,233	1,099	3,571	3,221
Reinsurance assumed	7	21	43	51
Reinsurance ceded	302	321	982	1,040
Net interest credited and other benefits to contract owners / policyholders	938	$ 799	2,632	$ 2,232
Deposit asset	$ 1,100		$ 1,100		$ 1,200

Separate Accounts - Separate Ac

Separate Accounts - Separate Account Liabilities (Details) - USD ($) $ in Millions	6 Months Ended	9 Months Ended	12 Months Ended
	Jun. 30, 2024	Sep. 30, 2024	Dec. 31, 2023
Separate Account, Liability [Roll Forward]
Balance at January 1	$ 93,133	$ 93,133
Net transfers (from) to the separate account	(523)	(866)
Balance at end of period		103,532	$ 93,133
Wealth Solutions
Separate Account, Liability [Roll Forward]
Balance at January 1	89,485	89,485	76,348
Premiums and deposits		8,212	10,992
Fee income		(383)	(460)
Surrenders, withdrawals and benefits		(10,018)	(10,973)
Net transfers (from) to the separate account		(971)	(518)
Investment performance		13,230	14,096
Balance at end of period		99,555	89,485
Cash surrender value		92,314	82,286
Other
Separate Account, Liability [Roll Forward]
Balance at January 1	3,648	3,648
Balance at end of period		3,977	3,648
Wealth Solutions Stabilizer | Wealth Solutions
Separate Account, Liability [Roll Forward]
Balance at January 1	7,175	7,175	7,196
Premiums and deposits		702	940
Fee income		(25)	(34)
Surrenders, withdrawals and benefits		(1,019)	(1,342)
Net transfers (from) to the separate account		0	0
Investment performance		384	415
Balance at end of period		7,217	7,175
Deferred Variable Annuity | Wealth Solutions
Separate Account, Liability [Roll Forward]
Balance at January 1	$ 82,310	82,310	69,152
Premiums and deposits		7,510	10,052
Fee income		(358)	(426)
Surrenders, withdrawals and benefits		(8,999)	(9,631)
Net transfers (from) to the separate account		(971)	(518)
Investment performance		12,846	13,681
Balance at end of period		$ 92,338	$ 82,310

Separate Accounts - Separate _2

Separate Accounts - Separate Account Assets (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Fair Value, Separate Account Investment [Line Items]
Assets held in separate accounts	$ 103,532	$ 93,133
U.S. Government agencies and authorities
Fair Value, Separate Account Investment [Line Items]
Assets held in separate accounts	886	1,015
Corporate and foreign debt securities
Fair Value, Separate Account Investment [Line Items]
Assets held in separate accounts	2,756	2,528
Mortgage-backed securities | Mortgage-Backed Securities, Issued by Private Enterprises
Fair Value, Separate Account Investment [Line Items]
Assets held in separate accounts	3,191	3,231
Equity securities (including mutual funds)
Fair Value, Separate Account Investment [Line Items]
Assets held in separate accounts	96,257	85,916
Cash, cash equivalents and short-term investments
Fair Value, Separate Account Investment [Line Items]
Assets held in separate accounts	300	399
Receivable for securities and accruals
Fair Value, Separate Account Investment [Line Items]
Assets held in separate accounts	$ 142	$ 44

Segments - Narrative (Details)

Segments - Narrative (Details)	9 Months Ended
	Sep. 30, 2024 segment
Segment Reporting [Abstract]
Number of operating segments	3

Segments - Operating Earnings B

Segments - Operating Earnings Before Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment Reporting Information [Line Items]
Income (loss) attributable to noncontrolling interests	$ (16)	$ (16)	$ 51	$ 107
Dividend payments made to preferred shareholders	16	14	37	32
Total adjustments to income (loss) before income taxes	116	172	679	576
Operating Segments
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	230	229	724	715
Total including Allianz noncontrolling interest	245	242	764	749
Less: Earning (loss) attributable to Allianz noncontrolling interest	16	14	40	35
Operating Segments | Wealth Solutions
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	211	179	611	485
Operating Segments | Health Solutions
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	23	53	142	271
Operating Segments | Investment Management
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	72	63	189	168
Operating Segments | Corporate
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	(60)	(52)	(178)	(175)
Adjustments
Segment Reporting Information [Line Items]
Net investment gains (losses)	(33)	42	50	(4)
Income (loss) related to businesses exited or to be exited through reinsurance or divestment	(52)	(68)	(121)	(122)
Other adjustments	(28)	(28)	(63)	(150)
Total adjustments to income (loss) before income taxes	$ (113)	$ (56)	$ (45)	$ (138)

Segments - Operating Revenues (

Segments - Operating Revenues (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment Reporting Information [Line Items]
Total revenues	$ 1,956	$ 1,823	$ 6,040	$ 5,529
Operating Segments
Segment Reporting Information [Line Items]
Total revenues	1,867	1,717	5,591	5,135
Operating Segments | Wealth Solutions
Segment Reporting Information [Line Items]
Total revenues	726	702	2,176	2,090
Operating Segments | Health Solutions
Segment Reporting Information [Line Items]
Total revenues	892	768	2,689	2,317
Operating Segments | Investment Management
Segment Reporting Information [Line Items]
Total revenues	243	233	711	688
Operating Segments | Corporate
Segment Reporting Information [Line Items]
Total revenues	6	14	15	39
Adjustments
Segment Reporting Information [Line Items]
Total revenues	89	106	449	395
Net investment gains (losses)	(33)	40	30	(21)
Revenues related to businesses exited or to be exited through reinsurance or divestment	52	21	89	53
Revenues attributable to noncontrolling interests	19	22	186	211
Other adjustments	50	24	144	152
Intersegment | Investment Management
Segment Reporting Information [Line Items]
Total revenues	$ 20	$ 21	$ 59	$ 65

Segments - Total Assets (Detail

Segments - Total Assets (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Segment Reporting Information [Line Items]
Total assets	$ 166,933	$ 157,085
Noncontrolling Interest
Segment Reporting Information [Line Items]
Total assets	4,268	4,304
Corporate
Segment Reporting Information [Line Items]
Total assets	25,386	25,527
Total | Parent
Segment Reporting Information [Line Items]
Total assets	162,665	152,781
Operating Segments | Wealth Solutions
Segment Reporting Information [Line Items]
Total assets	131,936	122,318
Operating Segments | Health Solutions
Segment Reporting Information [Line Items]
Total assets	3,553	3,336
Operating Segments | Investment Management
Segment Reporting Information [Line Items]
Total assets	$ 1,790	$ 1,600

Share-based Incentive Compens_3

Share-based Incentive Compensation Plans - Narrative (Details) - $ / shares	Sep. 30, 2024	May 23, 2024
Share-Based Payment Arrangement [Abstract]
Shares initially available for issuance (in sahres)		8,000,000
Shares deducted from shares available for issuance, per share granted under the prior plan (in shares)		$ 1
Shares available for grant (in shares)	7,048,255

Share-based Incentive Compens_4

Share-based Incentive Compensation Plans - Compensation Cost (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost	$ 23	$ 21	$ 85	$ 110
Income tax benefit	5	4	21	26
After-tax share-based compensation expense	18	17	64	84
Restricted Stock Unit (RSU) awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost	13	14	49	67
Performance Stock Unit (PSU) awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost	$ 10	$ 7	$ 36	$ 43

Share-based Incentive Compens_5

Share-based Incentive Compensation Plans - Awards Outstanding (Details)	9 Months Ended
	Sep. 30, 2024 $ / shares shares
RSU awards
Number of Awards
Outstanding, beginning balance (in shares) | shares	2,000,000
Adjustment for PSU performance factor (in shares) | shares	0
Granted (in shares) | shares	900,000
Vested (in shares) | shares	(800,000)
Forfeited (in shares) | shares	(100,000)
Outstanding, ending balance (in shares) | shares	2,000,000
Weighted Average Grant Date Fair Value
Outstanding, beginning balance (usd per share) | $ / shares	$ 67.06
Adjustment for PSU performance factor (usd per share) | $ / shares	0
Granted (usd per share) | $ / shares	67.70
Vested (usd per share) | $ / shares	64.91
Forfeited (usd per share) | $ / shares	69.42
Outstanding, ending balance (usd per share) | $ / shares	$ 68.06
PSU awards
Number of Awards
Outstanding, beginning balance (in shares) | shares	2,200,000
Adjustment for PSU performance factor (in shares) | shares	(100,000)
Granted (in shares) | shares	700,000
Vested (in shares) | shares	(600,000)
Forfeited (in shares) | shares	0
Outstanding, ending balance (in shares) | shares	2,200,000
Weighted Average Grant Date Fair Value
Outstanding, beginning balance (usd per share) | $ / shares	$ 61.17
Adjustment for PSU performance factor (usd per share) | $ / shares	46.94
Granted (usd per share) | $ / shares	59.21
Vested (usd per share) | $ / shares	53.53
Forfeited (usd per share) | $ / shares	69.19
Outstanding, ending balance (usd per share) | $ / shares	$ 63.55
Stock options
Number of Awards
Outstanding, beginning balance (in shares) | shares	1,200,000
Granted (in shares) | shares	0
Exercised (in shares) | shares	(300,000)
Forfeited (in shares) | shares	0
Outstanding, ending balance (in shares) | shares	900,000
Vested, exercisable (in shares) | shares	900,000
Weighted Average Exercise Price
Outstanding, beginning balance (usd per share) | $ / shares	$ 44.79
Granted (usd per share) | $ / shares	0
Exercised (usd per share) | $ / shares	42.55
Forfeited (usd per share) | $ / shares	50.03
Outstanding, ending balance (usd per share) | $ / shares	45.47
Vested, exercisable, weighted average exercise price (usd per share) | $ / shares	$ 45.47

Shareholders' Equity - Common S

Shareholders' Equity - Common Stock Rollforward (Details) - shares		9 Months Ended	12 Months Ended
	Sep. 12, 2024	Sep. 30, 2024	Dec. 31, 2023
Increase (Decrease) in Stockholders' Equity
Common stock, shares issued, beginning balance (in shares)		103,584,699
Common shares, held in treasury, beginning balance (in shares)		730,130
Common shares, beginning balance (in shares)		102,854,569
Common stock acquired - share repurchase (in shares)	1,061,853	6,900,000	5,400,000
Share-based compensation programs (in shares)		1,000,000	1,400,000
Treasury Stock retirement (in shares)			0
Common stock, shares issued, ending balance (in shares)		105,429,736	103,584,699
Common shares, held in treasury, ending balance (in shares)		8,287,943	730,130
Common shares, ending balance (in shares)		97,141,793	102,854,569
Common Stock
Increase (Decrease) in Stockholders' Equity
Common stock, shares issued, beginning balance (in shares)		103,600,000	97,800,000
Common shares, beginning balance (in shares)		102,900,000	97,200,000
Common shares issued (in shares)		100,000	9,700,000
Common stock acquired - share repurchase (in shares)		0	0
Share-based compensation programs (in shares)		1,700,000	2,100,000
Treasury Stock retirement (in shares)			(6,000,000)
Common stock, shares issued, ending balance (in shares)		105,400,000	103,600,000
Common shares, ending balance (in shares)			102,900,000
Treasury Stock
Increase (Decrease) in Stockholders' Equity
Common shares, held in treasury, beginning balance (in shares)		(700,000)	(600,000)
Common shares issued (in shares)		0	0
Common stock acquired - share repurchase (in shares)		6,900,000	5,400,000
Share-based compensation programs (in shares)		700,000	700,000
Treasury Stock retirement (in shares)			(6,000,000)
Common shares, held in treasury, ending balance (in shares)		8,300,000	(700,000)

Shareholders' Equity - Common_2

Shareholders' Equity - Common stock Dividends Declared (Details) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Equity [Abstract]
Dividends declared per share of Common Stock (usd per share)	$ 0.45	$ 0.40	$ 1.25	$ 0.80

Shareholders' Equity - Narrativ

Shareholders' Equity - Narrative (Details) - USD ($) $ in Millions		1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 12, 2024	Oct. 31, 2024	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Class of Stock [Line Items]
Remaining authorized repurchase amount			$ 382		$ 382
Common stock acquired - share repurchase (in shares)	1,061,853				6,900,000		5,400,000
Payment for share repurchases	$ 100		$ 172	$ 54	$ 520	$ 216
Preferred Stock, shares authorized (in shares)			100,000,000		100,000,000		100,000,000
Preferred Stock, amount of preferred dividends in arrears					$ 0
Subsequent Event
Class of Stock [Line Items]
Amount authorized for repurchase		$ 500
Common stock acquired - share repurchase (in shares)		997,994
Payment for share repurchases		$ 81

Shareholders' Equity - Share Re

Shareholders' Equity - Share Repurchases through Share Repurchase Agreements with Third Party Financial Institutions (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 12, 2024	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Equity [Abstract]
Payment	$ 100	$ 172	$ 54	$ 520	$ 216
Initial Shares Delivered (in shares)	1,061,853			6,900,000		5,400,000

Shareholders' Equity - Repurcha

Shareholders' Equity - Repurchases Pursuant to 10b5-1 Plans and Open Market Repurchases (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Equity [Abstract]
Shares of common stock	5,811,158	3,107,195
Payment	$ 415	$ 216

Shareholders' Equity - Preferre

Shareholders' Equity - Preferred Stock (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Class of Stock [Line Items]
Aggregate (in shares)	$ 16		$ 37
Preferred Stock
Class of Stock [Line Items]
Preferred Stock, shares issued (in shares)	625,000		625,000		625,000
Preferred Stock, shares outstanding (in shares)	625,000		625,000		625,000
Series A Preferred Stock
Class of Stock [Line Items]
Dividend rate, percentage			7.758%
Preferred Stock, shares issued (in shares)	325,000		325,000		325,000
Preferred Stock, shares outstanding (in shares)	325,000		325,000		325,000
Per Share (usd per share)	$ 38.790	$ 30.625	$ 77.580	$ 61.250
Aggregate (in shares)	$ 13	$ 10	$ 25	$ 20
Series B Preferred Stock
Class of Stock [Line Items]
Dividend rate, percentage			5.35%
Preferred Stock, shares issued (in shares)	300,000		300,000		300,000
Preferred Stock, shares outstanding (in shares)	300,000		300,000		300,000
Per Share (usd per share)	$ 13.375	$ 13.375	$ 40.125	$ 40.125
Aggregate (in shares)	$ 4	$ 4	$ 12	$ 12

Earnings per Common Share (Deta

Earnings per Common Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Net income (loss) available to common shareholders:
Net income (loss)	$ 98	$ 246	$ 621	$ 610
Less: Preferred stock dividends	16	14	37	32
Less: Net income (loss) attributable to noncontrolling interest	(16)	(16)	51	107
Net income (loss) available to Voya Financial, Inc.'s common shareholders	$ 98	$ 248	$ 533	$ 471
Weighted average common shares outstanding
Basic (in shares)	98.2	105.8	100.2	102.2
Dilutive Effects:
Diluted (in shares)	100.4	108.4	102.4	109.3
Net income (loss) available to Voya Financial, Inc.'s common shareholders per common share:
Basic (usd per share)	$ 1	$ 2.35	$ 5.32	$ 4.62
Diluted (usd per share)	$ 0.98	$ 2.29	$ 5.20	$ 4.31
Warrants
Dilutive Effects:
Dilutive Effects (in shares)	0	0	0	4.3
RSUs
Dilutive Effects:
Dilutive Effects (in shares)	1.1	1.1	1.1	1.1
PSUs
Dilutive Effects:
Dilutive Effects (in shares)	0.7	1.1	0.7	1.2
Stock options
Dilutive Effects:
Dilutive Effects (in shares)	0.4	0.4	0.4	0.5

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) - Components of AOCI (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Fixed maturities, net of impairment	$ (1,648)		$ (3,881)
Derivatives	34		100
Change in current discount rate	(838)		(850)
Deferred income tax asset (liability)	638		1,096
Total	(1,814)		(3,535)
Pension and other postretirement benefits liability, net of tax	2		2
AOCI	(1,812)	$ (2,400)	$ (3,533)
Other Contract
Accumulated Other Comprehensive Income (Loss) [Line Items]
Portion of AOCI expected to be reclassified into earnings within next 12 months	$ 12

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Income (Loss) - Changes in AOCI, including Reclassification Adjustments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Available-for-sale securities, Before-Tax Amount:
Fixed maturities	$ 1,047	$ (937)	$ 717	$ (619)
Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations	(20)	18	4	32
Change in unrealized gains/losses on available-for-sale securities	1,027	(919)	721	(587)
Available-for-sale securities, Income Tax:
Fixed maturities	(219)	197	(151)	130
Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations	4	(4)	(1)	(7)
Change in unrealized gains/losses on available-for-sale securities	(215)	193	(152)	123
Available-for-sale securities, After-Tax Amount:
Fixed maturities	828	(740)	566	(489)
Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations	(16)	14	3	25
Change in unrealized gains/losses on available-for-sale securities	812	(726)	569	(464)
Derivatives, Before-Tax Amount:
Derivatives	(28)	7	(17)	(11)
Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations	(4)	(4)	(12)	(14)
Change in unrealized gains/losses on derivatives	(32)	3	(29)	(25)
Derivatives, Income Tax:
Derivatives	6	(2)	4	2
Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations	1	1	3	3
Change in unrealized gains/losses on derivatives	7	(1)	7	5
Derivatives, After-Tax Amount:
Derivatives	(22)	5	(13)	(9)
Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations	(3)	(3)	(9)	(11)
Change in unrealized gains/losses on derivatives	(25)	2	(22)	(20)
Change in current discount rate, before-tax amount	(20)	(23)	52	7
Change in current discount rate, income tax	4	5	(11)	(1)
Change in current discount rate, after-tax amount	(16)	(18)	41	6
Other comprehensive income (loss), before tax	975	(939)	744	(605)
Other comprehensive income (loss), tax	(204)	197	(156)	127
Other comprehensive income (loss), after tax	$ 771	$ (742)	$ 588	$ (478)

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	$ 542	$ 491	$ 1,589	$ 1,462
Revenue from other sources	101	79	270	210
Total fee income and other revenue	643	570	1,859	1,672
Net receivables	339		339		$ 339
Wealth Solutions
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	163	125	463	369
Wealth Solutions | Distribution and shareholder servicing
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	34	29	100	88
Investment Management
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	248	236	732	698
Investment Management | Distribution and shareholder servicing
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	40	36	119	100
Health Solutions
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	7	4	19	15
Benefitfocus
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	50	53	154	167
Corporate
Disaggregation of Revenue [Line Items]
Total financial services and software subscriptions and services revenue	$ 0	$ 8	$ 2	$ 25

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Net Investment Income [Line Items]
Effective tax rate	15.50%	(43.00%)	8.50%	(5.90%)
Income tax expense (benefit)	$ 18	$ (74)	$ 58	$ (34)
Unrealized gains (losses) on securities	$ 995	$ (916)	692	(612)
SLD
Net Investment Income [Line Items]
Income tax expense (benefit)			$ (38)	$ (92)

Financing Agreements - Schedule

Financing Agreements - Schedule of Long-term Debt (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Mar. 17, 2015
Debt Instrument [Line Items]
Long-term debt	$ 2,500	$ 2,098
Less: Current portion of long-term debt	397	1
Total long-term debt, excluding current portion	2,103	2,097
Senior Notes
Debt Instrument [Line Items]
Annual interest rate on debt			1.875%
Senior Notes | 3.976% Senior Notes, Due 2025
Debt Instrument [Line Items]
Long-term debt	$ 397	390
Annual interest rate on debt	3.976%
Senior Notes | 3.65% Senior Notes, due 2026
Debt Instrument [Line Items]
Long-term debt	$ 446	446
Annual interest rate on debt	3.65%
Senior Notes | 5.0% Senior Notes, due 2034
Debt Instrument [Line Items]
Long-term debt	$ 395	0
Annual interest rate on debt	5%
Senior Notes | 5.7% Senior Notes, due 2043
Debt Instrument [Line Items]
Long-term debt	$ 396	396
Annual interest rate on debt	5.70%
Senior Notes | 4.8% Senior Notes, due 2046
Debt Instrument [Line Items]
Long-term debt	$ 297	297
Annual interest rate on debt	4.80%
Junior Subordinated Notes | Four Point Seven Percent Fixed-to-Floating Rate Junior Subordinated Notes, due 2048 [Member]
Debt Instrument [Line Items]
Long-term debt	$ 336	336
Annual interest rate on debt	4.70%
Debentures | 7.63% Voya Holdings Inc. debentures, due 2026
Debt Instrument [Line Items]
Long-term debt	$ 139	139
Annual interest rate on debt	7.625%
Debentures | 6.97% Voya Holdings Inc. debentures, due 2036
Debt Instrument [Line Items]
Long-term debt	$ 79	79
Annual interest rate on debt	6.97%
Notes payable, other | 8.42% Equitable of Iowa Companies Capital Trust II Notes, due 2027
Debt Instrument [Line Items]
Long-term debt	$ 13	13
Annual interest rate on debt	8.42%
Loans payable | 1.00% Windsor Property Loan
Debt Instrument [Line Items]
Long-term debt	$ 2	$ 2
Annual interest rate on debt	1%

Financing Agreements - Narrativ

Financing Agreements - Narrative (Details) - USD ($)		9 Months Ended
	Mar. 17, 2015	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	May 03, 2023	May 01, 2023	May 16, 2013
Debt Instrument [Line Items]
Outstanding par amount of guaranteed debentures		$ 2,500,000,000		$ 2,098,000,000
Total fees associated with credit facilities		0	$ 0
Business agreement processing and operation services period	10 years
Put option face amount	$ 500,000,000	100,000,000
Maximum borrowing capacity		512,000,000
Outstanding borrowings		12,000,000
Revolving Credit agreement
Debt Instrument [Line Items]
Outstanding borrowings		0
Aetna Notes
Debt Instrument [Line Items]
Amount of letters of credit outstanding		12,000,000
Revolving Credit agreement
Debt Instrument [Line Items]
Maximum borrowing capacity		500,000,000
Minimum net worth required for compliance						$ 4,998,000,000
Senior Notes
Debt Instrument [Line Items]
Annual interest rate on debt	1.875%
Revolving Credit agreement
Debt Instrument [Line Items]
Amount of letters of credit outstanding		0
Outstanding borrowings		0
5.0% Senior Notes, due 2034 | Senior Notes
Debt Instrument [Line Items]
Debt instrument face amount		$ 400,000,000
Annual interest rate on debt		5%
Net proceeds		$ 397,000,000
Outstanding par amount of guaranteed debentures		395,000,000		0
3.976% Senior Notes, Due 2025 | Senior Notes
Debt Instrument [Line Items]
Debt instrument face amount		$ 400,000,000
Annual interest rate on debt		3.976%
Outstanding par amount of guaranteed debentures		$ 397,000,000		390,000,000
7.63% Voya Holdings Inc. debentures, due 2026 | Debentures
Debt Instrument [Line Items]
Annual interest rate on debt		7.625%
Outstanding par amount of guaranteed debentures		$ 139,000,000		139,000,000
6.97% Voya Holdings Inc. debentures, due 2036 | Debentures
Debt Instrument [Line Items]
Annual interest rate on debt		6.97%
Outstanding par amount of guaranteed debentures		$ 79,000,000		$ 79,000,000
Voya Holdings Debentures | Aetna Notes
Debt Instrument [Line Items]
Amount of collateral for credit facility		231,000,000
Amount of collateral deposited to a control account		219,000,000
Voya Holdings Debentures | Debentures
Debt Instrument [Line Items]
Outstanding par amount of guaranteed debentures		$ 218,000,000
Pre-Capitalized Trust | Senior Notes
Debt Instrument [Line Items]
Debt instrument face amount					$ 400,000,000
Annual interest rate on debt	3.976%
U.S. Treasuries
Debt Instrument [Line Items]
Debt instrument face amount					$ 400,000,000
5.65% Fixed-to-Floating Rate Junior Subordinated Note, due 2053
Debt Instrument [Line Items]
Annual interest rate on debt							5.65%
Short-term Debt | Revolving Credit agreement
Debt Instrument [Line Items]
Maximum borrowing capacity						$ 25,000,000

Financing Agreements - Credit F

Financing Agreements - Credit Facilities (Details) - USD ($) $ in Millions	Sep. 30, 2024	Mar. 31, 2024	Dec. 31, 2023
Line of Credit Facility [Line Items]
Capacity	$ 512
Utilization	12
Unused Commitment	500
Unsecured and Committed | Voya Financial, Inc.
Line of Credit Facility [Line Items]
Capacity	500
Utilization	0
Unused Commitment	500
Unsecured and Committed | Voya Financial, Inc. Three
Line of Credit Facility [Line Items]
Capacity	12	$ 12	$ 200
Utilization	12
Unused Commitment	$ 0

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Loss Contingencies [Line Items]
Impairment of right-of-use asset	$ 0	$ 0	$ 0	$ 14
Pledged Collateral	2,176		2,176		$ 1,956
Possible losses in excess of amounts accrued	100		100
Potential future loss	93		93
Federal Home Loan Bank | Line of Credit
Loss Contingencies [Line Items]
Non-putable funding agreements issued to FHLB	1,251		1,251		1,175
Pledged Collateral	$ 2,176		2,176		$ 1,956
Acquisition of mortgage loans
Loss Contingencies [Line Items]
Amount of purchase commitments			119
Purchase of limited partnership and private placement investments
Loss Contingencies [Line Items]
Amount of purchase commitments			1,169
Purchase of limited partnership and private placement investments | VOEs
Loss Contingencies [Line Items]
Amount of purchase commitments			$ 411

Commitments and Contingencies_2

Commitments and Contingencies - Restricted Assets (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Loss Contingencies [Line Items]
Fixed maturity collateral pledged to FHLB	$ 2,176	$ 1,956
FHLB restricted stock	65	64
Other fixed maturities-state deposits	40	37
Cash and cash equivalents	22	25
Total restricted assets	3,766	3,242
Collateral Pledged
Loss Contingencies [Line Items]
Securities pledged	1,463	1,160
Securities pledged as collateral
Loss Contingencies [Line Items]
Fair value of loaned securities	1,091	842
Securities pledged under repurchase agreements, carrying value	204	117
Securities Loaned
Loss Contingencies [Line Items]
Securities pledged as collateral	$ 168	$ 201

Consolidated and Nonconsolida_3

Consolidated and Nonconsolidated Investment Entities - Narrative (Details) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024 USD ($) entity fund CLO	Sep. 30, 2023 entity	Sep. 30, 2024 USD ($) CLO fund entity	Sep. 30, 2023 entity	Dec. 31, 2023 USD ($) fund CLO
Variable Interest Entity [Line Items]
Consolidated collateral loan obligations | CLO	7		7		5
Limited Partnerships life			10 years
Consolidated funds | fund	13		13		11
Noncontrolling interest	$ 1,665		$ 1,665		$ 1,685
Maximum borrowing capacity	512		512
Outstanding borrowings	$ 12		12
Fair value transfers			$ 0
Number of deconsolidated investment entities | entity	0	0	2	1
Consolidated Investment Entities
Variable Interest Entity [Line Items]
Maximum exposure to loss	$ 385		$ 385		316
VIE, Corporate Loan Investments | Senior secured corporate loans
Variable Interest Entity [Line Items]
Unpaid principal exceeds fair value, amount	$ 23		$ 23		$ 46
Default of collateral assets, percentage	1%		1%		1%
VIE, Corporate Loan Investments | Maximum | Senior secured corporate loans | SOFR, EURIBOR or PRIME
Variable Interest Entity [Line Items]
Loans receivable basis spread	8.80%		8.80%
VIEs
Variable Interest Entity [Line Items]
Investment in unconsolidated partnerships	$ 3,033		$ 3,033		$ 2,861
VIE, CLO Notes | Senior secured corporate loans
Variable Interest Entity [Line Items]
Weighted average maturity on debt			11 years
VIE, CLO Notes | Minimum | Senior secured corporate loans | SOFR or EURIBOR
Variable Interest Entity [Line Items]
Basis spread on notes			1%
VIE, CLO Notes | Maximum | Senior secured corporate loans | SOFR or EURIBOR
Variable Interest Entity [Line Items]
Basis spread on notes			8.80%
VIE, Private Equity Funds
Variable Interest Entity [Line Items]
Maximum borrowing capacity	1,308		$ 1,308		1,330
Renewal period for term loan			3 years
Outstanding borrowings	1,180		$ 1,180		1,198
VIE, Private Equity Funds | Minimum
Variable Interest Entity [Line Items]
Basis spread on notes			1.40%
VIE, Private Equity Funds | Maximum
Variable Interest Entity [Line Items]
Basis spread on notes			2.40%
Nonconsolidated VIEs
Variable Interest Entity [Line Items]
Amount of ownership interest in unconsolidated CLOs	454		$ 454		383
Excluding consolidated VIEs
Variable Interest Entity [Line Items]
Investment in unconsolidated partnerships	$ 1,736		$ 1,736		$ 1,621

Consolidated and Nonconsolida_4

Consolidated and Nonconsolidated Investment Entities - Fair Value Hierarchy (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
CLO notes	$ 1,123	$ 1,332
Measured at fair value on a recurring basis
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total assets	4,538	4,446
Total liabilities	1,123	1,332
Measured at fair value on a recurring basis | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	84	181
Corporate loans	1,345	1,404
Limited partnerships/corporations	3,033	2,861
Other investments	23
CLO notes	1,123	1,332
Measured at fair value on a recurring basis | VOEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	4
Limited partnerships/corporations	49
Measured at fair value on a recurring basis | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total assets	88	181
Total liabilities	0	0
Measured at fair value on a recurring basis | Level 1 | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	84	181
Corporate loans	0	0
CLO notes	0	0
Measured at fair value on a recurring basis | Level 1 | VOEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	4
Measured at fair value on a recurring basis | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total assets	1,345	1,404
Total liabilities	1,123	1,332
Measured at fair value on a recurring basis | Level 2 | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	0	0
Corporate loans	1,345	1,404
CLO notes	1,123	1,332
Measured at fair value on a recurring basis | Level 2 | VOEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	0
Measured at fair value on a recurring basis | Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total assets	23	0
Total liabilities	0	0
Measured at fair value on a recurring basis | Level 3 | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	0	0
Corporate loans	0	0
Other investments	23
CLO notes	0	0
Measured at fair value on a recurring basis | Level 3 | VOEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	0
Measured at fair value on a recurring basis | NAV
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total assets	3,082	2,861
Measured at fair value on a recurring basis | NAV | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Limited partnerships/corporations	3,033	$ 2,861
Measured at fair value on a recurring basis | NAV | VOEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Limited partnerships/corporations	$ 49

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Goodwill (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Goodwill [Roll Forward]
Goodwill, Beginning Balance	$ 748	$ 327
Additions from business combinations	0	421
Goodwill, Ending Balance	748
Wealth
Goodwill [Roll Forward]
Goodwill, Beginning Balance	17	17
Additions from business combinations	0	0
Goodwill, Ending Balance	17
Health Solutions
Goodwill [Roll Forward]
Goodwill, Beginning Balance	343	24
Additions from business combinations	0	319
Goodwill, Ending Balance	343
Investment Management
Goodwill [Roll Forward]
Goodwill, Beginning Balance	286	286
Additions from business combinations	0	0
Goodwill, Ending Balance	286
Corporate
Goodwill [Roll Forward]
Goodwill, Beginning Balance	102	0
Additions from business combinations	0	$ 102
Goodwill, Ending Balance	102
Corporate | Wealth
Goodwill [Roll Forward]
Goodwill, Ending Balance	72
Corporate | Health Solutions
Goodwill [Roll Forward]
Goodwill, Ending Balance	20
Corporate | Investment Management
Goodwill [Roll Forward]
Goodwill, Ending Balance	$ 10

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Other Intangible Assets (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Mar. 31, 2024	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Indefinite-life intangibles, Gross Carrying Amount	$ 350	$ 350
Finite-life intangibles, Gross Carrying Amount		1,262		$ 1,344
Finite-life intangibles, Accumulated Amortization		400		487
Finite-life intangibles, Net Carrying Amount		862		857
Amortization of intangible assets		70	$ 63
Gross Intangibles written off		$ 156
Contractual Rights
Finite-Lived Intangible Assets [Line Items]
Finite-life intangibles, Weighted Average Amortization Lives		15 years
Finite-life intangibles, Gross Carrying Amount		$ 153		153
Finite-life intangibles, Accumulated Amortization		20		11
Finite-life intangibles, Net Carrying Amount		$ 133		142
Customer Relationships
Finite-Lived Intangible Assets [Line Items]
Finite-life intangibles, Weighted Average Amortization Lives		17 years
Finite-life intangibles, Gross Carrying Amount		$ 325		325
Finite-life intangibles, Accumulated Amortization		141		128
Finite-life intangibles, Net Carrying Amount		$ 184		197
Trademarks
Finite-Lived Intangible Assets [Line Items]
Finite-life intangibles, Weighted Average Amortization Lives		8 years
Finite-life intangibles, Gross Carrying Amount		$ 15		15
Finite-life intangibles, Accumulated Amortization		3		2
Finite-life intangibles, Net Carrying Amount		$ 12		13
Computer software
Finite-Lived Intangible Assets [Line Items]
Finite-life intangibles, Weighted Average Amortization Lives		5 years
Finite-life intangibles, Gross Carrying Amount		$ 419		501
Finite-life intangibles, Accumulated Amortization		236		346
Finite-life intangibles, Net Carrying Amount		183		$ 155
Contractual Rights
Finite-Lived Intangible Assets [Line Items]
Indefinite-life intangibles, Gross Carrying Amount	$ 350	350
Accumulated amortization for intangibles written off		$ 156